WO2015060296A1 - Drug distribution assistance system - Google Patents

Drug distribution assistance system Download PDF

Info

Publication number
WO2015060296A1
WO2015060296A1 PCT/JP2014/077934 JP2014077934W WO2015060296A1 WO 2015060296 A1 WO2015060296 A1 WO 2015060296A1 JP 2014077934 W JP2014077934 W JP 2014077934W WO 2015060296 A1 WO2015060296 A1 WO 2015060296A1
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
information
distribution
time
drug
Prior art date
Application number
PCT/JP2014/077934
Other languages
French (fr)
Japanese (ja)
Inventor
和明 森
安岡 啓太
Original Assignee
株式会社湯山製作所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社湯山製作所 filed Critical 株式会社湯山製作所
Priority to JP2015509241A priority Critical patent/JP5773104B1/en
Publication of WO2015060296A1 publication Critical patent/WO2015060296A1/en

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/10Bar codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/30Printed labels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/40General identification or selection means by shape or form, e.g. by using shape recognition
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers

Definitions

  • the present invention relates to a drug distribution support system for supporting drug distribution work.
  • a packaging container such as a medicine package in which a medicine is packaged at each time of taking is collected for each of a plurality of users belonging to a predetermined medicine distribution group and accommodated in a delivery container such as a medicine bag.
  • a delivery destination such as a nursing care health facility for the elderly (hereinafter referred to as “old health facility”).
  • old health facility a nursing care health facility for the elderly
  • the technique which suppresses the mistake of putting the medicine package into the medicine bag by printing medicine bag identification information on the medicine package and the medicine bag is known as a conventional technique (see Patent Document 1).
  • An object of the present invention is to provide a drug distribution support system capable of suppressing human error in a drug distribution operation in which a plurality of dosers' packaging containers are collected at each time of taking and stored in a delivery container and delivered to a delivery destination. Is to provide.
  • the drug distribution support system includes first recording means, second recording means, and determination means.
  • the first recording means includes a packaging container used when a medicine taken by a single user is packaged at each dosage time, or a first recording medium attached to the packaging container, the dosage time and the first recording medium in advance.
  • the first medicine distribution information including the determined delivery destination identification information is recorded.
  • the second recording means is a delivery container used when accommodating the packaging containers of a plurality of users belonging to a predetermined medicine distribution group at the same dosage time or a second record attached to the delivery container.
  • the second medicine distribution information including the time of taking and predetermined delivery destination identification information is recorded on the medium.
  • the determination means reads the dosing time and the delivery destination identification information of the first medicine distribution information read from the packaging container or the first recording medium and the second reading from the delivery container or the second recording medium. It is determined whether the dosing time and the delivery destination identification information of the medicine distribution information match.
  • the packaging containers of a plurality of users are collectively stored in the delivery container for each taking time.
  • the medicine distribution support system further includes a notification unit that notifies the determination result of the determination unit. Thereby, the user can recognize the determination result of the determination means.
  • the determination means may receive the first medicine distribution information from all the packaging containers predetermined as the packaging containers accommodated in the same delivery container or the first recording medium of the packaging containers. It can be considered to determine whether or not it has been read. Thereby, it becomes possible to suppress the accommodation leakage of the said packaging container to the said delivery container.
  • the determination unit may include all of the delivery containers predetermined as delivery containers to be delivered simultaneously to delivery destinations corresponding to the same delivery destination identification information or the second recording medium of the delivery containers. It may be possible to further determine whether or not the 2-drug distribution information has been read. Thereby, it becomes possible to suppress the delivery omission of the delivery container to the delivery destination corresponding to the same delivery destination identification information.
  • the medicine distribution support system is configured to store the face image of each of the user corresponding to the user identification information and the first medicine distribution information is read from the packaging container. It is conceivable to further comprise display control means for reading out and displaying the face image of the user corresponding to the user identification information of the first medicine distribution information from the storage means.
  • the medicine delivery support system matches the delivery destination identification information of the second medicine delivery information read from the delivery container at the delivery destination and the delivery destination identification information corresponding to the delivery destination. It is also conceivable to further include a delivery destination determination means for determining Thereby, it is possible to suppress erroneous delivery of the delivery container to the delivery destination.
  • a pharmacy side terminal having a medication data output means capable of outputting medication data including the pharmacy side, and a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered and output from the pharmacy side terminal
  • a facility-side terminal having medicine distribution data input means capable of inputting the medicine distribution data.
  • the medicine distribution support system is based on prescription data used when a medicine is packaged in a packaging container at every time of taking the medicine.
  • a pharmacy side terminal having a medication data output means capable of outputting medication data including medication time and information on a user and a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered
  • a facility side terminal having medicine distribution data input means capable of inputting the medicine distribution data outputted from the pharmacy side terminal.
  • the facility-side terminal further includes prescription display means for displaying the relationship between each of the user and each of the taking times based on the medicine distribution data input by the medicine distribution data input means. .
  • prescription display means for displaying the relationship between each of the user and each of the taking times based on the medicine distribution data input by the medicine distribution data input means.
  • the prescription display means includes a first display processing means for displaying a first display screen for selecting the dosing time based on the medicine distribution data, and selection of the dosing time on the first selection screen. And a second display processing means for displaying a second display screen for displaying whether or not each of the users needs to dispense medicine at the time of taking the medicine. Thereby, the user who needs medicine distribution can be easily grasped
  • the second display processing means can display the second display screen for each medicine distribution group including a plurality of predetermined users. As a result, it is easier to confirm whether or not medicines are required at each time of taking the user for each medicine group than when the information on all the users is displayed on one second display screen. can do.
  • the first display processing means displays the necessity of the medicine distribution at each of the dose periods on the first display screen.
  • the medicine distribution operator can easily confirm the necessity of the medicine distribution for each time of taking, and the medicine distribution work is made efficient.
  • the second display processing means displays the medication status of the medication recipient in a preset display form.
  • the medicine distribution operator can grasp
  • the facility terminal further includes a medication completion input means for accepting an input operation for medication completion for each user displayed on the second display screen. Thereby, it becomes possible to easily confirm whether or not the medication has been completed for each user.
  • the facility-side terminal further includes a remaining medicine information output unit capable of receiving the remaining medicine information input operation regarding the remaining medicine that the user has not taken and can output the remaining medicine information.
  • a remaining medicine information output unit capable of receiving the remaining medicine information input operation regarding the remaining medicine that the user has not taken and can output the remaining medicine information.
  • the pharmacy side terminal can input the remaining medicine information input means that can input the remaining medicine information output from the remaining medicine information output means, the remaining medicine information input by the remaining medicine information input means, and the distribution. It is conceivable to further comprise a remaining medicine notification means capable of notifying information on available remaining medicine based on the medicine data. Thus, by using the remaining medicine indicated in the remaining medicine information, it is possible to suppress waste of medicine in the next dispensing.
  • the pharmacy side terminal can output the drug distribution data in units of a drug distribution group including a plurality of predetermined users. Furthermore, it is conceivable that the pharmacy side terminal can extract one or more preset items from the prescription data and output it as the medicine distribution data. Thereby, it is possible to easily use only necessary prescription data among the prescription data.
  • the drug distribution data includes information on side effects of the drug. Thereby, it is possible to easily refer to information on the drug side effects on the facility side where the drug is delivered.
  • the facility-side terminal further includes an alarm notification means for executing an alarm notification process for performing notification at an alarm time set in advance for each of the dose times. Thereby, the omission leak in each said dosing time is suppressed.
  • the facility-side terminal further includes an alarm setting means for executing an alarm setting process for automatically setting the alarm time according to a predetermined alarm condition for each of the dose times.
  • an alarm setting means for executing an alarm setting process for automatically setting the alarm time according to a predetermined alarm condition for each of the dose times.
  • the medicine distribution assistance system which can suppress the human error in the medicine distribution operation which collects the packaging container of several users for every taking time, accommodates in a delivery container, and delivers to a delivery destination. Is realized.
  • FIG. 1 is a block diagram showing a schematic configuration of a drug distribution support system according to an embodiment of the present invention.
  • FIG. 2 is a diagram showing an example of medicine distribution management information used in the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 3 is a flowchart showing an example of a flow of a drug distribution operation executed at a pharmacy where a drug distribution support system according to an embodiment of the present invention is installed and a delivery destination.
  • FIG. 4 is a schematic diagram illustrating an example of a flow of a drug distribution operation executed at a pharmacy where a drug distribution support system according to an embodiment of the present invention is installed and a delivery destination.
  • FIG. 1 is a block diagram showing a schematic configuration of a drug distribution support system according to an embodiment of the present invention.
  • FIG. 2 is a diagram showing an example of medicine distribution management information used in the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 3 is a flowchart showing an example of a flow of a drug distribution operation
  • FIG. 5 is a flowchart showing an example of a procedure of prescription data issuing processing executed in the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 6 is a diagram showing an example of packaging data generated by a prescription data issuing process executed by the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 7 is a diagram showing another example of the packaging data generated by the prescription data issuing process executed by the drug distribution support system according to the embodiment of the present invention.
  • FIG. 8 is a flowchart showing an example of the procedure of the medicine packaging process executed by the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 9 is a diagram showing an example of the packaging result of the medicine packaging process executed by the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 10 is a flowchart showing an example of a procedure of the collation process at the time of accommodation executed by the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 11 is a flowchart showing an example of a procedure of a delivery verification process executed by the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 12 is a flowchart showing an example of a procedure of a receiving collation process executed by the medicine distribution support system according to the embodiment of the present invention.
  • FIG. 13 is a flowchart which shows an example of the procedure of the collation process at the time of medicine distribution performed with the medicine distribution assistance system which concerns on embodiment of this invention.
  • FIG. 14 is a block diagram showing a schematic configuration of a drug distribution support system according to another embodiment of the present invention.
  • FIG. 15 is a diagram illustrating an example of a facility master and a resident master used in a drug distribution support system according to another embodiment of the present invention.
  • FIG. 16 is a diagram showing an example of a facility registration screen used in the drug distribution support system according to another embodiment of the present invention.
  • FIG. 17 is a diagram showing an example of a resident registration screen used in the drug distribution support system according to another embodiment of the present invention.
  • FIG. 18 is a flowchart showing an example of a procedure of prescription data issuing processing executed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 19 is a diagram showing an example of drug distribution data used in a drug distribution support system according to another embodiment of the present invention.
  • FIG. 16 is a diagram showing an example of a facility registration screen used in the drug distribution support system according to another embodiment of the present invention.
  • FIG. 17 is a diagram showing an example of a resident registration screen used in the drug distribution support system according to another embodiment of the present invention.
  • FIG. 18 is
  • FIG. 20 is a flowchart showing an example of a procedure of a matching process at the time of drug distribution executed by the drug distribution support system according to another embodiment of the present invention.
  • FIG. 21 is a diagram showing an example of an initial screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 22 is a diagram showing an example of an initial screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 23 is a diagram showing an example of a resident list screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 24 is a diagram showing an example of a resident list screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 21 is a diagram showing an example of an initial screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 22 is a diagram showing an example of an initial screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 23 is a diagram showing an example of a
  • FIG. 25 is a diagram showing an example of a resident confirmation screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 26 is a diagram showing an example of a non-medicine input screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 27 is a diagram showing an example of a schedule input screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 28 is a diagram showing an example of a side effect information input screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 29 is a diagram showing an example of a resident status screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 30 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 31 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 32 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 33 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 34 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 35 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention.
  • FIG. 36 is a diagram showing an example of the packaging result of the medicine packaging process executed by the medicine distribution support system according to another embodiment of the present invention.
  • a medicine distribution support system 10 includes a dispensing support apparatus 1, a reading terminal 2, a medicine packaging apparatus 3, a printer 4, a medicine distribution support apparatus 5, a portable terminal 6, And a reading terminal 7 and the like.
  • the dispensing support device 1, the reading terminal 2, the medicine packaging device 3, and the printer 4 are connected via a network N ⁇ b> 1 so that they can communicate wirelessly or by wire.
  • the said medicine distribution assistance apparatus 5, the said portable terminal 6, and the said reading terminal 7 are connected via the network N2 so that communication is possible by radio
  • the network N1 and the network N2 are a LAN, a WAN, the Internet, an intranet, or the like.
  • the dispensing support device 1, the reading terminal 2, the medicine packaging device 3, and the printer 4 are arranged in a pharmacy A where medicine dispensing is performed.
  • the said dispensing assistance apparatus 1 is an example of a pharmacy side terminal, the arrangement
  • positioning place may be the said pharmacy A outside as long as it can connect to the said network N1.
  • the medicine distribution support device 5, the portable terminal 6, and the reading terminal 7 are arranged in each of the old facilities B serving as delivery destinations of medicines dispensed in the pharmacy A.
  • the health facility B is a facility where a plurality of users who take medicines dispensed at the pharmacy A are resident.
  • the old health facility B is merely an example of a predetermined drug distribution group, and for example, a predetermined region including a home of a plurality of users or a delivery route is also an example of the drug distribution group.
  • the said medicine distribution assistance apparatus 5 is an example of a facility side terminal, if the arrangement place is connected to the said network N2 and can be used in the said health facility B, it will be outside the said health facility B. Also good.
  • the dispensing support device 1 also functions as the medicine distribution support device 5.
  • the medicine packaging device 3 is a dispensing device capable of dispensing a medicine in a medicine package 81 (see FIG. 4) at every dose based on prescription data input from the dispensing support device 1.
  • the medicine packing device 3 is a tablet packing machine for packing tablets or a powder packing machine for packing powder.
  • the tablet packaging machine has a plurality of drug cassettes containing a plurality of types of tablets, dispenses tablets from the drug cassette according to prescription data, and packs them in the drug package 81 at each time of taking. Perform the action.
  • the powder medicine packaging machine performs a packaging operation of packaging the powdered medicine in the medicine pack 81 at each dose according to prescription data.
  • the medicine package 81 used for these packaging operations is an example of a packaging container. Furthermore, the structure in which the said tablet packaging machine or the said powder medicine packaging machine can pack a tablet and powder medicine for every taking time is also considered.
  • the medicine package 81 is formed by heating and melting a part of a continuous long medicine package sheet provided in the medicine packaging device 3. A perforation is formed between them for easy separation.
  • the medicine packaging apparatus 3 includes a control unit 31 that controls the medicine packaging apparatus 3 and a packaging printer 32 that prints information on the medicine package 81.
  • the control unit 31 includes a CPU, a ROM, a RAM, and the like.
  • the packaging printer 32 takes a medicine ID (an example of a person identification information) indicating a medicine person taking a medicine contained in the medicine package 81 in the medicine package 81.
  • the first medicine distribution information including the timing of taking medicines contained in the medicine package 81 and predetermined delivery destination identification information is printed.
  • the delivery destination identification information is information such as a delivery destination ID or a delivery destination name indicating the health facility B in which a medicine taker of the medicine package 81 is occupying, and is registered in a later-described taker master. Yes.
  • a number for example, a two-digit number
  • a dose time code predetermined for each dose time or a pictogram indicating the dose time, etc. It is also conceivable that the image is printed on the medicine bag 81.
  • the number of the timing code may be printed as characters, but when the medicine packaging device 3 has a function of printing the pictogram, the control unit 31 uses the function, It is also conceivable to print an image registered in advance as a numeric image of the dosing time code instead of the pictogram. Thereby, in the existing system, it is possible to print the number of the dosing time code on the medicine package 81.
  • a code 811 such as a one-dimensional code or a two-dimensional code indicating the first medicine distribution information is printed on the medicine package 81 by the packaging printer 32.
  • the controller 31 when the first medicine distribution information is printed on the medicine package 81 using the packaging printer 32 is an example of a first recording unit.
  • the first medicine distribution information is printed on a first recording medium such as a label attached to the medicine package 81.
  • a first recording medium such as an IC tag is attached to the medicine package 81.
  • the medicine packaging device 3 includes recording means such as an IC reader / writer that records the first medicine distribution information on the first recording medium is conceivable.
  • the medicine packaging device 3 includes a medicine-specific packaging process in which a medicine taken by a single user is continuously packaged in a series of the medicine packs 81 at each time of taking, and a predetermined medicine distribution. It is possible to perform a time-specific packaging process in which medicines taken by a plurality of users belonging to a group are arranged at each time of taking and are continuously packaged in the series of medicine packages 81.
  • the code 811 is printed on each medicine package 81 by the packaging printer 32, regardless of whether the user-specific packaging process or the time-based packaging process is performed. .
  • the series of medicine packages 81 may be delivered without being separated, so that only the first or last medicine package 81 is delivered by the packaging printer 32. It is also conceivable as another embodiment that the code 811 is printed. In this case, in the collation process at the time of accommodation (see FIG. 10) described later, the first medicine distribution information printed on the first or last medicine pack 81 among the medicine packs 81 connected at each time of taking is collated. It becomes a target.
  • the printer 4 has a medicine bag 82 (an example of a delivery container: see FIG. 4) used when storing the medicine packs 81 of a plurality of users belonging to a predetermined medicine distribution group at the same time of administration. It is used for printing information on a label 821 (an example of a second recording medium: see FIG. 4) affixed to. Specifically, according to the control instruction from the dispensing support device 1, the printer 4 uses the label 821 to take a dose corresponding to the medicine pack 81 contained in the medicine bag 82 and predetermined delivery destination identification information. 2nd medicine distribution information including is printed (recorded). In particular, the printer 4 prints on the label 821 a code 822 (see FIG.
  • the label 821 is attached to the medicine bag 82 for use.
  • the delivery destination identification information is information indicating the health facility B in which a medicine taker of the medicine package 81 is occupying, and is registered in advance in a later-described taker master.
  • the label 821 is an example of a unit for recording the second medicine distribution information on the medicine bag 82, and the printer 4 may directly print the second medicine information on the medicine bag 82.
  • a second recording medium such as an IC tag is attached to the medicine bag 82.
  • the dispensing support device 1 includes a recording unit such as an IC reader / writer that records the second medicine distribution information on the second recording medium is conceivable.
  • the printer 4 is also used for printing a prescription corresponding to the prescription data in accordance with the print data received from the dispensing support device 1.
  • the dispensing support device 1 is a personal computer including a control unit 11, a data storage unit 12, a communication interface 13, a display device 14, an operation device 15, a drive device 16, and the like.
  • the single unit of the dispensing support device 1 may be regarded as a drug distribution support system according to the present invention.
  • the dispensing support apparatus 1 is connected to a host system (not shown) such as an electronic medical record system or a prescription input terminal for inputting prescription data to the dispensing support apparatus 1 via the network N1.
  • a host system not shown
  • the structure which can input prescription data using the said operating device 15 in the said dispensing assistance apparatus 1 is also considered.
  • the control unit 11 includes a CPU, a ROM, a RAM, and the like.
  • the CPU is a processor that controls the dispensing support device 1 by executing processing according to various control programs.
  • the ROM is a non-volatile memory in which programs such as BIOS executed by the CPU are stored in advance.
  • the RAM is a volatile memory or a non-volatile memory used for development of various control programs and temporary storage of data by the CPU.
  • the data storage unit 12 is a non-volatile storage unit such as a hard disk or an SSD that stores various application programs and various data executed by the control unit 11. Specifically, the data storage unit 12 includes a prescription data issuing process (see FIG. 5), a collation process at the time of accommodation (see FIG. 10), a collation process at the time of delivery (see FIG. 11), etc. A dispensing support program for execution is stored.
  • control unit 11 functions as the second recording unit 111, the determination unit 112, and the first notification unit 113 by executing various processes according to the dispensing support program.
  • control unit 11 when functioning as the second recording unit 111, the determination unit 112, and the first notification unit 113 is an example of a second recording unit, a determination unit, and a first notification unit.
  • the second recording unit 111 is used to store the medicine packs 81 of a plurality of users belonging to the predetermined health facility B (medicine distribution group) at the same dosage time using the printer 4.
  • the code 822 which is the second medicine distribution information including the time of taking and the delivery destination identification information of the health facility B is printed (recorded).
  • the determination unit 112 includes the time of taking the first medicine distribution information read from the medicine package 81 and the delivery destination identification information and the time of taking the second medicine information read from the medicine bag 82 and the delivery destination. It is determined whether or not the identification information matches.
  • the reading terminal 2 reads the first medicine distribution information and the second medicine distribution information.
  • the first notification unit 113 notifies the determination result of the determination unit 112. For example, the first notification unit 113 causes the reading terminal 2 or the display device 14 to display whether the determination result of the determination unit 112 is the same. Note that the first notification unit 113 may display an error message only when the determination result of the determination unit 112 does not match.
  • the data storage unit 12 also stores various databases such as a medicine master, a user master, a pharmacist master, a prescription division master, a medical department master, and a ward master.
  • the medicine master includes a medicine code, a medicine name, a JAN code (or RSS), a medicine bottle code, a classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), specific gravity, kind of medicine (ordinary medicine, Information on poisoning, narcotics, powerful drugs, antipsychotics, therapeutics, etc.), formulation changes, excipients, and precautions.
  • the drug master includes side effect related information regarding side effects that may occur for each drug.
  • the control unit 11 can select the drug that is likely to cause the side effect as the side effect related information and the prescription data. It is also possible to execute a suspected drug identifying process that identifies based on the above.
  • the taker master includes the taker ID, name, gender, age, address, medical history, family information, medical department, and hospital ward, along with the health facility B of the tenant. Information such as delivery destination identification information is included.
  • the said taker is a concept including a resident who lives in the old health facility B and a patient who receives medical care at a medical institution.
  • the data storage unit 12 includes a prescription data storage unit 121 and a medicine distribution management information storage unit 122.
  • the prescription data storage unit 121 stores the prescription data acquired from the host system (not shown) in a database format.
  • the prescription data includes, for example, prescription delivery date, order number, prescription classification, BCD, user ID, user name, user birth date, drug information (drug code, drug name, dose, etc.), dosage form Information such as information (internal use, external use, etc.), usage information (including time of taking), medical treatment type (outpatient, hospitalization, etc.), medical department, etc. are included.
  • the medicine distribution management information storage unit 122 stores medicine distribution management information D1 in which delivery destination identification information, dosage time, and user identification information are associated with each other.
  • FIG. 2 is a diagram showing an example of the medicine distribution management information D1. As shown in FIG. 2, in the medicine distribution management information D1, the delivery date, the delivery destination ID and the name of the old facility B, which is the delivery destination identification information, the time of taking, and the user identification information are shown. The user ID and name are stored in association with each other.
  • the control unit 11 generates the medicine distribution management information D1 based on prescription data of a plurality of users input from the host system (not shown) and the user master.
  • the information corresponding to the taking time for one day is shown, However, It is not limited to this.
  • the control unit 11 generates the medicine distribution management information D1 corresponding to an arbitrary predetermined period of time that is simultaneously delivered from the pharmacy A to the health facility B, such as for a plurality of days or a week. .
  • the said medicine distribution management information D1 shown in FIG. 2 although the case where two old health facilities B1 and old health facilities B2 are registered as the said old health facilities B is mentioned as an example, one or three or more The old health facility B may be registered in advance as a delivery destination. Furthermore, in the present embodiment, the case where the health facility B is set as one medicine distribution group will be described. For example, in the health facility B, a room or a floor in which a plurality of users are occupying is arranged. It can also be set as a medicine group.
  • the communication interface 13 is a network that performs data communication between the reading terminal 2, the medicine packaging device 3, and the printer 4 via the network N1 in a wireless or wired manner according to a predetermined communication protocol. Have cards etc.
  • the display device 14 is a display unit such as a liquid crystal display or an organic EL display that displays various types of information in accordance with control instructions from the control unit 11.
  • the operation device 15 is an operation means operated by a user in order to input various information to the dispensing support device 1. Specifically, the operation device 15 includes a keyboard and a mouse (pointing device) that accept input operations of various information according to the display screen of the display device 14.
  • the drive device 16 can read the dispensing support program from a computer-readable recording medium 17 on which the dispensing support program is recorded.
  • the recording medium 17 is a CD, DVD, BD, USB memory or the like.
  • the dispensing support program read by the drive device 16 from the recording medium 17 is installed in the data storage unit 12 by the control unit 11.
  • the reading terminal 2 is a reading means such as a barcode reader for reading the first medicine distribution information and the second medicine distribution information from the code 811 and the code 822 attached to the medicine bag 81 and the medicine bag 82. is there.
  • the first medicine distribution information and the second medicine distribution information read by the reading terminal 2 are input to the dispensing support device 1.
  • the reading terminal Reference numeral 2 denotes reading means such as an IC reader / writer for reading information from the first recording medium or the second recording medium.
  • the reading terminal 2 may be a portable terminal such as a mobile phone, a smartphone, a PDA, a media player, or a tablet terminal as long as it can read information from the code 811 and the code 822.
  • the medicine distribution support device 5 is a personal computer including a control unit 51, a data storage unit 52, a communication interface 53, a display device 54, an operation device 55, a drive device 56, and the like.
  • the control unit 51 includes a CPU, a ROM, a RAM, and the like.
  • the CPU is a processor that controls the medicine distribution support device 5 by executing processing according to various control programs.
  • the ROM is a non-volatile memory in which programs such as BIOS executed by the CPU are stored in advance.
  • the RAM is a volatile memory or a non-volatile memory used for development of various control programs and temporary storage of data by the CPU.
  • the data storage unit 52 is a non-volatile storage unit such as a hard disk or an SSD that stores various application programs and various data executed by the control unit 51. Specifically, in the data storage unit 52, there is a medicine distribution support program for causing the control unit 51 to execute a later-described receipt-time verification process (see FIG. 12), a drug-delivery verification process (see FIG. 13), and the like. It is remembered.
  • control unit 51 functions as a display control unit 511, a delivery destination determination unit 512, and a second notification unit 513 by executing various processes according to the medicine distribution support program.
  • control unit 51 when functioning as the display control unit 511, the delivery destination determination unit 512, and the second notification unit 513 is an example of a display control unit, a delivery destination determination unit, and a second notification unit. is there.
  • the display control section 511 displays the face image of the user corresponding to the user ID of the first medicine distribution information in the data storage section 52. Read from and display. Specifically, the display control unit 511, when the first medicine distribution information is read by the portable terminal 6, based on a resident master described later stored in the master storage unit 521, the user Are displayed on the portable terminal 6.
  • the delivery destination determination unit 512 determines whether or not the delivery destination identification information of the second medicine distribution information read from the medicine bag 82 at the delivery destination matches the delivery destination identification information corresponding to the delivery destination. judge. That is, the delivery destination determination unit 512 determines whether or not the delivery destination is correct as a delivery destination to which the medicine bag 82 should be delivered.
  • the second notification unit 513 notifies the determination result by the delivery destination determination unit 512.
  • the second notification unit 513 may cause the display device 54 or the reading terminal 7 to display whether the determination result of the delivery destination determination unit 512 matches.
  • the second notification unit 513 may display an error message only when the determination result of the delivery destination determination unit 512 does not match.
  • the data storage unit 52 includes a master storage unit 521 and a conversion information storage unit 522.
  • the master storage unit 521 stores a resident master including information such as a resident ID, a resident name, a face image, a medical history, or a medical history about the resident who is in the health facility B.
  • the face image is registered in advance as an image such as a facial photograph or a portrait showing the resident's appearance.
  • conversion information predetermined in order to realize compatibility between the user master managed in the pharmacy A and the tenant master managed in the health facility B is stored. It is remembered.
  • the conversion information is information indicating a correspondence relationship between the user ID and the resident ID.
  • the taker ID in the taker master is a combination of the delivery destination identification information corresponding to the health facility B and the resident ID.
  • the said control part 51 converts the said user ID in the said user master managed in the said pharmacy A into the said resident ID based on the said conversion information. Is possible. Therefore, in the medicine distribution support system 10, the system on the pharmacy A side and the system on the health facility B side can be separated from each other, and the information on the resident master on the health facility B side is obtained as described above. There is no need to tell pharmacy A.
  • the communication interface 53 includes a network card or the like that performs data communication with the dispensing support device 1 or the like via the network N1 in a wireless or wired manner according to a predetermined communication protocol.
  • the display device 54 includes a display unit such as a liquid crystal display or an organic EL display that displays various types of information according to a control instruction from the control unit 51, a speaker that outputs sound according to the control instruction from the control unit 51, and the like. It is an example of a terminal display means.
  • the operation device 55 is an operation means operated by a user in order to input various information to the medicine distribution support device 5. Specifically, the operation device 55 includes a keyboard and a mouse (pointing device) that accept input operations of various information according to the display screen of the display device 54.
  • the drive device 56 can read the medicine distribution support program from a computer-readable recording medium 57 in which the medicine distribution support program is recorded.
  • the recording medium 57 is a CD, DVD, BD, USB memory or the like.
  • the medicine distribution support program read by the drive device 56 from the recording medium 57 is installed in the data storage unit 52 by the control unit 51.
  • the mobile terminal 6 is, for example, a mobile phone, a smart phone, a PDA, a media player, or a tablet terminal. In the old health facility B, the mobile terminal 6 distributes the medicine pack 81 accommodated in the medicine bag 82 to a user. Carried by a pharmacist.
  • the portable terminal 6 includes a control unit 61 and a camera 62.
  • the control unit 61 includes a CPU, a RAM, a ROM, and the like, and controls the portable terminal 6. In the mobile terminal 6, various processes are executed by the control unit 61 according to an application program installed in advance.
  • the camera 62 is a photographing means for photographing an image or a video.
  • the control unit 61 has a code reading function for reading a one-dimensional code or a two-dimensional code included in an image or video captured by the camera 62.
  • the portable terminal 6 can read information from a one-dimensional code or a two-dimensional code printed on the medicine package 81 and the medicine bag 82 using the code reading function. Then, the control unit 61 transmits information read using the camera 62 to the medicine distribution support device 5.
  • the mobile terminal 6 also includes a display unit that displays various types of information and an operation unit that receives various types of operations.
  • the reading terminal 7 is a reading means such as a barcode reader that reads information from a one-dimensional code or a two-dimensional code printed on the medicine package 81 or the medicine bag 82, as in the case of the reading terminal 2. Information read by the reading terminal 7 is input to the medicine distribution support device 5. When a recording medium such as an IC tag is attached to the medicine package 81 or the medicine bag 82, the reading terminal 7 is a reading means such as an IC reader / writer that reads information from the recording medium.
  • the portable terminal 6 can be used as the reading terminal 7 and the reading terminal 7 can be omitted.
  • FIG. 4 is a diagram schematically showing a flow of the medicine distribution work when medicine is delivered from the pharmacy A to the health facility B1 and the health facility B2, which are examples of the health facility B.
  • Step S1> First, in the dispensing support device 1, the control unit 11 selects the old health facility B that delivers medicine in response to a user operation of the operating device 15 and issues prescription data corresponding to the old health facility B. A prescription data issuing process is executed (S1).
  • Step S2> And in the said dispensing assistance apparatus 1, the said control part 11 produces
  • step S2 in the medicine packaging device 3, the control unit 31 uses the packaging printer 32 to generate the code 811 indicating the first medicine distribution information as shown in FIG.
  • the medicine package 81 is printed.
  • the first medicine distribution information includes the user ID, the time of taking, and the delivery destination identification information.
  • the medicine package 81 is also printed with the name of the user, the date and time of taking, and the time of taking.
  • the control unit 11 uses the printer 4 to label the code 822 indicating the second medicine distribution information on the medicine bag 82 as shown in FIG. To print.
  • the second medicine distribution information includes the dose time and the delivery destination identification information.
  • the medicine bag 82 is also printed with the name of the old facility, the date and time of taking, and the time of taking.
  • Step S3 When the dispensing operation by the medicine packaging device 3 is completed, the pharmacist in charge of inspection subsequently inspects the medicine dispensed by the medicine packaging device 3 (S3).
  • the inspection it is also conceivable for the inspection to use an image inspection system that images the medicine dispensed by the medicine packaging device 3 and automatically inspects based on the captured image. For example, when the time-specific packaging process is executed in the medicine packaging process, the image inspection system divides the images of the medicine packages 81 arranged for each taking time in units of health facilities, An inspection image arranged for each dose time in units of users is generated. Then, the image inspection system inspects the medicine dispensed by the medicine packaging device 3 based on the inspection image.
  • Step S4> the person in charge of delivery accommodates each of the medicine packs 81 to be delivered to each of the health facilities B in the medicine bag 82 corresponding to the time of taking the medicine pack 81 and the delivery destination ( S4).
  • the delivery person uses the reading terminal 2 to read the first medicine distribution information and the second medicine distribution information from the medicine bag 81 and the medicine bag 82, respectively.
  • the control part 11 of the said dispensing management apparatus 1 determines whether the said 1st medicine distribution information and the said 2nd medicine distribution information correspond in the below-mentioned accommodation time collation process.
  • Step S5> the delivery person delivers each medicine bag 82 to the delivery destination (S5).
  • the delivery person uses the reading terminal 2 to read the second medicine distribution information from each medicine bag 82.
  • the control part 11 of the said dispensing management apparatus 1 determines whether the said medicine bag 82 which should be delivered to the said delivery destination has a leak in the below-mentioned collation process at the time of delivery.
  • Step S6> in each of the old health facilities B, when each medicine bag 82 is received from the pharmacy A, a person in charge of medicine distribution reads the second medicine information from the code 822 of the medicine bag 82 using the reading terminal 7. (S6).
  • the control part 51 of the said medicine distribution assistance apparatus 51 is the delivery of the said health facility B where the delivery destination identification information contained in the said 2nd medicine distribution information and the said reading terminal 7 are arrange
  • Step S7> the person in charge of medicine at the health facility B dispenses each medicine package 81 contained in the medicine bag 82 corresponding to the time of taking the medicine to the resident at every time of taking (S7).
  • the medicine packs 81 of a plurality of users are collectively stored in the medicine bag 82 for each time of taking, in the old facility B as a delivery destination, for each time of taking
  • the medicine bags 81 of a plurality of users can be taken out from the medicine bag 82 and can be easily administered to each user.
  • step S ⁇ b> 7 the person in charge of medicine distribution reads the first medicine information from each medicine package 81 using the portable terminal 6.
  • the face image 63 is read from the user information storage unit 521 of the data storage unit 52 and displayed on the portable terminal 6.
  • step S ⁇ b> 11 the control unit 11 determines whether or not a prescription data issuing operation has been performed for one or a plurality of the healthy facilities B. Specifically, the control unit 11 selects one or a plurality of the health facilities B according to a user operation of the operation device 15 in the dispensing support device 1, and issues a prescription data issue operation for each of the health facilities B. Accept.
  • the prescription data issuance operation is performed (S11: Yes)
  • the process proceeds to step S12.
  • the prescription data issuance operation is performed (S11: No)
  • the process waits in step S11.
  • step S12 the control unit 11 divides the prescription data of each of the users belonging to each of the old-age facilities B into pieces of package data obtained by disassembling and arranging them for each old-age facility belonging to the user. Generate.
  • the control unit 11 For example, as shown in FIG. 6, the control unit 11 generates group prescription data obtained by grouping prescription data of a plurality of users belonging to “old health facility B1” and “old health facility B2”. Thereafter, as shown in FIG. 7, the control unit 11 arranges prescription data corresponding to each user belonging to “health care facility B1” and “health care facility B2” for each taking time based on the group prescription data. Generate the replaced parcel data.
  • the packaging data includes data (empty data) indicating that a user who does not have a medicine corresponding to the time of taking does not.
  • step S ⁇ b> 13 the control unit 11 outputs the packaging data to the medicine packaging device 3.
  • the medicine packaging process (refer FIG. 8) mentioned later according to the said packaging data is performed.
  • the said medicine packaging apparatus 3 it is possible to perform the packaging operation according to the said packaging data by reading the said packaging data from the said printed paper with a Harcode reader etc.
  • step S21 the control unit 31 waits for input of the packaging data from the dispensing support device 1 (S21: No). When it is determined that the packaging data has been input (S21: Yes), the control unit 31 shifts the process to step S22.
  • step S22 the control unit 31 sets the first healthy facility B1 in the packaging data as a packaging target. Specifically, when the packaging data shown in FIG. 7 is input, the control unit 11 sets “healthy facility B1” as a packaging target in the first step S22. And when said step S22 is performed after the 2nd time, the said control part 11 will set the said 2nd or later hospital room in order as a packaging object. That is, when the packaging data shown in FIG. 7 is input, the control unit 31 sets “old health facility B2” as a packaging target in the second step S22.
  • step S23 the control unit 31 starts packaging using the first dose corresponding to the health facility B selected as the packaging target in step S22 in the packaging data as the packaging target. .
  • the control unit 31 takes the “Departure of ⁇ month ⁇ day after breakfast” of “healthy facility B1” in the first step S23. Start the packaging with the target of packaging. And when said step S23 is performed after the 2nd time, the said control part 31 will start the packaging as a packaging object in order about the said 2nd and subsequent dosing time. That is, when the packaging data shown in FIG. 7 is input, the control unit 31 determines the taking time of “ ⁇ month ⁇ day after lunch” of “healthy facility B1” in the second step S23. Start packaging as the target of packaging.
  • FIG. 9A is a diagram showing an example of the packaging result when the medicine packaging process is executed based on the packaging data shown in FIG.
  • the packaging result shown in FIG. 9 (A) medicines taken by a plurality of users belonging to the same old facility B are continuously packaged at every time of taking.
  • the medicine packs 81 corresponding to the users “Ichiro Yuyama”, “Jiro Yuyama”, and “Saburo Yuyama” of the health facility B1 are consecutive after every month after breakfast, lunch, and after dinner. Is formed.
  • the next day ⁇ month ⁇ day is also packaged in the same manner.
  • the package data includes information (type, time of use, etc.) of non-packaged medicines such as eye drops, liquids, or external medicines that are not packaged in the package 81
  • the package data includes It is conceivable that information on the medicine outside the package is included in addition to the data on the medicine packaged by the medicine packaging device 3.
  • the control unit 31 displays information such as the fact that the medicine outside the packaging is present in the medicine package 81 corresponding to the use time of the medicine outside the packaging and the contents of the medicine outside the packaging and the pictogram. It is possible to print with (image). Thereby, the presence of the medicine outside the package can be easily grasped when the medicine package 81 is dispensed, and forgetting to use the medicine outside the package can be suppressed.
  • the control unit 31 outputs the medicine package 81 that is empty, and the medicine outside the package contains the medicine package 81. It is conceivable to print information such as the presence and contents of the unpackaged medicine in characters or pictograms (images). Thereby, even when there is the unpackaged medicine to be used at a time different from the time when the medicine package 81 is taken, the presence of the unpackaged medicine can be easily grasped by referring to the medicine package 81. And forgetting to use the unpackaged medicine can be suppressed.
  • step S24 the control unit 31 sequentially determines whether or not there is a medicine to be taken at the time of taking the data of each of the users included in the packaging data. And the said control part 31 makes a process transfer to step S241, when the chemical
  • step S ⁇ b> 25 the control unit 31 performs a packaging operation on the data included in the packaging data. Specifically, the control unit 31 uses the packaging printer 32 to print the name and timing of the user and the code 811 indicating the first medicine distribution information on the medicine package 81, and to the data. The corresponding medicine is packaged in the medicine package 81.
  • step S241 the control unit 31 creates an empty medicine package 81 printed by the packaging printer 32 to the effect that there is no medicine to be taken at the time of taking.
  • the empty medicine package 81 is printed with the name and timing of the user, the code 811, and information indicating that there is no medicine (no medicine).
  • step S26 the control unit 31 determines whether or not the packaging for the same dosing time started in step S23 is completed.
  • the control unit 31 shifts the process to step S27.
  • the control unit 31 returns the process to step S24.
  • step S27 the control unit 31 determines whether or not the packaging of all the taking times for the same health facility B set as the packaging target in the step S22 is completed. Here, if it is determined that the all-packaging period has been finished (S27: Yes), the control unit 31 shifts the process to step S28. On the other hand, if it is determined that the all-packaging period packaging has not ended (S27: No), the control unit 31 shifts the process to step S271.
  • step S271 the control unit 31 executes a package separation process for clearly indicating the timing at which the dosing time is switched, and returns the process to step S23.
  • the separation process is to provide one empty medicine package 81.
  • the empty medicine pack 81 may be printed with various information for drug inspection and inspection related to the contents of each medicine pack 81 connected in front of it.
  • segmentation process may cut
  • step S28 it is determined whether or not the packaging for all the healthy facilities B included in the packaging data has been completed.
  • the control unit 31 terminates a series of the drug packaging processes and returns the process to the step S21.
  • the control unit 31 shifts the processing to the step S22, and performs the next packaging operation for the old health facilities B. Start.
  • FIG. 9B is a diagram showing a packaging result when the individual packaging process is performed on the “old health facility B1” according to the group prescription data shown in FIG.
  • the medicine taken by one user is continuously packaged at every time of taking.
  • the medicine packs 81 corresponding to are continuously formed.
  • the medicine pack 81 corresponding to each dose time is continuously formed.
  • each medicine bag 81 is separated and accommodated in each medicine bag 82 when the medicine bag 81 is accommodated in the medicine bag 82 in step S3.
  • the time-specific packaging process when the medicine pack 81 is accommodated in the medicine bag 82 in the step S3, each medicine bag 81 is separated and accommodated in each medicine bag 82. It is good, but you may accommodate in the said medicine bag 82, without separating the said several medicine package 81 continued for every taking time.
  • the pharmacy A prepares a plurality of the medicine bags 82 in which the medicine packages 81 of a plurality of medicine users corresponding to each time of taking are collectively stored.
  • step S ⁇ b> the control unit 11 determines whether or not the second dispensing information has been read from the code 822 of the medicine bag 82 by the reading terminal 2.
  • the said control part 11 judges that the said 2nd medicine distribution information was read (S31: Yes)
  • it will transfer a process to step S32.
  • the process waits at step S31.
  • control part 11 is the presence or absence of the said user ID which exists only in the said 1st medicine distribution information, for example between the 1st medicine distribution information of the said medicine package 81, and the 2nd medicine distribution information of the said medicine bag 82 It can be determined according to Of course, information that can be identified may be included in the first drug distribution information and the second drug distribution information.
  • step S32 the control unit 11 determines the medicine pack 81 accommodated in the same medicine bag 82 based on the second medicine distribution information and the medicine management information D1 of the medicine bag 82 read in step S31.
  • One or a plurality of the medicine packs 81 determined in advance are specified.
  • the control unit 11 stores the medicine package containing the medicine of the user ID whose delivery destination identification information and the time of taking are the same as the second medicine information in the medicine management information D1.
  • 81 is specified as the medicine pack 81 to be accommodated in the medicine bag 82.
  • step S ⁇ b> 33 the control unit 11 determines whether or not the first dispensing information has been read from the code 811 of the medicine package 81 by the reading terminal 2. Here, if the said control part 11 judges that the said 1st medicine distribution information was read (S33: Yes), it will transfer a process to step S34, and until the said 1st medicine distribution information is read (S33). : No), the determination in step S33 is repeated.
  • Step S34 the control unit 11 sends the delivery destination identification information and the dosing time of the second medicine information read in step S31 and the delivery of the first medicine information read in step S33. It is determined whether the previous identification information and the timing of taking are the same.
  • the step S34 is a process executed by the determination unit 112 of the control unit 11.
  • the control unit 11 stores the first medicine distribution information read in Step S33 and the determination result in Step S34 in the data storage unit 12 as a reading history. Thereby, the dispensing support device 1 can refer to and output the reading history.
  • step S35 the control unit 11 notifies the determination result in step S34.
  • the step S35 is a process executed by the first notification unit 113 of the control unit 11. Specifically, the control unit 11 notifies the user of the determination result by causing the display device 14 or the reading terminal 2 to display the determination result. Thereby, the user can recognize the determination result. Therefore, human errors in a medicine distribution operation in which the medicine packages 81 of a plurality of users are collected at each time of taking and stored in the medicine bag 82 and delivered to a delivery destination are suppressed.
  • the determination result notification method is not limited to display, and the determination result notification may be performed by sound or a light emission mode.
  • step S ⁇ b> 36 the control unit 11 determines whether or not to end the reading operation of the first medicine distribution information from the medicine package 81 stored in the medicine bag 82 by the reading terminal 2. Specifically, the control unit 11 ends the reading operation when a user's continuous operation on the reading terminal 2 or a reading operation of the first medicine distribution information from the next medicine pack 81 is performed. It is determined not to do so (S36: No), and the process proceeds to step S33. Thereby, the reading of the first medicine distribution information from each of the medicine packs 81 accommodated in the medicine bag 82 is sequentially executed.
  • control unit 11 receives an end signal from the reading terminal 2 in response to a user's end operation on the reading terminal 2, or from the medicine bag 82 different from the medicine bag 82 read in the step S31.
  • the second medicine distribution information is read, it is determined that the reading operation is finished (S36: Yes), and the process is shifted to step S37.
  • step S37 the control unit 11 determines whether or not the first medicine distribution information has been read from all the medicine packages 81 to be stored in the same medicine bag 82 based on the medicine distribution management information D1. To do.
  • the step S37 is a process executed by the determination unit 112 of the control unit 11.
  • the said control part 11 determines with the said 1st medicine distribution information having been read from all the said medicine packs 81 which should be accommodated in the said medicine bag 82 (S37: Yes)
  • the process returns to step S31.
  • step S38 when it is determined that the reading is completed by reading the second medicine information from the different medicine bag 82, the same processing is executed based on the second medicine information in the subsequent step S31.
  • the said control part 11 determines with the said 1st medicine distribution information not being read from all the said medicine packs 81 which should be accommodated in the said medicine bag 82 (S37: No), it will transfer a process to step S38.
  • step S38 the control unit 11 notifies the determination result in step S37, and returns the process to step S33. Specifically, the control unit 11 indicates that there is the medicine pack 81 that has not been read in step S33 among the medicine packs 81 to be stored in the medicine bag 82 based on the medicine distribution management information D1. And the information of the unread medicine package 81 is displayed on the display device 14 or the reading terminal 2. Thereby, accommodation omission of the medicine bag 81 in the medicine bag 82 is suppressed. For example, the control unit 11 displays the ID or name of the user corresponding to the medicine pack 81 that has not been read in step S33 among the medicine packs 81 to be stored in the medicine bag 82 together with the time of taking the medicine. .
  • step S ⁇ b> 41 the control unit 11 determines whether or not the delivery destination identification information has been input by the reading terminal 2. Specifically, the person in charge of delivery inputs the delivery destination identification information indicating the old facility B, which is the delivery destination of the medicine bag 82 to be shipped, to the reading terminal 2. Further, the delivery person uses the reading terminal 2 to read the delivery destination identification information previously attached to a container such as a container to be accommodated when the medicine bag 82 to be shipped is delivered. It is also possible to input identification information.
  • the said control part 11 judges that the said delivery destination identification information was input (S41: Yes), it will transfer a process to step S42. On the other hand, until the delivery destination identification information is input (S41: No), the process waits in step S41.
  • step S42 the control unit 11 simultaneously delivers to the same old facility B indicated by the delivery destination identification information based on the delivery destination identification information and the medicine distribution management information D1 input in step S41.
  • One or a plurality of the medicine bags 82 to be specified are specified.
  • the control unit 11 specifies the medicine bag 82 having the same delivery destination identification information and the same delivery date as the medicine bag 82 to be delivered to the health facility B at the same time.
  • step S ⁇ b> 43 the control unit 11 determines whether or not the reading terminal 2 has read the second medicine distribution information from the code 822 of the medicine bag 82. Here, if the said control part 11 judges that the said 2nd medicine distribution information was read (S43: Yes), it will transfer a process to step S44 and will continue until the said 2nd medicine distribution information is read (S43). : No), the determination in step S43 is repeated.
  • step S44 the control unit 11 determines whether or not the delivery destination identification information input in step S41 matches the delivery destination identification information of the second medicine distribution information read in step S43. judge.
  • the step S44 is a process executed by the determination unit 112 of the control unit 11.
  • the control unit 11 stores the second medicine distribution information read in Step S43 and the determination result in Step S44 in the data storage unit 12 as a reading history. Thereby, the dispensing support device 1 can refer to and output the reading history.
  • step S45 the control unit 11 notifies the determination result in step S44.
  • the step S45 is a process executed by the first notification unit 113 of the control unit 11. Specifically, the control unit 11 notifies the user of the determination result by causing the display device 14 or the reading terminal 2 to display the determination result. Thereby, the user can recognize the determination result. Therefore, human errors in a medicine distribution operation in which the medicine packages 81 of a plurality of users are collected at each time of taking and stored in the medicine bag 82 and delivered to a delivery destination are suppressed.
  • the determination result notification method is not limited to display, and the determination result notification may be performed by sound or a light emission mode.
  • step S46 the control unit 11 determines whether or not to end the reading operation of the second medicine distribution information from the medicine bag 82 delivered to the same health facility B by the reading terminal 2. Specifically, the control unit 11 does not end the reading operation when a user's continuous operation on the reading terminal 2 or a reading operation of the second medicine distribution information from the next medicine bag 82 is performed. (S46: No), the process proceeds to step S43. Thereby, the reading of the second medicine distribution information from each of the medicine bags 82 delivered to the same health facility B is sequentially executed.
  • control unit 11 is different from the delivery destination identification information input in the case where an end signal is input from the reading terminal 2 in response to a user's end operation on the reading terminal 2, or in the step S41.
  • delivery destination identification information it is determined that the reading operation is to be terminated (S46: Yes), and the process proceeds to step S47.
  • step S47 the control unit 11 performs the second medicine distribution from all the medicine bags 82 to be simultaneously delivered to the same health facility B corresponding to the delivery destination identification information based on the medicine management information D1. It is determined whether information has been read.
  • the step S47 is a process executed by the determination unit 112 of the control unit 11.
  • the said control part 11 determines with the said 2nd medicine distribution information having been read from all the said medicine bags 82 which should be delivered to the said healthy facility B simultaneously (S47: Yes)
  • the said collation process at the time of delivery will be complete
  • step S41 If it is determined that the reading has been completed by inputting different delivery destination identification information, the same processing is executed based on the delivery destination identification information in subsequent step S41. On the other hand, if the said control part 11 determines with the said 2nd medicine distribution information not being read from all the said medicine bags 82 which should be delivered to the said healthy facility B simultaneously (S47: No), it will transfer a process to step S48. .
  • step S48 the control unit 11 notifies the determination result in step S47, and returns the process to step S43. Specifically, the control unit 11 is not read in step S43 among the medicine bags 82 to be delivered simultaneously to the health facility B corresponding to the delivery destination identification information based on the medicine distribution management information D1.
  • the display device 14 or the reading terminal 2 displays information indicating that the medicine bag 82 exists and information about the medicine bag 82 that has not been read. Thereby, the delivery omission of the medicine bag 82 to the health facility B is suppressed.
  • control unit 11 sends the dose time corresponding to the medicine bag 82 that has not been read in step S43 among the medicine bags 82 to be delivered to the health facility B corresponding to the delivery destination identification information at the same time. Displayed together with the previous identification information.
  • step S51 the control unit 51 determines whether or not the second medicine distribution information has been read from the medicine bag 82. Here, until the second medicine distribution information is read from the medicine bag 82 (S51: No), the process waits in step S51. On the other hand, if it is determined that the second medicine distribution information has been read from the medicine bag 82 (S51: Yes), the process proceeds to step S52.
  • step S52 the control unit 51 indicates the delivery destination identification information included in the second medicine distribution information read in step S51 and the health facility B where the medicine distribution support device 5 is installed. It is determined whether or not the delivery destination identification information registered in advance in the medicine distribution support device 5 as information matches.
  • the step S52 is a process executed by the delivery destination determination unit 512 of the control unit 51.
  • the control unit 51 causes the data storage unit 52 to store the second medicine distribution information read in step S51 and the determination result in step S52 as a reading history. Thereby, the medicine distribution support device 5 can refer to and output the reading history.
  • step S53 the control unit 51 notifies the determination result in step S52. Specifically, the control unit 51 displays the determination result on the display device 54 or the reading terminal 7.
  • the step S53 is a process executed by the second notification unit 513 of the control unit 51.
  • step S ⁇ b> 61 the control unit 51 determines whether or not the first medicine distribution information has been read from the medicine package 81. Here, until the first medicine distribution information is read from the medicine package 81 (S61: No), the process waits in the step S61. On the other hand, if it is determined that the first medicine distribution information has been read from the medicine package 81 (S61: Yes), the process proceeds to step S62.
  • Step S62 the control unit 51 moves in corresponding to the user based on the user ID, the conversion information, and the resident master included in the first medicine information read in step S61. Identify the person.
  • step S62 the control unit 51 stores the first medicine distribution information read in step S61 and the specific result in step S62 in the data storage unit 52 as a reading history. Thereby, the medicine distribution support device 5 can refer to and output the reading history.
  • step S63 the control unit 51 displays the time of taking the medicine package 81 and the name and face image 63 of the resident corresponding to the user specified in step S62 on the portable terminal 6. Display (see FIG. 4).
  • the step S63 is a process executed by the display control unit 511 of the control unit 51.
  • the configuration of the drug distribution support system 100 according to the present embodiment will be described with reference to FIG.
  • symbol is attached
  • the dispensing support device 1 includes a USB port 18.
  • the USB port 18 is detachably attachable to the USB memory 19 and can write data to the USB memory 19 and read data from the USB memory 19. It should be noted that not only the USB memory 19 but also other recording media such as a CD, a DVD, and a BD may be used.
  • the said control part 11 functions as the medicine distribution data output part 114, the remaining medicine information input part 115, and the remaining medicine notification part 116 by performing various processes according to the said dispensing assistance program.
  • the drug distribution data output unit 114 is an example of a drug distribution data output unit
  • the residual drug information input unit 115 is an example of a residual drug information input unit
  • the residual drug notification unit 116 is an example of a residual drug notification unit.
  • the medicine distribution data output unit 114 is used when dispensing medicines into each medicine package 81, and outputs medicine distribution data based on prescription data stored in the prescription data storage unit 121 to the USB port 18. It is possible to record from the USB port 18 to the USB memory 19.
  • the medicine distribution data output unit 114 can output the medicine distribution data in units of the medicine distribution group. Specifically, when the health facility B is designated by a user operation on the operation device 15, the medicine distribution data output unit 114 displays prescription data corresponding to each resident in the health facility B. Extraction and distribution data based on the prescription data can be output. Thereby, it is possible to easily use only necessary prescription data among the prescription data.
  • a facility master and a resident master are stored in the data storage unit 12 of the dispensing support device 1, and the medicine distribution data output unit 114 is necessary based on the facility master and the resident master.
  • the prescription data is extracted.
  • the said medicine distribution data output part 114 can also add and output a part or all of the information of the said facility master and the said tenant master to the said medicine distribution data.
  • FIG. 15 is a diagram showing an example of the facility master and the resident master.
  • the registration work of each of the facility master and the resident master is performed by using the display device 14 and the operation device 15 of the dispensing support device 1 in the initial setting or master maintenance of the dispensing support device 1, for example. Done.
  • the facility master stores a facility code, a facility name, and a print format corresponding to each of the old facilities B in association with each other.
  • the facility code and the facility name are examples of identification information for identifying the health facility B
  • the print format is the format type of items to be printed on the medicine package 81 in the medicine packaging device 3 It is information for identifying.
  • the facility code is, for example, the same as the delivery destination ID (see FIG. 2).
  • each of the tenant masters is stored in association with each of the old facility B registered in the facility master.
  • the resident master stores a occupant ID, a occupant name, a resident ID, a group, and a print format corresponding to each resident.
  • the taker ID, the taker name, and the resident ID are examples of identification information for identifying a resident who enters the health facility B.
  • the user ID is identification information registered in advance for identifying the resident (taker) in the dispensing support device 1 or the like on the pharmacy A side
  • the resident ID is the health facility. This is identification information registered in advance in order to identify the resident in the medicine distribution support device 5 on the B side.
  • the resident master stored in the master storage unit 521 is provided from the health facility B side to the pharmacy A side, so that the pharmacy A side can provide the resident master of the dispensing support device 1 to the resident master.
  • the resident ID is registered.
  • the correspondence between the doser ID and the resident ID in the resident master is the same as the correspondence between the doser ID and the resident ID in the conversion information used in the medicine distribution support device 5. It is.
  • the group is identification information for identifying a group classified as a series of medicine distribution groups by a ward, a hospital room, a floor, or the like in the old-age facility B.
  • a medicine distribution operation to residents is performed for each group.
  • the print format is information for identifying the type of format such as items and arrangements to be printed on the medicine package 81 and the medicine bag 82 in the medicine packaging device 3.
  • the print format registered in the resident master is preferentially adopted even when the print format is registered in the facility master, for example.
  • the dispensing support device 1 can grasp the correspondence between the user ID and the resident ID. Therefore, the control unit 11 causes the medicine packaging device 3 to print the resident ID on the medicine package 81 instead of the medicine person ID included in the first medicine distribution information or together with the medicine person ID. It is possible.
  • the remaining medicine information input unit 115 can input the remaining medicine information output from the remaining medicine information output unit 516 described later in the medicine distribution support device 5.
  • the remaining medicine information input unit 115 requests the medicine distribution support apparatus 5 to transmit the remaining medicine information via the network N1, the network N2, and the like, and is transmitted from the medicine distribution support apparatus 5.
  • the remaining medicine information is acquired.
  • the remaining medicine information input unit 115 can also read and input the remaining medicine information from a recording medium such as the USB memory 19, and the remaining medicine information transmitted from the medicine distribution support apparatus 5 by e-mail or the like. It is also possible to enter drug information.
  • the remaining medicine notification unit 116 notifies information on remaining medicines that can be used as prescription drugs included in the prescription data based on the remaining medicine information and the prescription data input by the remaining medicine information input unit 115.
  • the remaining medicine notification unit 116 can display a warning that there is a remaining medicine that can be used in the prescription data to be dispensed in the prescription data issuance process (step S1 in FIG. 4). It is.
  • the control unit 11 can display the remaining medicine information on the display device 14 or the like at an arbitrary timing in accordance with a user operation of the operation device 15.
  • the remaining medicine notification unit 116 can also transmit the remaining medicine information to a higher-level system (not shown) such as the electronic medical record system or the prescription input terminal connected to the dispensing support device 1 so as to be communicable. It is. Accordingly, it is possible to notify the doctor using the host system of the remaining medicine information and prompt the correction of the prescription data, etc., and suppress waste of medicine.
  • the pharmacist at the pharmacy A side refers to the remaining medicine information displayed on the dispensing support device 1, notifies the doctor of the amount of the remaining medicine, and inputs the prescription without removing the remaining medicine when inputting a new prescription. Or correction (reissue) to remove the remaining medicine from the prescription that has already been entered.
  • the medicine distribution support device 5 includes a USB port 58.
  • the USB memory 19 can be attached to and removed from the USB port 58, and data can be written to and read from the USB memory 19.
  • the data storage unit 523 is included in the data storage unit 52.
  • the medicine distribution data storage unit 523 stores the medicine distribution data output from the dispensing support device 1 and read from the USB memory 19 by the USB port 58.
  • the said control part 51 performs various processes according to the said medicine distribution assistance program, and thereby, a medicine distribution data input part 514, a medication completion input part 515, and a remaining medicine information output part 516 Function as.
  • the drug distribution data input unit 514 is an example of a drug distribution data input unit
  • the drug completion input unit 515 is an example of a drug completion input unit
  • the remaining drug information output unit 516 is an example of a residual drug information output unit.
  • the medicine distribution data input unit 514 can input the medicine distribution data output by the dispensing support device 1 to the medicine distribution support device 5 provided in the old health facility B which is a medicine delivery destination. It is. Specifically, the medicine distribution data input unit 514 reads out the medicine distribution data by reading out the medicine distribution data from the USB memory 19 connected to the USB port 58 in response to a user operation of the operation device 55. Input to the medicine distribution support device 5.
  • the medication completion input unit 515 accepts a medication completion input operation for each user displayed on the resident list screen 211 (see FIG. 23) described later by the display device 54 or the mobile terminal 6. Specifically, the medication completion input unit 515 accepts an input operation of the medication completion of the user for the operation device 55 or the mobile terminal 6.
  • the remaining medicine information output unit 516 can receive the remaining medicine information input operation regarding the remaining medicine that the user has not taken, and can output the remaining medicine information. Specifically, the remaining medicine information output unit 516 receives an input operation of the remaining medicine information with respect to the operation device 55 or the portable terminal 6. Then, the remaining medicine information output unit 516 stores the remaining medicine information in the data storage unit 52 and transmits and outputs it to the dispensing support apparatus 1 via the network N1, the network N2, and the like.
  • control unit 11 can register the information about the old facility B and the resident as initial setting information according to the user operation of the operation device 55 or the mobile terminal 6.
  • FIG. 16 shows an example of the facility registration screen
  • FIG. 17 shows an example of the resident registration screen.
  • the control unit 11 displays a facility registration screen for registering a facility code and a facility name in response to a user operation of the operation device 55.
  • a registration key is operated, and the information is stored in the master storage unit 521 as a facility master.
  • the facility code and the facility name are the same as the facility code and the facility name registered in the facility master (see FIG. 15) of the dispensing support device 1.
  • the control unit 11 displays a resident registration screen for registering resident information in response to a user operation of the operation device 55.
  • the tenant ID, tenant name, pseudonym, date of birth, gender, management classification, group, room code, comment, and face image (photograph) can be input on the tenant registration screen.
  • the management category for example, it is selected whether or not self-management for self-administration of medicines is performed.
  • the camera 62 of the portable terminal 6 is used when registering a resident information by inputting a capture input by selecting a photograph taken in advance from a list. There is a shooting input to shoot.
  • the resident registration screen after the resident information is input, the registration key is operated, and the information is stored in the master storage unit 521 as the resident master.
  • the resident ID, resident name (kana), group, etc. included in the resident information are the resident ID registered in the resident master (see FIG. 15) of the dispensing support device 1 and the dose. The same as the name and group.
  • the control unit 11 imports or exports resident information according to the subsequent operation.
  • the medicine packaging process (see FIG. 8), the collation process at the time of accommodation (see FIG. 10), the collation process at the time of delivery (see FIG. 11), and the process at the time of receiving ( Etc.) are executed.
  • Step S111> As shown in FIG. 18, when the operation for issuing the prescription data is performed in step S11, in step S111, the control unit 11 executes a remaining medicine information input process for inputting the remaining medicine information. .
  • the step S111 is executed by the remaining medicine information input unit 115 of the control unit 11.
  • step S111 the control unit 11 requests the medicine distribution support apparatus 5 to transmit the remaining medicine information via the network N1, the network N2, and the like. And the said control part 11 receives the said remaining medicine information transmitted via the said network N1, the said network N2, etc. from the said medicine distribution assistance apparatus 5.
  • FIG. Note that the remaining medicine information is automatically transmitted from the medicine distribution support device 5 via the network N1, the network N2, and the like automatically every predetermined period or at a predetermined timing. It is also conceivable that 115 acquires the remaining medicine information.
  • the remaining medicine information is recorded on a recording medium such as the USB memory 19 in the medicine distribution support device 5, and the remaining medicine information is read from the recording medium such as the USB memory 19 in the dispensing support device 1. Conceivable. Thereby, it becomes possible to utilize the said remaining medicine information with the said dispensing assistance apparatus 1 without accompanying via the said network N1 and the said network N2.
  • step S112 the control unit 11 notifies information on a remaining medicine that can be used as a prescription medicine included in the prescription data based on the remaining medicine information and the prescription data acquired in step S111.
  • the step 112 is executed by the remaining medicine notification unit 116 of the control unit 11.
  • the said control part 11 judges whether the prescription date in the said prescription data is in the expiration date of the remaining medicine contained in the said remaining medicine information in the said step S112, and is it in the said expiration date? It is also possible to display whether or not the display device 14 or the like is displayed.
  • step S112 the control unit 11 determines a medicine that does not need to be packaged because it exists as a remaining medicine in the remaining medicine information in the prescription data based on the remaining medicine information and the prescription data. To do. And the information of the medicine which exists as the said remaining medicine is displayed on the said display apparatus 14 grade
  • the packaging data is generated in step S12, the packaging data is generated so that an empty medicine package 81 is also issued for a medicine removed from the packaging target due to the presence of the remaining medicine. It can be considered.
  • the packaging data corresponding to the medicine removed from the packaging target due to the presence of the remaining medicine in the packaging data to specify the taking time and the remaining medicine to be used at the taking time. It is conceivable that the remaining medicine specifying information (for example, the time of taking) is included.
  • the time of taking the remaining medicine and the remaining medicine specifying information are printed on the empty medicine package 81.
  • a message such as “please take medicine after dinner for ⁇ month and ⁇ day after dinner” is displayed on the empty medicine package 81.
  • the determination as to whether or not the remaining medicine can be used is performed at each time of taking, that is, performed in units of the medicine package 81.
  • step S14 the control unit 11 waits for an operation of outputting medicine distribution data used on the side of the old facility B (S14: No side). Specifically, the control unit 11 determines whether or not an operation for outputting the medicine distribution data has been executed by a user operation on the operation device 15. Here, if it is determined that the operation of outputting the medicine distribution data has been performed (S14: Yes side), the process proceeds to step S15.
  • step S15 the control unit 11 generates the medicine distribution data based on the prescription data subjected to the issuing operation in step S11, and outputs the medicine distribution data to the USB port 18 to output the USB memory. 19 is recorded. That is, the control unit 11 outputs the medicine distribution data in units of the old health facility B or the group which is the medicine distribution group, similarly to the prescription data and the packaging data.
  • the USB memory 19 is delivered to the medicine distribution support device 5 together with the medicine package 81 and the medicine bag 82, etc., and the medicine distribution data stored in the USB memory 19 is transferred to the medicine distribution support device 5. This makes it possible to improve the efficiency of drug distribution work by the person in charge of drug distribution and to suppress drug distribution mistakes.
  • the medicine distribution data is generated for the prescription data for which the issuing operation has been performed in step S11, it is possible to reduce time and effort for setting again the extraction conditions for generating the medicine distribution data, The dispensing data different from the prescription data, which is a subject of dispensing, is prevented.
  • the drug distribution data includes the resident ID, resident (taker) name, group, pseudonym, drug code (YJ code), drug name, date taken, time taken (usage), dose, dosage form, and package. Includes categories, side-effect related information, and daily maximum dose (maximum frequency).
  • the one-packing section is a section for identifying medicines packaged in the same medicine package 81.
  • the side effect related information is information about side effects described in a package insert of medicines, or information about side effects arbitrarily registered in advance in association with medicines in the pharmacy A or the like.
  • information such as a resident ID and a group managed on the medicine distribution support apparatus 5 side is also registered in the resident master in the dispensing support apparatus 1 on the pharmacy A side. .
  • the control unit 11 can add the information such as the resident ID and the group to the medicine distribution data by referring to the resident master and output the information.
  • the medicine distribution support device 5 may identify a resident based on the medicine distribution data.
  • the said user ID is contained in the said medicine distribution data, and the said medicine distribution support apparatus 5 is based on the correspondence (the said conversion information) of the said user ID and the said tenant ID in each of the said healthy facilities B. It is also conceivable as another embodiment to determine the resident corresponding to the user ID.
  • FIG. 19 is a diagram showing an example of medicine distribution data used in the old health facility B1.
  • the medicine distribution data includes a tenant ID, a tenant (taker) name, a group, a dosage form, and a package classification. It is.
  • the medicine M1 and medicine M3 of “Yuyama Ichiro” are both “1” in the packaging classification and are packaged in the same medicine package 81 in the example shown in FIG.
  • the medicine M7 and the medicine M8 of “Yuyama Saburo” have the package classification “1” and “2” and are divided into different medicine packages 81.
  • the drug distribution data includes side effect related information, daily maximum dose (maximum number of times), and the like.
  • the USB memory 19 is an example of a recording medium used for moving the medicine distribution data, and various recording media such as other flash memories or hard disk drives may be used instead of the USB memory 19. Is possible.
  • a configuration in which the medicine distribution data can be moved using a recording medium such as the USB memory 19 will be described.
  • the medicine distribution data can be transmitted to the medicine distribution support device 5.
  • the method is not limited to this.
  • a configuration in which the medicine distribution data output unit 114 outputs the medicine distribution data to the communication interface 13 and is transmitted from the communication interface 13 to the medicine distribution support apparatus 5 through the network N1 such as the Internet is also conceivable.
  • the structure which can transmit and output the said prescription data corresponding to the said medicine distribution data to the said medicine distribution assistance apparatus 5 is also considered for the said medicine distribution data output part 114.
  • control unit 11 outputs the drug distribution data to a storage unit such as a server to which the dispensing support device 1 and the drug distribution support device 5 are communicably connected via the network N1, the network N2, and the like. It is also possible to memorize it. That is, a configuration in which the dispensing support device 1 and the medicine distribution support device 5 share the medicine distribution data on the cloud is conceivable. Thereby, the said control part 51 of the said medicine distribution assistance apparatus 5 can read and input the said medicine distribution data from memory
  • a code such as a one-dimensional code or a two-dimensional code indicating the medicine distribution data related to the user is printed on the medicine pack 81.
  • the control unit 51 can input the medicine distribution data for each user by reading the code from the medicine pack 81 for the medicine.
  • the code is not limited to the medicine package 81 but may be printed on a paper medium delivered together with the medicine package 81, for example.
  • the drug distribution data included in the code includes a dose start time that is the first dose time and a dose end time that indicates the last dose time in the current drug distribution data corresponding to the user.
  • the prescription data (for example, drug name, usage, dose, start date of taking, end date of taking, etc.) corresponding to the user is printed out on the medicine pack 81 for the medicine instead of the medicine distribution data. It may be included in the code.
  • the said control part 11 takes the remaining medicine. It is conceivable to output the medicine distribution data including the remaining medicine specifying information indicating the relationship between the time and the new taking time. And in the said medicine distribution assistance apparatus 5, when the said code
  • the said control part 11 is the said distribution data. It is also possible to output in accordance with the operation of the operating device 15 at an arbitrary timing. Specifically, the control unit 11 waits for an extraction condition setting operation for extracting prescription data to be output from the prescription data stored in the prescription data storage unit 121. For example, in the dispensing support device 1, the control unit 11 displays a setting screen for setting the extraction condition on the display device 14 in response to a setting start operation on the operation device 15. And the said control part 11 sets the said extraction conditions according to operation of the said operating device 15 according to the said setting screen.
  • one or more conditions can be set among the facility code, the facility name, the group, the user ID, the user name, and the resident ID. If it is determined that the extraction condition is set, the control unit 11 generates the medicine distribution data corresponding to the extraction condition based on the prescription data stored in the prescription data storage unit 121.
  • the facility code when the facility code is selected, from each of the prescription data stored in the prescription data storage unit 121, each of the users occupying the old health facility B corresponding to the facility code Prescription data is extracted. Further, when the group is selected as the extraction condition, prescription data for each user belonging to the group is extracted from the prescription data stored in the prescription data storage unit 121. And the said control part 11 extracts the one part or all item predetermined among the said prescription data as said medicine distribution data. Thereby, by omitting unnecessary information as the drug distribution data in the prescription data, the data amount is reduced, or the prescription data is used while minimizing the use of personal information of the user. Is possible. Then, the said control part 11 outputs the said medicine distribution data similarly to the said step S15. Thereby, in the said dispensing assistance apparatus 1, it is possible to output the said medication distribution data not only at the issue timing of the said prescription data but at arbitrary timing.
  • step S ⁇ b> 81 the control unit 51 determines whether a predetermined medicine distribution start operation has been performed on the operation device 55 or the mobile terminal 6. If it is determined that the medicine distribution start operation has been performed, the process proceeds to step S82. If the medicine distribution start operation has not been performed, the process proceeds to step S811.
  • the medicine distribution start operation it is conceivable that a login operation of a person in charge of medicine distribution such as a predetermined staff is performed.
  • an identification code, a password, and the like of each person in charge of medicine distribution are set in the data storage unit 52.
  • the control unit 51 reads a code such as a one-dimensional code or a two-dimensional code written on a name tag or the like possessed by the person in charge of medicine by the reading terminal 7.
  • the information on the code matches the identification code of the person in charge of medicine distribution, the person in charge of medicine distribution may be logged in.
  • the control unit 51 may consider logging in the person in charge of dispensing the medicine after verifying the password. It is done. Thereby, the said control part 51 restrict
  • Steps S811 to S812 In steps S811 to S812, an input process for inputting the medicine distribution data output from the dispensing support device 1 is executed. The steps S811 to S812 are executed by the medicine distribution data input unit 514.
  • step S811 the control unit 51 waits for an input timing of the medicine distribution data (S811: No side). For example, when the USB memory 19 is attached to the USB port 58 and a user operation is performed on the operation device 55, the control unit 51 determines that the timing of inputting the medicine distribution data is reached. The control unit 51 also determines that it is the timing for inputting the medicine distribution data even when the medicine distribution data is received by the communication interface 53 via the network N2 or the like. And if it judges that the input timing of the said medicine distribution data has arrived (S811: Yes side), a process will transfer to step S812.
  • S811 No side
  • step S812 the control unit 51 inputs the medicine distribution data to the dispensing support device 1.
  • the control unit 51 stores information necessary for executing the drug distribution matching process in the drug distribution data storage unit 523 in accordance with a predetermined database format.
  • the said medicine distribution assistance apparatus 5 it becomes possible to perform various processes using the said medicine distribution data used at the time of the dispensing in the said dispensing assistance apparatus 1.
  • step S81 when it is determined that a predetermined medicine distribution start operation has been performed on the operation device 55 or the portable terminal 6, in the subsequent step S82, the controller 51 determines that the person in charge of medicine distribution has performed.
  • An initial screen 210 (an example of a first display screen) to be referred to when dispensing is displayed.
  • the control unit 51 displays the initial screen 210 on the display device 54 when the medicine distribution start operation is performed by the operation device 55.
  • the said control part 51 displays the said initial screen 210 on the display part of the said portable terminal 6, when the said medicine distribution start operation is performed by the said portable terminal 6.
  • FIG. Similarly, in the subsequent processing, the operation by the operation device 55 is reflected on the display of the display device 54, and the operation on the mobile terminal 6 is reflected on the display of the display unit of the mobile terminal 6.
  • FIG. 21 shows an example of the initial screen 210.
  • the control unit 51 displays a selection key for selecting a dose time to be taken based on the medicine distribution data. Specifically, in the example shown in FIG. 21, the control unit 51 displays the dosing time corresponding to today on the initial screen 210 as a selection candidate.
  • “before”, “after”, and “between” are displayed in a tree for each of breakfast, lunch, and dinner, so that the person in charge of drug distribution can easily find the intended time of taking.
  • former stage of the said initial screen 210 is also considered as other embodiment.
  • the control unit 51 causes the initial screen 210 to display in different display modes the dosing time when there is a medicine to be taken and the dosing time when there is no medicine to be taken.
  • the person in charge of medicine distribution can easily determine the presence or absence of a medicine to be taken at each time of taking.
  • the difference in the background pattern of the dosing time in FIG. 21 indicates that there is a difference in the display mode. For example, the time when the medicine to be taken is present (after dinner in FIG. 21, between dinner, etc.) is highlighted, and the time when the medicine to be taken is not present (before breakfast, after breakfast, between breakfast, etc. in FIG. 21). ) May not be highlighted.
  • the display color of the medication time when there is a medicine to be taken and the display color of the medication time when there is no medicine to be taken are different. Furthermore, it is conceivable that the display size of the dosing time when there is a medicine to be taken is large and the display size of the dosing time when there is no medicine to be taken is small.
  • the control unit 51 causes the initial screen 210 to display the dosing time closest to the current time in a display mode different from other dosing times.
  • the medicine distribution support device 5 stores the dose name corresponding to each dose time, the dose time, the dose time code, and the dose category in the data storage unit 52. Time information is stored in advance. Thereby, the said control part 51 can determine the dosing time which should be taken at this time based on the said dosing time information.
  • the medication time code is information indicating the same content as the medication time code printed on the medicine package 81, and is unified information used in common in the dispensing support device 1 and the medicine distribution support device 5. .
  • the said control part 51 can change the said dosing time information according to user operation in the initial setting of the said medicine distribution assistance apparatus 5, etc.
  • an initial screen 210 in which the dosing time is displayed as a tree is shown.
  • the initial screen 210 for selecting the dosing time for example, as shown in FIG.
  • the symbols are arranged and displayed individually.
  • the control unit 51 can arbitrarily arbitrarily set the display position, the display size, and the display color of each of the dosing times on the initial screen 210 in accordance with the operation of the operation device 55 or the mobile terminal 6. Can be considered.
  • a configuration is also conceivable in which the control unit 51 can arbitrarily set in advance the type of dosing time displayed on the initial screen 210 in accordance with the operation of the operation device 55 or the mobile terminal 6. Accordingly, for example, the user can arbitrarily customize the initial screen 210 to make it easy to see for the user, or can eliminate unnecessary information display on the initial screen 210.
  • the control unit 51 can synthesize the medicine distribution data acquired from the plurality of pharmacies A.
  • the said control part 51 can consider the structure which can input the said medicine distribution data arbitrarily according to operation of the said operation apparatus 55 or the said portable terminal 6.
  • a registration screen is displayed, and information input on the registration screen is input as the medicine distribution data.
  • step S83 the control unit 51 waits for selection of a dosing time to be taken (S83: No side). If it is determined that the dosing time has been selected (S83: Yes side), the process proceeds to step S84.
  • control unit 51 determines that the dosing time has been selected when an operation for selecting the dosing time on the initial screen 210 is performed by the operation device 55 or the operation unit of the mobile terminal 6. .
  • control unit 51 uses the portable terminal 6 or the reading terminal 7 to display a one-dimensional code indicating a dosing time attached in advance to a medicine box containing the medicine pack 81 corresponding to each dosing time. When a code such as a two-dimensional code is read, it may be determined that the taking time has been selected.
  • the medicine distribution support system 100 includes an automatic accommodation device that automatically accommodates medicines such as the medicine package 81 corresponding to each time taken by a plurality of users in the medicine distribution box corresponding to each time taken. Configuration is also conceivable. As a result, medicines prescribed to a plurality of users are automatically stored in the medicine box at every time of taking, so that the medicine package 81 is placed in the medicine box 81 at the pharmacy A or the old facility B. The time and labor required for storage in the container is omitted.
  • the automatic storage device may be mounted on the medicine packaging device 3.
  • the said medicine distribution box is a box provided with the some accommodating part divided, for example, what is called a blister pack may be sufficient.
  • the blister pack is an accommodating member in which a plurality of closed packaging parts are formed by joining a packaging member having a plurality of packaging regions with one side open to a flat plate-like member. Further, in the blister pack, a cut dotted line (perforation) for easily separating each of the packaging parts is formed.
  • the control unit 51 determines whether or not the dosing time selected in step S83 is an appropriate dosing time corresponding to the current date and time counted by the medicine distribution support device 5, and is not appropriate. In such cases, it is possible to notify the fact.
  • a taking time or a taking time zone corresponding to each taking time is set in advance and stored in the data storage unit 52. For example, the taking time corresponding to the taking time “after lunch” is set to “13:00”, the taking time corresponding to the taking time “between lunch” is set to “15:00”, and the taking time “before dinner” is supported. It is conceivable that the taking time zone to be set is “18:00”.
  • control unit 51 determines whether or not the current time is within a predetermined allowable range such as 30 minutes before and after the dosing time corresponding to the dosing time selected in step S83. Can be considered.
  • a predetermined allowable range such as 30 minutes before and after the dosing time corresponding to the dosing time selected in step S83.
  • the current time for example, a time measured as a system clock of the medicine distribution support device 5 or a time that can be acquired from a predetermined time notification organization via the network N2 or the like is used.
  • the time period corresponding to the dose period “after lunch” is set to “12:30 to 13:00”, and the time period corresponding to the dose period “between lunch” is set to “15:00 to 16:00” Therefore, it is conceivable that the taking time zone corresponding to the taking time “before dinner” is set to “18:30 to 19:00”. In this case, it is conceivable that the control unit 51 determines whether or not the current time is in the dosing time zone corresponding to the dosing time selected in step S83.
  • control unit 51 may select a dose time selected on the initial screen 210 and a one-dimensional code or a two-dimensional code attached to the medicine box read by the portable terminal 6 or the reading terminal 7.
  • a configuration is also conceivable in which it is possible to collate with the timing of taking the code, and to notify that when the collation results do not match.
  • the control unit 51 includes one-dimensional information including information to be pasted on the medicine distribution box such as a medication date and time, a medication time, and a group according to the operation of the operation device 55. It is conceivable that a code such as a code or a two-dimensional code can be printed on a label or the like by an arbitrary printer.
  • control unit 51 may select the date and time of taking before the initial screen 210 is displayed, and the date and time of taking the code attached to the medicine box read by the mobile terminal 6 or the reading terminal 7. Can be collated, and when the collation results do not match, a configuration that can notify that fact is also conceivable.
  • control unit 51 can collate the group displayed on the initial screen 210 with the group of codes attached to the medicine box read by the portable terminal 6 or the reading terminal 7. A configuration is also conceivable in which, when the collation results do not match, that fact can be notified.
  • step S ⁇ b> 84 the control unit 51 displays a resident list screen 211 (an example of a second display screen) on which a resident list is displayed on the display device 54 or the display unit of the mobile terminal 6.
  • FIG. 23 is a diagram showing an example of the resident list screen 211.
  • the control unit 51 is configured to display the resident list screen based on the resident master stored in the master storage unit 521 and the medicine distribution data stored in the medicine distribution data storage unit 523. 211 is displayed.
  • the control unit 51 uses the resident list screen 211 for a resident who has a medicine to be taken at the taking time determined to have been selected at the step S83, and is taken at the taking time.
  • the resident who does not have the medicine to be displayed is displayed in a different display mode. That is, the control unit 51 can display the relationship between each resident and each time of taking by executing the steps S81 to S84.
  • the display processing is executed by the display control unit 511, and the display control unit 511 is an example of a prescription display unit.
  • the display control unit 511 when displaying the initial screen 210 for selecting the dosing time in the steps S81 to S82 is an example of a first display processing unit.
  • the display control unit 511 when displaying the tenant list screen 211 that displays whether or not each tenant needs to dispense medicine at the dosing time according to the selection of the dosing time in 210 is a second display processing unit. It is an example.
  • the person in charge of medicine distribution can easily determine the resident who has the medicine to be taken at each time of taking, using the initial screen 210 and the resident list screen 211.
  • the difference in the background pattern of the resident in FIG. 23 indicates that there is a difference in the display mode. For example, a resident who has a medicine to be taken (such as “Ichiro Yuyama”) may be highlighted, and a resident who has no medicine to be taken (such as “Saburo Yuyama”) may not be highlighted. It is also conceivable that the display color of a resident who has a medicine to be taken is different from the display color of a resident who has no medicine to be taken. Furthermore, the display size of a resident who has a medicine to be taken is large, and the display size of a resident who has no medicine to be taken may be small.
  • the resident list screen 211 as status information regarding the resident's medication status, in addition to the presence / absence of a medicine to be taken at the above-mentioned taking time, “not taking”, “done”, “going out” , “Non-medicine completed", “No self-management confirmed”, “Self-managed unconfirmed”, “Self-managed confirmed”, “Working", “Unable to take medication”, “In hospital”, etc. Conceivable. That is, on the resident list screen 211, the plurality of status information can be displayed in different display modes such as different color schemes or display sizes.
  • status information such as whether or not each resident has gone out is preliminarily stored in the resident of the master storage unit 521 by the control unit 51 according to the operation of the operation unit 55 or the operation unit of the mobile terminal 6. It can be stored as part of the master.
  • “At work” indicates that the resident is at work
  • “Unable to take medication” indicates that the resident is in a difficult health state
  • “In hospital” indicates that the resident Indicates that the person is hospitalized.
  • “not taking medicine” indicates that the user has not taken the medicine but the medicine has been processed as a remaining medicine and the medicine has been completed.
  • “No self-confirmation confirmation” indicates that it is necessary to self-manage the user by preliminarily depositing the medicine for a predetermined period of time and it is not necessary to confirm the presence or absence of the medicine.
  • “Self-managed unconfirmed” and “Self-managed confirmed” indicate that the patient is self-managed by prescribing the medicine for a predetermined period in advance, but the presence or absence of the medicine needs to be confirmed. “Unconfirmed management” indicates that the medication has not yet been confirmed, and “Self-administered confirmed” indicates that the medication has already been confirmed and an input operation to that effect has been performed.
  • the resident who is not displayed on the same screen can be displayed by scrolling, and the display order of the resident in the resident list screen 211 is, for example, in alphabetical order or alphabetical order. is there.
  • the control unit 51 displays the resident display on the resident list screen 211 only for unoccupied residents. It is possible to alternately switch between a state and a state where all residents are displayed. Further, the control unit 51 changes the status information of the tenant currently displayed on the tenant list screen 211 to the state of “untreated medicine” in response to the selection of the “complete” operation key on the tenant list screen 211.
  • the control unit 51 calculates the state of the tablets contained in the medicine package 81 without calculating the total of the remaining medicine information. Store it as it is. For example, when one pill and 0.5 tablet (half tablet) are packed in a medicine pack 81 as a medicine of a certain resident, and the medicine pack 81 remains three times, the data storage unit 52 , Information of 1.5 tablets ⁇ 3 instead of 4.5 tablets is stored as the remaining medicine information.
  • the resident in the medicine distribution support system 100, as shown in the resident master (see FIG. 15) and the resident registration screen (see FIG. 17), the resident can be classified into a plurality of groups. is there.
  • the control unit 51 displays the resident list screen 211 for each group.
  • FIG. 24 is a diagram showing an example of a resident list screen 211 when each resident is displayed for each group.
  • the resident list screen 211 shown in FIG. 24 tabs corresponding to each group are displayed.
  • a list of residents belonging to the group of the tab is displayed.
  • the display mode of the resident shown in FIG. 23 is the same as that of the resident list screen 211, and the description thereof will be omitted.
  • the control unit 51 indicates the code read by the mobile terminal 6 or the reading terminal 7. It is conceivable to display the resident list screen 211 corresponding to the group.
  • the control unit 51 includes the group of the tab selected on the resident list screen 211 in FIG. 24 and the group indicated by the code read from the medicine box by the portable terminal 6 or the reading terminal 7. It is possible to collate whether or not and match, and when the matching result does not match, a configuration that can notify that fact is also conceivable.
  • step S85 the control unit 51 waits for selection of a resident to be taken (S85: No side). If it is determined that a resident has been selected (S85: Yes side), the process proceeds to step S86.
  • control unit 51 determines that a resident is selected when an operation for selecting a resident on the resident list screen 211 is performed by the operation unit 55 or the operation unit of the portable terminal 6. to decide.
  • control unit 51 receives a code such as a name tag, a wristband, or a one-dimensional code or a two-dimensional code attached to the medicine package 81 owned by a resident by the portable terminal 6 or the reading terminal 7.
  • a code such as a name tag, a wristband, or a one-dimensional code or a two-dimensional code attached to the medicine package 81 owned by a resident by the portable terminal 6 or the reading terminal 7.
  • the control unit 51 can collate the tenant selected on the tenant list screen 211 with the tenant indicated by the code read by the mobile terminal 6 or the reading terminal 7, and the collation result If there is a mismatch, a configuration that can notify that is also conceivable.
  • step S85 when the menu key on the resident list screen 211 is operated, the control unit 51 performs the medicine distribution start operation to display the display device 54 or the portable terminal 6. Return to the previous menu screen. In addition, when the return key is operated, the control unit 51 returns the display of the display device 54 or the mobile terminal 6 to the initial screen 210.
  • step S86 the control unit 51 causes the display device 54 or the display unit of the portable terminal 6 to display a resident confirmation screen 213 for confirming the resident determined to have been selected in step S85. Specifically, the control unit 51 displays the resident information, information on medicines to be taken, and the like based on the resident master and the medicine distribution data stored in the master storage unit 521. To display.
  • FIG. 25 is a diagram showing an example of the resident confirmation screen 213.
  • the resident confirmation screen 213 As shown in FIG. 25, in the resident confirmation screen 213, the resident's name, face image (photograph), and comment are displayed as the resident information. In addition, on the resident confirmation screen 213, usage and medicine information is displayed in the distribution data. Thereby, the person in charge of medicine distribution can easily grasp the suitability of the residents and medicines to be medicines.
  • a confirmation key, a cancel key, and an unused key are displayed.
  • the confirmation key is an operation key for inputting that the resident has confirmed that it is appropriate.
  • the cancel key is an operation key for canceling the resident selection and returning the display on the display device 54 or the mobile terminal 6 to the resident list screen 211.
  • the non-medicine key is an operation key for inputting the reason for non-medication when the resident does not take the medicine and completing the medicine without taking the medicine.
  • the drug distribution confirmation data is a part or all of the prescription data itself, it may be impossible to grasp the contents of the medicine (for example, packaging state) after actually dispensing.
  • the control unit 51 may omit displaying medicine information on the resident confirmation screen 213.
  • the data storage unit 52 stores a drug master including the side effect related information on the side effects to be noted for each drug
  • the resident confirmation screen 213 stores the side effect related to the drug taken by the resident. Information may be displayed.
  • the control unit 51 may access the dispensing support device 1 through the network N1 and display the side effect related information of the drug by referring to the medicine master stored in the dispensing support device 1. Conceivable. Thereby, the person in charge of the medicine can easily grasp the matters to be careful about the state of the resident with reference to the side effect related information at the time of the medicine to the resident, for example, the abnormality of the resident Etc. can be detected early.
  • the taking time code may be displayed instead of the character indicating the taking time or together with the taking time.
  • the person in charge of medicine distribution can easily check the medication time by referring to the medication time code when the medication time code is also printed on the medicine package 81.
  • the status information regarding the resident's medication (“unmedicated”, “medicine completed”, “going out”, “unmedicated”, “no self-management confirmation”, “self-management”) "Unconfirmed”, “Self-confirmed confirmed”, "Working", “Unable to take medication", “In hospital”, etc.) may be displayed.
  • the medicine master includes medicine image data such as a photograph of each medicine
  • the control unit 51 can display the medicine image data on the resident confirmation screen 213.
  • step S87 the control unit 51 waits for a confirmation operation (S87: No side). If it is determined that the confirmation operation has been performed, the process proceeds to step S871. If the confirmation operation has not been performed, the process proceeds to step S88.
  • control unit 51 determines that the confirmation operation has been performed when the confirmation key on the resident confirmation screen 213 is operated. At this time, the control unit 51 displays an input screen for inputting a resident ID according to the operation of the confirmation key, and displays the resident ID input on the input screen on the resident confirmation screen 213.
  • a configuration is also conceivable in which it is possible to collate with a resident ID corresponding to a resident who is informed, and to notify the fact when the collation result is inconsistent. For example, when the collation results do not match, the control unit 51 displays an error message on the display device 54 or the mobile terminal 6 and then returns the display screen to the resident list screen 211.
  • control unit 51 displays an input screen for inputting a resident ID in accordance with the operation of the confirmation key before displaying the resident confirmation screen 213 in the step S86. It is also conceivable to collate the entered resident ID with the resident ID corresponding to the resident selected in step S85. In this case, if the collation result is coincident, the control unit 51 shifts the processing to step S86 to display the resident confirmation screen 213, and notifies that fact when the collation result is inconsistent. Can be considered. Similarly, in the configuration in which the control unit 51 collates the tenant selected on the tenant list screen 211 with the tenant indicated by the code read by the portable terminal 6 or the reading terminal 7, It can be considered that the resident confirmation screen 213 is displayed after it is confirmed that the collation results are the same.
  • control unit 51 reads the code 811 attached to the medicine package 81 by the mobile terminal 6 or the reading terminal 7, and the resident indicated by the code 811 is displayed on the resident confirmation screen 213. It is also conceivable to determine that the confirmation operation has been performed when it coincides with a resident who has been admitted. If the tenants do not match, the control unit 51 displays an error message on the display device 54 or the portable terminal 6 and then returns the display screen to the tenant list screen 211. By the way, in order to thoroughly check the reading of the medicine package 81 by the portable terminal 6 or the reading terminal 7, it is possible to omit the display of the confirmation key on the resident confirmation screen 213 as another embodiment.
  • step S871 the control unit 51 causes the display device 54 or the portable terminal 6 to display a message prompting the resident to start medication. Then, the person in charge of medicine distribution distributes the medicine package 81 to the resident. In addition, it is also conceivable that information indicating whether or not the tenant management screen is self-managed as the tenant management category is displayed. Thereby, the person in charge of medicine distribution can easily determine the management classification of the resident at the time of medicine distribution of the medicine package 81.
  • Step S872> the control unit 51 associates the medicine distribution data stored in the medicine distribution data storage unit 523 with the result of medicine distribution to the resident displayed on the resident confirmation screen 213. "Medication complete" is recorded, and the process returns to step S81. Thereby, when the resident list screen 211 is displayed next, the resident's name is displayed in a display mode indicating that no medication is required for the time when the medication has already been taken.
  • the process for accepting the confirmation operation as an input operation for completing the medication of each resident is performed by the medication completion input unit 515. Note that the step S87 may be omitted.
  • step S88 the control unit 51 waits for an operation of the non-taking key (S88: No side).
  • the process proceeds to step S881, and if the non-administration key has not been operated, the process proceeds to step S89.
  • the control unit 51 may display a confirmation message such as “Can I take it?” When the non-taken key is operated.
  • step S881 the control unit 51 pops up on the resident confirmation screen 213 a non-medicine input screen 214 for inputting the reason for non-medicine that the resident did not take medicine.
  • the reason for non-medication input in the non-medicine input is stored in association with the drug distribution data stored in the drug distribution data storage unit 523.
  • the reason for not taking medication is entered by displaying a list of pre-registered reasons for taking medication and selecting the reason for not taking medication.
  • the reason for not taking the medicine can be input by selecting from a plurality of predetermined candidates displayed in a pull-down format.
  • control unit 51 associates the drug distribution data stored in the drug distribution data storage unit 523 with the result of the drug distribution to the resident displayed on the resident confirmation screen 213 as “untreated drug”. Record Completed. Accordingly, when the resident list screen 211 is displayed next time, the name of the resident is displayed in a display mode indicating that no medication is required for the time of taking the reason for not taking medication already entered. Will be.
  • FIG. 27 is a diagram illustrating an example of a schedule input screen 215 for inputting a plan of a resident who has not taken medication.
  • a schedule input screen 2115 for inputting a plan of a resident who has not taken medication.
  • an arbitrary schedule is selected by operating the operation device 55 or the portable terminal 6, a pre-registered dosing time is selected, and the reason for not taking the drug is shown. Entered.
  • FIG. 27 shows a state in which March 12-14, 2014 is selected on the schedule input screen 215.
  • control unit 51 When the non-medicine schedule is input in this way, the control unit 51 omits the non-medicine reason input process in step S881 when the non-medicine key is operated (S88: Yes side). Then, it is conceivable to display information on an already registered schedule that has not been taken. In addition, when an unscheduled schedule has been input, the control unit 51 displays the fact that the medicine has not been taken on the resident list screen 211, thereby omitting the confirmation work of the resident. It is possible to make it.
  • step S882 the control unit 51 sets the medicine that the resident should have taken as the remaining medicine information regarding the remaining medicine that the resident has not taken, which is displayed on the resident confirmation screen 213. Information is output together with the resident information (such as drug distribution data). This processing is executed by the remaining medicine information output unit 516.
  • the control unit 51 outputs the remaining medicine information to the communication interface 53, and transmits the remaining medicine information to the dispensing support device 1 through the network N2 such as the Internet. Can be considered.
  • the remaining medicine information can be transmitted to the dispensing support device 1, the method is not limited to this.
  • the control unit 51 may record and output the USB memory 19 via the USB port 58. Conceivable.
  • a doctor or a pharmacist can refer to the said remaining medicine information at the time of the prescription of the next chemical
  • the remaining medicine information is also stored in the data storage unit 52. Thereby, it becomes possible to refer to the remaining medicine information also in the medicine distribution support device 5 or the portable terminal 6.
  • step S89 the control unit 51 waits for an operation of the cancel key (S89: No side). If it is determined that the cancel key has been operated (S89: Yes side), the process proceeds to step S84, and the resident list screen 211 is displayed again. If the cancel key is not operated (S89: No side), the process proceeds to step S87.
  • the drug distribution support device 100 executes the drug distribution support device 5 by providing the drug distribution data from the dispensing support device 1 to the drug distribution support device 5. It is possible to realize display and operation in consideration of the drug distribution data in the collating process at the time of drug distribution. Thereby, while it becomes possible to perform the medicine distribution work to the tenant by the person in charge of medicine distribution efficiently, the medicine person in charge of medicine distribution can be suppressed.
  • the following other functions can be realized by providing the drug distribution data to the drug distribution support device 5.
  • control unit 51 can arbitrarily input the health status or side effect status of the resident on the resident confirmation screen 213.
  • the control unit 51 can input a plurality of predetermined items in a pull-down format in consideration of the display space of the resident confirmation screen 213.
  • the control unit 51 may narrow down and display side effect candidates corresponding to medicines taken by the resident based on the side effect related information and the medicine distribution data. Thereby, the side of the old health facility B can easily input the side effect by selecting from the candidates.
  • control unit 51 displays an input start key such as the health status or side effect status of the resident on the resident confirmation screen 213, and the resident confirmation screen 213 displays the input start key according to the operation of the input start key. It is also conceivable to display the side effect information input screen 216 in a pop-up.
  • FIG. 28 is a diagram showing an example of the side effect information input screen 216.
  • the control unit 51 when a predetermined operation for inputting side effect information is performed on a menu screen or the like different from the resident confirmation screen 213, the control unit 51, as shown in FIG.
  • the side effect information and the comment are displayed on the resident status screen 217, and when the side effect information input operation is performed on the resident status screen 217, the side effect information input screen 216 is displayed in a pop-up. Is also possible.
  • the side effect information input screen 216 is also used for inputting arbitrary comment information in advance for each resident.
  • the control unit 51 stores the side effect information in the data storage unit 52. It can be considered that the communication interface 53 transmits the information to the dispensing support device 1.
  • the side effect information is recorded on a recording medium such as the USB memory 19, and the USB memory 19 is connected to the dispensing support device 1 or the upper system (not shown) or the like, so that the dispensing support device 1 or the It is also conceivable that the side effect information is input to a host system (not shown) or the like.
  • control unit 51 can identify and display a suspected drug that is likely to cause a side effect that is expressed based on the side effect information and the side effect related information.
  • the medicine master includes medicine image data such as a photograph of each medicine
  • the control unit 51 displays the medicine image data of the suspected medicine on the resident confirmation screen 213. Is also possible. Thereby, for example, an artificial mistake when extracting the suspected drug from the medicine pack 81 in which a plurality of medicines are packaged is suppressed.
  • the pharmacy can easily grasp information such as the health status or side effect status of the resident.
  • the side effect information can be transmitted to the host system (not shown) by the control unit 11.
  • the doctor prescribing the resident's medicine can also refer to the side effect information in the host system (not shown), and the hospital (doctor), pharmacy (pharmacist), and health facility (in charge of drug distribution) Medical system in close cooperation.
  • the side effect information can be referred to by the dispensing support device 1 or the host system (not shown), for example, a pharmacist can use the side effect information at the time of dispensing based on the next prescription data of the resident. On the basis of it, it is possible to dispense with the dispensing of certain chemicals.
  • the said control part 11 automatically excludes the chemical
  • the control unit 11 in the dispensing support device 1 it is also conceivable to identify the medicine and the remaining amount that have not been taken based on the above, and to generate the packaging data by excluding the remaining amount from the prescription amount of the medicine that has not been taken at the next generation of the packaging data.
  • the pharmacist at the pharmacy A side refers to the side effect information displayed on the dispensing support device 1 and informs the doctor of the suspected drug that may cause the side effect, and inputs a new prescription.
  • a medicine distribution box that accommodates the medicine package 81 corresponding to each time of taking is provided, and a medicine distribution box that can be opened and closed for each container is connected to the medicine distribution support device 5 and used. It is possible.
  • the control unit 51 controls the opening and closing of each of the storage units in the medicine distribution box based on the medicine distribution data so that the medicine corresponding to the medicine timing cannot be taken out unless the medicine time comes. It is possible to do. Thereby, the medicine distribution mistake with respect to the said resident
  • FIG. 30 to FIG. 33 are diagrams showing examples of history screens that can be displayed by the medication history display function.
  • the control unit 51 displays a history screen 218 shown in FIG. 30 when a predetermined operation for displaying a medication history is performed in a state where the menu screen is displayed on the display device 54 or the like.
  • the medication result of each resident is displayed on a daily basis.
  • a mark “ ⁇ ” indicates medication
  • a “ ⁇ ” mark indicates that some medications have not been taken
  • a “ ⁇ ” symbol indicates medications that have not been taken.
  • the said partial non-medication shows the state in which the medication and the non-medication are contained in a plurality of taking times included in one day.
  • the partial non-medicine means that one or two dose periods of morning, noon, and evening are not taken when three doses of morning, noon, and evening are included in one day. This is the case.
  • the control unit 51 In the history screen 218, it is conceivable to display a schedule of necessity of taking corresponding to each patient.
  • the medicine distribution data or the prescription data is input from, for example, the dispensing support device 1, read from the USB memory 19, or read from the medicine package 81.
  • the control unit 51 displays a diamond-shaped mark or the like that is set in advance in order to indicate that it is necessary to take a dose in a column corresponding to a date that needs to be taken.
  • a schedule that does not need to be taken such as a resident's going-out plan or a plan to stay overnight
  • the control unit 51 displays a history screen 219 shown in FIG. 31 instead of the history screen 218.
  • the history screen 219 shown in FIG. 31 the history of each medicine taken by the selected resident is displayed on a daily basis.
  • a display field of “other information” is provided at the bottom.
  • “ ⁇ ” is displayed on the day when information such as information on remaining medicine or information on side effects is recorded. Is described.
  • the control unit 51 selects the area where “ ⁇ ” is written in the “other information” display field, or the operation pointer of the operation device 55 or the mobile terminal 6 is displayed in the area. In the case where it exists, it may be possible to display information such as residual drug information or side effect information corresponding to the display column in a pop-up.
  • the control unit 51 displays a history screen 220 shown in FIG. 32 instead of the history screen 219.
  • the history screen 220 shown in FIG. 32 the history of each medicine taken by the selected resident is displayed in units of taking time.
  • the history screen 220 also displays a display column of “other information” as in the history screen 219.
  • the control unit 51 displays the information of the remaining medicine. It is conceivable to read out from the medicine distribution data storage unit 523 and display it on the history screen 221 shown in FIG. In the history screen 221 shown in FIG. 33, “2 tablets” is shown as the remaining drug status of the medicine M1, and “1.5 tablets ⁇ 3” is shown as the remaining drug status of the medicine M2. Here, it may be possible to display “4.5 tablets” which is the calculation result of 1.5 tablets ⁇ 3 as the remaining drug status of the medicine M2, but the control unit 51 determines the dosage form of the medicine M2. In consideration, “1.5 tablets ⁇ 3” is displayed.
  • the remaining medicine of the medicine M2 is not a total of 5 tablets of 4 tablets and 0.5 tablets, but a total of 6 tablets of 1 tablet and 0.5 tablets, for example, the following prescription data It is possible to easily determine whether or not to use it as a prescription drug included in. For this reason, in the medicine distribution support device 5, the control unit 51 manages the remaining amount of medicine in the remaining medicine information of each resident's medicine in the state at the time of dispensing, and similarly to the dispensing assistance device 1. The remaining drug information is transmitted.
  • FIG. 34 to FIG. 35 are diagrams showing an example of a medication schedule screen that is displayed when the medication distribution data is input.
  • FIG. 36 is a view showing an example of a series of the medicine packs 81 in which the medicine inspection code is printed on the first medicine package 81.
  • a two-dimensional code is printed as the drug detection code on the first medicine pack 81, and the code indicating the first medicine distribution information is displayed on the second and subsequent medicine packs 81.
  • a one-dimensional code is printed as 811.
  • the drug inspection code includes pre-determined information necessary for drug inspection of the medicine package 81 and drug distribution data such as a tenant ID, a tenant name, a start date of taking, an end date of taking, and a taking time code. included.
  • the dosing time code is a number or symbol indicating the dosing time (before breakfast, after breakfast, before lunch, etc.) that needs to be taken between the start date of taking and the end date of taking. That is, here, the medicine distribution data corresponding to each resident is sequentially obtained by reading the drug inspection code of the first or last medicine pack 81 of the series of medicine packs 81 corresponding to each resident. It is assumed that it is input to the medicine distribution management device 5.
  • the series of medicine packs 81 are delivered as they are from the pharmacy A side to the health facility B side, or the medicine packages 81 are individually separated from the pharmacy A side to the health facilities. Delivered to B side.
  • the said control part 51 when the said medicine distribution data is read from the said test
  • the corresponding medication schedule of the resident is registered in the data storage unit 52.
  • the control unit 51 may display a dosing schedule screen 222 for confirming that the medicine distribution data has been read on the reading terminal 7 or the display device 54 that has read the medicine distribution data. Conceivable. Further, the dosing schedule screen 222 is displayed on the portable terminal 6 and the reading terminal 7 even when a predetermined user operation for confirming a medication schedule is performed on the portable terminal 6 and the reading terminal 7 or the like. Is displayed.
  • FIG. 34 is a diagram showing an example of the dosing schedule screen 222.
  • the resident ID, occupant name, and start of taking corresponding to the medicine distribution data read from the medicine pack 81 at the end are displayed.
  • the date, the end date of taking, etc. are displayed.
  • the medication schedule screen 222 displays a list of the medicine distribution data corresponding to one or a plurality of residents already read and stored in the data storage unit 52 in the lower part.
  • a medication detail screen 223 that displays details of the medication schedule corresponding to the medication data is displayed. .
  • the said control part 51 can also delete the medication schedule corresponding to the said medicine distribution data, when the said specific medicine distribution data is selected and the deletion key is operated. Further, the information displayed on the upper part of the dosing schedule screen 222 may be switched to information corresponding to the selected medicine distribution data according to the selection of the medicine distribution data on the lower part of the dosing schedule screen 222. .
  • FIG. 35 is a diagram showing an example of the dosing detail screen 223.
  • the resident ID, resident name, medication start date, medication end date, etc. of the resident corresponding to the read medicine distribution data are displayed on the upper row. Is displayed.
  • the scheduled dosage date and timing from the medication start date to the medication end date corresponding to the medicine distribution data corresponding to one resident are displayed.
  • the control unit 51 automatically, based on the medicine distribution data, according to an alarm condition set in advance for each occupant's dosing time corresponding to the medicine distribution data.
  • the alarm setting process for setting the alarm time is executed.
  • the said control part 51 when performing the process which concerns here is an example of an alarm setting means. Specifically, as the alarm condition, the alarm time corresponding to the taking time “after lunch” is “13:00”, the alarm time corresponding to the taking time “between lunch” is “15:00”, and the taking time “before dinner”. It is conceivable that the corresponding alarm time is “18:00”.
  • the alarm time corresponding to the taking time “after lunch” is “12:30”
  • the alarm time corresponding to the taking time “between lunch” is “15:00”
  • the control unit 51 urges the taking of the taking time, etc. Is displayed on the portable terminal 6, the reading terminal 7, or the display device 54 of the medicine distribution support device 5 or the like.
  • the said control part 51 when performing the process which concerns here is an example of an alarm alerting
  • the content of the alarm notification process is not limited to display, but may be notification by voice, for example.
  • the control unit 51 displays a list of patients whose dosing completion has not been input, or displays a message or the like in order for each patient whose dosing completion has not been input. It is possible.
  • the control unit 51 displays a “x” mark in a column corresponding to the non-dosing time. For example, the control unit 51 does not need to take the code information 811 corresponding to the dosing time within a predetermined time after execution of the alarm notification process or when the code information 811 corresponding to the dosing time is not read. When a certain operation is performed, it is determined that the dose at the dose time has not been taken.
  • the said control part 51 moves a drug distribution object in order in the state in which the list of the patients whose dosing completion is not input is displayed, it respond
  • the code information 811 it may be determined that the current patient to be dispensed has not been taken.
  • the said control part 51 moves a drug distribution object in the state where the list of patients is displayed, when the said code information 811 corresponding to the patient of the current drug distribution object is read, the said patient's list is displayed. It is determined that the dose has been taken, and the next patient is selected as a drug distribution target.
  • control unit 51 sequentially displays a message or the like for each patient for which the completion of taking is not input, the code information 811 corresponding to a patient different from the patient corresponding to the currently displayed message or the like. It is also possible to determine that the patient corresponding to the displayed message or the like has not been taken.
  • control unit 51 displays messages corresponding to each patient in order, when the code information 811 of the patient corresponding to the currently displayed message or the like is read, the patient is taken. The message or the like corresponding to the next patient is displayed.
  • Dispensing support device 11 Control unit 12: Data storage unit 2: Reading terminal 3: Drug packaging device 31: Control unit 32: Packaging printer 4: Printer 5: Drug distribution support device 51: Control unit 52: Data storage Unit 6: portable terminal 61: control unit 62: camera 7: reading terminal 81: medicine package (an example of a packaging container) 82: Medicine bag (an example of a delivery container) 10: Drug distribution support system 100: Drug distribution support system

Abstract

 In this drug distribution assistance system (1), first drug distribution information is recorded on drug sachets (81) used when drugs received by one recipient are separately packaged for each dosage time, the first drug distribution information including the dosage time and predetermined delivery destination identity information. Second drug distribution information is recorded on a drug packet (82) for accommodating drug sachets (81) to be received at the same dosage time by a plurality of recipients belonging to a predetermined drug distribution group, the second drug distribution information including the dosage time and predetermined delivery destination identity information. By determining whether the dosage time and delivery destination identity information of the first drug distribution information read from the drug sachets (81) is the same as the dosage time and delivery destination identity information of the second drug distribution information read from the drug packet (82), human error can be reduced when distributing drugs by collecting separate packages for a plurality of recipients into dosage times and then packaging the same into a delivery package and delivering the delivery package to a delivery destination.

Description

配薬支援システムDrug distribution support system
 本発明は、配薬作業を支援するための配薬支援システムに関する。 The present invention relates to a drug distribution support system for supporting drug distribution work.
 近年、服用時期ごとに薬品を分包した薬包などの分包容器を、予め定められた配薬グループに属する複数の服用者ごとに纏めて薬袋などの配送容器に収容し、その配送容器を介護老人保健施設(以下「老健施設」と称する)などの配送先に配送する運用が望まれることがある。このような運用によれば、配送先において、服用時期ごとに配送容器から同一の配薬グループに属する複数の服用者の分包容器を取り出して服用者各々に容易に投薬することが可能になる。ここで、複数の分包容器を配送容器に収容する際には、分包容器と配送容器との対応関係が正しいことを厳重にチェックする必要がある。なお、従来技術として、薬包及び薬袋に薬袋識別情報を印刷することにより、薬袋への薬包の入れ間違いを抑制する技術が知られている(特許文献1参照)。 In recent years, a packaging container such as a medicine package in which a medicine is packaged at each time of taking is collected for each of a plurality of users belonging to a predetermined medicine distribution group and accommodated in a delivery container such as a medicine bag. There is a case where it is desired to deliver to a delivery destination such as a nursing care health facility for the elderly (hereinafter referred to as “old health facility”). According to such an operation, at the delivery destination, it becomes possible to take out the packaging containers of a plurality of users belonging to the same medicine distribution group from the delivery container at every time of taking and easily dispense each of them. . Here, when accommodating a plurality of packaging containers in the delivery container, it is necessary to strictly check that the correspondence between the packaging container and the delivery container is correct. In addition, the technique which suppresses the mistake of putting the medicine package into the medicine bag by printing medicine bag identification information on the medicine package and the medicine bag is known as a conventional technique (see Patent Document 1).
特開2000-24087号公報Japanese Unexamined Patent Publication No. 2000-24087
 しかしながら、前述の従来技術では、複数の服用者の薬包を服用時期ごとに纏めて薬袋に収容して配送先に配送するという配薬作業の実施が考慮されていないため、薬包及び薬袋の両方に印刷される情報に配送先及び服用時期の情報が含まれていない。 However, in the above-mentioned prior art, since it is not considered to carry out a medicine distribution operation in which medicine packages of a plurality of users are collected in a medicine bag for each time of taking and delivered to a delivery destination, The information printed on both does not include information on the delivery destination and the timing of taking.
 本発明の目的は、複数の服用者の分包容器を服用時期ごとに纏めて配送容器に収容して配送先に配送する配薬作業における人為的ミスを抑制することが可能な配薬支援システムを提供することにある。 An object of the present invention is to provide a drug distribution support system capable of suppressing human error in a drug distribution operation in which a plurality of dosers' packaging containers are collected at each time of taking and stored in a delivery container and delivered to a delivery destination. Is to provide.
 本発明の一の局面に係る配薬支援システムは、第1記録手段、第2記録手段、及び判定手段を備える。前記第1記録手段は、一の服用者が服用する薬品を服用時期ごとに分包する際に用いられる分包容器又は前記分包容器に付される第1記録媒体に、前記服用時期及び予め定められた配送先識別情報を含む第1配薬情報を記録する。前記第2記録手段は、予め定められた配薬グループに属する複数の服用者の前記分包容器を同一服用時期ごとに収容する際に用いられる配送容器又は前記配送容器に付される第2記録媒体に、前記服用時期及び予め定められた配送先識別情報を含む第2配薬情報を記録する。前記判定手段は、前記分包容器又は前記第1記録媒体から読み取られる前記第1配薬情報の前記服用時期及び前記配送先識別情報と前記配送容器又は前記第2記録媒体から読み取られる前記第2配薬情報の前記服用時期及び前記配送先識別情報とが一致するか否かを判定する。 The drug distribution support system according to one aspect of the present invention includes first recording means, second recording means, and determination means. The first recording means includes a packaging container used when a medicine taken by a single user is packaged at each dosage time, or a first recording medium attached to the packaging container, the dosage time and the first recording medium in advance. The first medicine distribution information including the determined delivery destination identification information is recorded. The second recording means is a delivery container used when accommodating the packaging containers of a plurality of users belonging to a predetermined medicine distribution group at the same dosage time or a second record attached to the delivery container. The second medicine distribution information including the time of taking and predetermined delivery destination identification information is recorded on the medium. The determination means reads the dosing time and the delivery destination identification information of the first medicine distribution information read from the packaging container or the first recording medium and the second reading from the delivery container or the second recording medium. It is determined whether the dosing time and the delivery destination identification information of the medicine distribution information match.
 本発明によれば、分包容器及び配送容器の服用時期及び配送先が一致するか否かが判定されるため、複数の服用者の分包容器を服用時期ごとに纏めて配送容器に収容して配送先に配送する配薬作業における人為的ミスを抑制することが可能になる。 According to the present invention, since it is determined whether or not the taking time and the delivery destination of the packaging container and the delivery container coincide with each other, the packaging containers of a plurality of users are collectively stored in the delivery container for each taking time. Thus, it is possible to suppress human error in the medicine distribution work to be delivered to the delivery destination.
 より具体的には、前記配薬支援システムが、前記判定手段の判定結果を報知する報知手段を更に備える構成が考えられる。これにより、ユーザーは、前記判定手段の判定結果を認識することができる。 More specifically, a configuration may be considered in which the medicine distribution support system further includes a notification unit that notifies the determination result of the determination unit. Thereby, the user can recognize the determination result of the determination means.
 さらに、前記判定手段は、同一の前記配送容器に収容される前記分包容器として予め定められた全ての前記分包容器又は前記分包容器の前記第1記録媒体から前記第1配薬情報が読み取られたか否かを判定することが考えられる。これにより、前記配送容器への前記分包容器の収容漏れを抑制することが可能となる。 Further, the determination means may receive the first medicine distribution information from all the packaging containers predetermined as the packaging containers accommodated in the same delivery container or the first recording medium of the packaging containers. It can be considered to determine whether or not it has been read. Thereby, it becomes possible to suppress the accommodation leakage of the said packaging container to the said delivery container.
 また、前記判定手段が、同一の前記配送先識別情報に対応する配送先に同時に配送される前記配送容器として予め定められた全ての前記配送容器又は前記配送容器の前記第2記録媒体から前記第2配薬情報が読み取られたか否かを更に判定することも考えられる。これにより、同一の前記配送先識別情報に対応する配送先への前記配送容器の配送漏れを抑制することが可能となる。 In addition, the determination unit may include all of the delivery containers predetermined as delivery containers to be delivered simultaneously to delivery destinations corresponding to the same delivery destination identification information or the second recording medium of the delivery containers. It may be possible to further determine whether or not the 2-drug distribution information has been read. Thereby, it becomes possible to suppress the delivery omission of the delivery container to the delivery destination corresponding to the same delivery destination identification information.
 さらに、前記第1配薬情報に、前記服用者の服用者識別情報が含まれていることが考えられる。この場合、前記配薬支援システムは、前記服用者識別情報に対応する前記服用者各々の顔画像が記憶される記憶手段と、前記分包容器から前記第1配薬情報が読み取られた場合に前記第1配薬情報の前記服用者識別情報に対応する前記服用者の顔画像を前記記憶手段から読み出して表示する表示制御手段と、を更に備えることが考えられる。これにより、前記分包容器を服用者に提供する際に、前記分包容器に対応する服用者の顔画像を確認することができ、投薬ミスを抑制することが可能となる。 Furthermore, it is conceivable that the user's identification information of the user is included in the first medicine distribution information. In this case, the medicine distribution support system is configured to store the face image of each of the user corresponding to the user identification information and the first medicine distribution information is read from the packaging container. It is conceivable to further comprise display control means for reading out and displaying the face image of the user corresponding to the user identification information of the first medicine distribution information from the storage means. Thereby, when the packaging container is provided to the user, the face image of the user corresponding to the packaging container can be confirmed, and a medication error can be suppressed.
 ところで、前記配薬支援システムが、前記配送先において前記配送容器から読み取られる前記第2配薬情報の前記配送先識別情報と前記配送先に対応する前記配送先識別情報とが一致するか否かを判定する配送先判定手段を更に備えることも考えられる。これにより、前記配送先への前記配送容器の誤配送を抑制することが可能となる。 Incidentally, whether or not the medicine delivery support system matches the delivery destination identification information of the second medicine delivery information read from the delivery container at the delivery destination and the delivery destination identification information corresponding to the delivery destination. It is also conceivable to further include a delivery destination determination means for determining Thereby, it is possible to suppress erroneous delivery of the delivery container to the delivery destination.
 さらに、前記配薬支援システムが、薬品を服用時期ごとに分包容器に分包する際に用いられる処方データに基づいて、前記分包容器に分包された薬品の服用時期及び服用者の情報を含む配薬データを出力可能な配薬データ出力手段を有する薬局側端末と、複数の服用者に対応する複数の前記分包容器が配送される配送先に設けられ、前記薬局側端末から出力された前記配薬データを入力可能な配薬データ入力手段を有する施設側端末と、を備えることが考えられる。これにより、前記配送先において、前記配薬データを配薬作業の効率化及び配薬作業における投薬ミスの抑制に利用することが可能となる。 Furthermore, based on prescription data used when the medicine distribution support system divides the medicine into the sachets at each time of taking, information on the time of taking the medicine packed in the sachet and information on the user A pharmacy side terminal having a medication data output means capable of outputting medication data including the pharmacy side, and a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered and output from the pharmacy side terminal It is conceivable to include a facility-side terminal having medicine distribution data input means capable of inputting the medicine distribution data. Thereby, at the delivery destination, the drug distribution data can be used for improving efficiency of drug distribution work and suppressing medication errors in the drug distribution work.
 また、本発明の他の局面に係る配薬支援システムは、薬品を服用時期ごとに分包容器に分包する際に用いられる処方データに基づいて、前記分包容器に分包された薬品の服用時期及び服用者の情報を含む配薬データを出力可能な配薬データ出力手段を有する薬局側端末と、複数の服用者に対応する複数の前記分包容器が配送される配送先に設けられ、前記薬局側端末から出力された前記配薬データを入力可能な配薬データ入力手段を有する施設側端末と、を備える。これにより、前記配送先において、前記配薬データを配薬作業の効率化及び配薬作業における投薬ミスの抑制に利用することが可能となる。 Moreover, the medicine distribution support system according to another aspect of the present invention is based on prescription data used when a medicine is packaged in a packaging container at every time of taking the medicine. A pharmacy side terminal having a medication data output means capable of outputting medication data including medication time and information on a user and a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered And a facility side terminal having medicine distribution data input means capable of inputting the medicine distribution data outputted from the pharmacy side terminal. Thereby, at the delivery destination, the drug distribution data can be used for improving efficiency of drug distribution work and suppressing medication errors in the drug distribution work.
 また、前記施設側端末が、前記配薬データ入力手段により入力された前記配薬データに基づいて前記服用者各々と前記服用時期各々との関係を表示させる処方表示手段を更に備えることが考えられる。これにより、配薬担当者が前記服用者各々と前記服用時期各々との関係を容易に把握することができ、配薬作業の効率化及び配薬作業における投薬ミスの抑制が図られる。 Further, it is conceivable that the facility-side terminal further includes prescription display means for displaying the relationship between each of the user and each of the taking times based on the medicine distribution data input by the medicine distribution data input means. . Thereby, the person in charge of medicine distribution can easily grasp the relationship between each of the user and each of the time of administration, so that the efficiency of the medicine distribution work and the suppression of medication errors in the medicine distribution work can be achieved.
 具体的に、前記処方表示手段は、前記服用時期を選択するための第1表示画面を前記配薬データに基づいて表示する第1表示処理手段と、前記第1選択画面における前記服用時期の選択に応じて前記服用時期における前記服用者各々の配薬の要否を表示する第2表示画面を表示する第2表示処理手段と、を含むことが考えられる。これにより、前記服用時期ごとにおいて配薬が必要な服用者を容易に把握することができる。 Specifically, the prescription display means includes a first display processing means for displaying a first display screen for selecting the dosing time based on the medicine distribution data, and selection of the dosing time on the first selection screen. And a second display processing means for displaying a second display screen for displaying whether or not each of the users needs to dispense medicine at the time of taking the medicine. Thereby, the user who needs medicine distribution can be easily grasped | ascertained for every said dosing time.
 さらに、前記第2表示処理手段が、予め定められた複数の服用者を含む配薬グループごとに前記第2表示画面を表示可能であることも考えられる。これにより、前記服用者全員の情報が1つの前記第2表示画面に表示される場合に比べて、前記配薬グループごとの前記服用者について前記服用時期ごとにおける配薬の要否を容易に確認することができる。 Further, it is also conceivable that the second display processing means can display the second display screen for each medicine distribution group including a plurality of predetermined users. As a result, it is easier to confirm whether or not medicines are required at each time of taking the user for each medicine group than when the information on all the users is displayed on one second display screen. can do.
 また、前記第1表示処理手段は、前記第1表示画面において前記服用時期各々の配薬の要否を表示することが考えられる。これにより、配薬作業者は、前記服用時期ごとについて配薬の要否を容易に確認することができ、配薬作業が効率化される。 Further, it is conceivable that the first display processing means displays the necessity of the medicine distribution at each of the dose periods on the first display screen. Thereby, the medicine distribution operator can easily confirm the necessity of the medicine distribution for each time of taking, and the medicine distribution work is made efficient.
 一方、前記第2表示処理手段は、前記服薬者の服薬の状況を予め設定された表示形態で表示することが考えられる。これにより、配薬作業者は、前記服薬者の服薬の状況を容易に把握することができ、配薬作業が効率化される。 On the other hand, it is conceivable that the second display processing means displays the medication status of the medication recipient in a preset display form. Thereby, the medicine distribution operator can grasp | ascertain easily the condition of the said medication person's medication, and a medicine distribution work is made efficient.
 また、前記施設側端末が、前記第2表示画面に表示された前記服用者ごとの服薬完了の入力操作を受け付ける服薬完了入力手段を更に備えることが考えられる。これにより、前記服用者ごとの服薬完了の有無を容易に確認することが可能になる。 Also, it is conceivable that the facility terminal further includes a medication completion input means for accepting an input operation for medication completion for each user displayed on the second display screen. Thereby, it becomes possible to easily confirm whether or not the medication has been completed for each user.
 また、前記施設側端末が、前記服用者が服用しなかった残薬に関する残薬情報の入力操作を受け付けると共に、前記残薬情報を出力可能な残薬情報出力手段を更に備えることが考えられる。これにより、前記残薬情報を参照することにより前記服用者ごとの残薬の有無などを容易に把握することができ、例えば次の薬品の処方時に薬品に無駄が生じないように考慮することが可能である。 Also, it is conceivable that the facility-side terminal further includes a remaining medicine information output unit capable of receiving the remaining medicine information input operation regarding the remaining medicine that the user has not taken and can output the remaining medicine information. Thereby, by referring to the remaining medicine information, it is possible to easily grasp the presence or absence of the remaining medicine for each user, and for example, consider not to waste the medicine when prescribing the next medicine. Is possible.
 例えば、前記薬局側端末が、前記残薬情報出力手段から出力された前記残薬情報を入力可能な残薬情報入力手段と、前記残薬情報入力手段により入力された前記残薬情報と前記配薬データとに基づいて使用可能な残薬の情報を通知可能な残薬通知手段と、を更に備えることが考えられる。これにより、前記残薬情報に示された残薬を利用することで、次の調剤における薬品の無駄を抑制することが可能になる。 For example, the pharmacy side terminal can input the remaining medicine information input means that can input the remaining medicine information output from the remaining medicine information output means, the remaining medicine information input by the remaining medicine information input means, and the distribution. It is conceivable to further comprise a remaining medicine notification means capable of notifying information on available remaining medicine based on the medicine data. Thus, by using the remaining medicine indicated in the remaining medicine information, it is possible to suppress waste of medicine in the next dispensing.
 また、前記薬局側端末が、前記配薬データを予め定められた複数の服用者を含む配薬グループの単位で出力可能であることが考えられる。さらに、前記薬局側端末が、前記処方データのうち予め設定された一又は複数の項目を抽出して前記配薬データとして出力可能であることが考えられる。これにより、前記処方データのうち必要な処方データだけを容易に利用することが可能である。 Also, it is conceivable that the pharmacy side terminal can output the drug distribution data in units of a drug distribution group including a plurality of predetermined users. Furthermore, it is conceivable that the pharmacy side terminal can extract one or more preset items from the prescription data and output it as the medicine distribution data. Thereby, it is possible to easily use only necessary prescription data among the prescription data.
 ところで、前記配薬データに、前記薬品の副作用に関する情報が含まれることが考えられる。これにより、前記薬品が配送される施設側で、前記薬品副作用に関する情報を容易に参照することが可能である。 By the way, it is conceivable that the drug distribution data includes information on side effects of the drug. Thereby, it is possible to easily refer to information on the drug side effects on the facility side where the drug is delivered.
 前記施設側端末が、前記服用時期各々について予め設定されたアラーム時刻に報知を行うアラーム報知処理を実行するアラーム報知手段を更に備えることが考えられる。これにより、前記服用時期各々における服用漏れが抑制される。 It is conceivable that the facility-side terminal further includes an alarm notification means for executing an alarm notification process for performing notification at an alarm time set in advance for each of the dose times. Thereby, the omission leak in each said dosing time is suppressed.
 前記施設側端末が、前記服用時期各々について前記アラーム時刻を予め定められたアラーム条件に従って自動的に設定するアラーム設定処理を実行するアラーム設定手段を更に備えることが考えられる。これにより、前記服用時期各々についての前記アラーム時刻が自動的に設定されるため前記アラーム時刻の設定の手間が軽減される。 It is conceivable that the facility-side terminal further includes an alarm setting means for executing an alarm setting process for automatically setting the alarm time according to a predetermined alarm condition for each of the dose times. Thereby, since the alarm time for each of the dosing times is automatically set, the labor for setting the alarm time is reduced.
 本発明によれば、複数の服用者の分包容器を服用時期ごとに纏めて配送容器に収容して配送先に配送する配薬作業における人為的ミスを抑制することが可能な配薬支援システムが実現される。 ADVANTAGE OF THE INVENTION According to this invention, the medicine distribution assistance system which can suppress the human error in the medicine distribution operation which collects the packaging container of several users for every taking time, accommodates in a delivery container, and delivers to a delivery destination. Is realized.
図1は、本発明の実施の形態に係る配薬支援システムの概略構成を示すブロック図である。FIG. 1 is a block diagram showing a schematic configuration of a drug distribution support system according to an embodiment of the present invention. 図2は、本発明の実施の形態に係る配薬支援システムで使用される配薬管理情報の一例を示す図である。FIG. 2 is a diagram showing an example of medicine distribution management information used in the medicine distribution support system according to the embodiment of the present invention. 図3は、本発明の実施の形態に係る配薬支援システムが設置された薬局及び配送先で実行される配薬作業のフローの一例を示すフローチャートである。FIG. 3 is a flowchart showing an example of a flow of a drug distribution operation executed at a pharmacy where a drug distribution support system according to an embodiment of the present invention is installed and a delivery destination. 図4は、本発明の実施の形態に係る配薬支援システムが設置された薬局及び配送先で実行される配薬作業のフローの一例を示す模式図である。FIG. 4 is a schematic diagram illustrating an example of a flow of a drug distribution operation executed at a pharmacy where a drug distribution support system according to an embodiment of the present invention is installed and a delivery destination. 図5は、本発明の実施の形態に係る配薬支援システムで実行される処方データ発行処理の手順の一例を示すフローチャートである。FIG. 5 is a flowchart showing an example of a procedure of prescription data issuing processing executed in the medicine distribution support system according to the embodiment of the present invention. 図6は、本発明の実施の形態に係る配薬支援システムで実行される処方データ発行処理で生成される分包データの一例を示す図である。FIG. 6 is a diagram showing an example of packaging data generated by a prescription data issuing process executed by the medicine distribution support system according to the embodiment of the present invention. 図7は、本発明の実施の形態に係る配薬支援システムで実行される処方データ発行処理で生成される分包データの他の例を示す図である。FIG. 7 is a diagram showing another example of the packaging data generated by the prescription data issuing process executed by the drug distribution support system according to the embodiment of the present invention. 図8は、本発明の実施の形態に係る配薬支援システムで実行される薬品分包処理の手順の一例を示すフローチャートである。FIG. 8 is a flowchart showing an example of the procedure of the medicine packaging process executed by the medicine distribution support system according to the embodiment of the present invention. 図9は、本発明の実施の形態に係る配薬支援システムで実行される薬品分包処理の分包結果の一例を示す図である。FIG. 9 is a diagram showing an example of the packaging result of the medicine packaging process executed by the medicine distribution support system according to the embodiment of the present invention. 図10は、本発明の実施の形態に係る配薬支援システムで実行される収容時照合処理の手順の一例を示すフローチャートである。FIG. 10 is a flowchart showing an example of a procedure of the collation process at the time of accommodation executed by the medicine distribution support system according to the embodiment of the present invention. 図11は、本発明の実施の形態に係る配薬支援システムで実行される配送時照合処理の手順の一例を示すフローチャートである。FIG. 11 is a flowchart showing an example of a procedure of a delivery verification process executed by the medicine distribution support system according to the embodiment of the present invention. 図12は、本発明の実施の形態に係る配薬支援システムで実行される受取時照合処理の手順の一例を示すフローチャートである。FIG. 12 is a flowchart showing an example of a procedure of a receiving collation process executed by the medicine distribution support system according to the embodiment of the present invention. 図13は、本発明の実施の形態に係る配薬支援システムで実行される配薬時照合処理の手順の一例を示すフローチャートである。FIG. 13: is a flowchart which shows an example of the procedure of the collation process at the time of medicine distribution performed with the medicine distribution assistance system which concerns on embodiment of this invention. 図14は、本発明の他の実施の形態に係る配薬支援システムの概略構成を示すブロック図である。FIG. 14 is a block diagram showing a schematic configuration of a drug distribution support system according to another embodiment of the present invention. 図15は、本発明の他の実施の形態に係る配薬支援システムで使用される施設マスター及び入居者マスターの一例を示す図である。FIG. 15 is a diagram illustrating an example of a facility master and a resident master used in a drug distribution support system according to another embodiment of the present invention. 図16は、本発明の他の実施の形態に係る配薬支援システムで使用される施設登録画面の一例を示す図である。FIG. 16 is a diagram showing an example of a facility registration screen used in the drug distribution support system according to another embodiment of the present invention. 図17は、本発明の他の実施の形態に係る配薬支援システムで使用される入居者登録画面の一例を示す図である。FIG. 17 is a diagram showing an example of a resident registration screen used in the drug distribution support system according to another embodiment of the present invention. 図18は、本発明の他の実施の形態に係る配薬支援システムで実行される処方データ発行処理の手順の一例を示すフローチャートである。FIG. 18 is a flowchart showing an example of a procedure of prescription data issuing processing executed in the medicine distribution support system according to another embodiment of the present invention. 図19は、本発明の他の実施の形態に係る配薬支援システムで使用される配薬データの一例を示す図である。FIG. 19 is a diagram showing an example of drug distribution data used in a drug distribution support system according to another embodiment of the present invention. 図20は、本発明の他の実施の形態に係る配薬支援システムで実行される配薬時照合処理の手順の一例を示すフローチャートである。FIG. 20 is a flowchart showing an example of a procedure of a matching process at the time of drug distribution executed by the drug distribution support system according to another embodiment of the present invention. 図21は、本発明の他の実施の形態に係る配薬支援システムで表示される初期画面の一例を示す図である。FIG. 21 is a diagram showing an example of an initial screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図22は、本発明の他の実施の形態に係る配薬支援システムで表示される初期画面の一例を示す図である。FIG. 22 is a diagram showing an example of an initial screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図23は、本発明の他の実施の形態に係る配薬支援システムで表示される入居者一覧画面の一例を示す図である。FIG. 23 is a diagram showing an example of a resident list screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図24は、本発明の他の実施の形態に係る配薬支援システムで表示される入居者一覧画面の一例を示す図である。FIG. 24 is a diagram showing an example of a resident list screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図25は、本発明の他の実施の形態に係る配薬支援システムで表示される入居者確認画面の一例を示す図である。FIG. 25 is a diagram showing an example of a resident confirmation screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図26は、本発明の他の実施の形態に係る配薬支援システムで表示される未服薬入力画面の一例を示す図である。FIG. 26 is a diagram showing an example of a non-medicine input screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図27は、本発明の他の実施の形態に係る配薬支援システムで表示される予定入力画面の一例を示す図である。FIG. 27 is a diagram showing an example of a schedule input screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図28は、本発明の他の実施の形態に係る配薬支援システムで表示される副作用情報入力画面の一例を示す図である。FIG. 28 is a diagram showing an example of a side effect information input screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図29は、本発明の他の実施の形態に係る配薬支援システムで表示される入居者状態画面の一例を示す図である。FIG. 29 is a diagram showing an example of a resident status screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図30は、本発明の他の実施の形態に係る配薬支援システムで表示される履歴画面の一例を示す図である。FIG. 30 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図31は、本発明の他の実施の形態に係る配薬支援システムで表示される履歴画面の一例を示す図である。FIG. 31 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図32は、本発明の他の実施の形態に係る配薬支援システムで表示される履歴画面の一例を示す図である。FIG. 32 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図33は、本発明の他の実施の形態に係る配薬支援システムで表示される履歴画面の一例を示す図である。FIG. 33 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図34は、本発明の他の実施の形態に係る配薬支援システムで表示される履歴画面の一例を示す図である。FIG. 34 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図35は、本発明の他の実施の形態に係る配薬支援システムで表示される履歴画面の一例を示す図である。FIG. 35 is a diagram showing an example of a history screen displayed in the medicine distribution support system according to another embodiment of the present invention. 図36は、本発明の他の実施の形態に係る配薬支援システムで実行される薬品分包処理の分包結果の一例を示す図である。FIG. 36 is a diagram showing an example of the packaging result of the medicine packaging process executed by the medicine distribution support system according to another embodiment of the present invention.
[第1実施形態]
 以下添付図面を参照しながら、本発明の実施の形態について説明し、本発明の理解に供する。なお、以下の実施の形態は、本発明を具体化した一例であって、本発明の技術的範囲を限定する性格のものではない。
[First Embodiment]
Embodiments of the present invention will be described below with reference to the accompanying drawings for understanding of the present invention. In addition, the following embodiment is an example which actualized this invention, Comprising: The thing of the character which limits the technical scope of this invention is not.
[配薬支援システム10]
 図1に示すように、本発明の実施の形態に係る配薬支援システム10は、調剤支援装置1、読取端末2、薬品分包装置3、プリンタ4、配薬支援装置5、携帯端末6、及び読取端末7などを備える。前記調剤支援装置1、前記読取端末2、前記薬品分包装置3、及び前記プリンタ4は、ネットワークN1を介して無線又は有線で通信可能に接続されている。また、前記配薬支援装置5、前記携帯端末6、及び前記読取端末7は、ネットワークN2を介して無線又は有線で通信可能に接続されている。なお、前記ネットワークN1及び前記ネットワークN2は、LAN、WAN、インターネット、又はイントラネットなどである。
[Medicine distribution support system 10]
As shown in FIG. 1, a medicine distribution support system 10 according to an embodiment of the present invention includes a dispensing support apparatus 1, a reading terminal 2, a medicine packaging apparatus 3, a printer 4, a medicine distribution support apparatus 5, a portable terminal 6, And a reading terminal 7 and the like. The dispensing support device 1, the reading terminal 2, the medicine packaging device 3, and the printer 4 are connected via a network N <b> 1 so that they can communicate wirelessly or by wire. Moreover, the said medicine distribution assistance apparatus 5, the said portable terminal 6, and the said reading terminal 7 are connected via the network N2 so that communication is possible by radio | wireless or a wire communication. The network N1 and the network N2 are a LAN, a WAN, the Internet, an intranet, or the like.
 前記調剤支援装置1、前記読取端末2、前記薬品分包装置3、及び前記プリンタ4は、薬品の調剤が行われる薬局Aに配置される。なお、前記調剤支援装置1は薬局側端末の一例であるが、その配置場所は、前記ネットワークN1に接続可能であれば前記薬局Aの外部であってもよい。一方、前記配薬支援装置5、前記携帯端末6、及び前記読取端末7は、前記薬局Aで調剤された薬品の配送先となる老健施設B各々に配置される。前記老健施設Bには、前記薬局Aで調剤された薬品を服用する複数の服用者が入居する施設である。なお、前記老健施設Bは、予め定められた配薬グループの一例に過ぎず、例えば予め定められた複数の服用者の自宅を含む地域又は配送ルートも前記配薬グループの一例である。また、前記配薬支援装置5は、施設側端末の一例であるが、その配置場所は、前記ネットワークN2に接続されて前記老健施設Bで使用可能であれば前記老健施設Bの外部であってもよい。さらに、前記調剤支援装置1が前記配薬支援装置5の機能を兼ねることも考えられる。 The dispensing support device 1, the reading terminal 2, the medicine packaging device 3, and the printer 4 are arranged in a pharmacy A where medicine dispensing is performed. In addition, although the said dispensing assistance apparatus 1 is an example of a pharmacy side terminal, the arrangement | positioning place may be the said pharmacy A outside as long as it can connect to the said network N1. On the other hand, the medicine distribution support device 5, the portable terminal 6, and the reading terminal 7 are arranged in each of the old facilities B serving as delivery destinations of medicines dispensed in the pharmacy A. The health facility B is a facility where a plurality of users who take medicines dispensed at the pharmacy A are resident. The old health facility B is merely an example of a predetermined drug distribution group, and for example, a predetermined region including a home of a plurality of users or a delivery route is also an example of the drug distribution group. Moreover, although the said medicine distribution assistance apparatus 5 is an example of a facility side terminal, if the arrangement place is connected to the said network N2 and can be used in the said health facility B, it will be outside the said health facility B. Also good. Furthermore, it is conceivable that the dispensing support device 1 also functions as the medicine distribution support device 5.
[薬品分包装置3]
 前記薬品分包装置3は、前記調剤支援装置1から入力される処方データに基づいて薬品を服用時期ごとに薬包81(図4参照)で分包することが可能な調剤機器である。例えば、前記薬品分包装置3は、錠剤を分包する錠剤分包機又は散薬を分包する散薬分包機である。具体的に、前記錠剤分包機は、複数種類の錠剤が収容された複数の薬剤カセットを有し、処方データに従って前記薬剤カセットから錠剤を払い出して服用時期ごとに前記薬包81で包装する分包動作を実行する。また、前記散薬分包機は、投入された散薬を処方データに従って服用時期ごとに前記薬包81で包装する分包動作を実行する。これらの分包動作に用いられる前記薬包81が分包容器の一例である。さらに、前記錠剤分包機又は前記散薬分包機が、錠剤及び散薬を服用時期ごとに一包化することが可能な構成も考えられる。なお、前記薬品分包装置3では、前記薬品分包装置3に設けられた連続する長尺状の薬包シートの一部の加熱溶融により前記薬包81が形成され、前記薬包81各々の間には切り離しを容易に行うためのミシン目が形成される。
[Medical packaging device 3]
The medicine packaging device 3 is a dispensing device capable of dispensing a medicine in a medicine package 81 (see FIG. 4) at every dose based on prescription data input from the dispensing support device 1. For example, the medicine packing device 3 is a tablet packing machine for packing tablets or a powder packing machine for packing powder. Specifically, the tablet packaging machine has a plurality of drug cassettes containing a plurality of types of tablets, dispenses tablets from the drug cassette according to prescription data, and packs them in the drug package 81 at each time of taking. Perform the action. In addition, the powder medicine packaging machine performs a packaging operation of packaging the powdered medicine in the medicine pack 81 at each dose according to prescription data. The medicine package 81 used for these packaging operations is an example of a packaging container. Furthermore, the structure in which the said tablet packaging machine or the said powder medicine packaging machine can pack a tablet and powder medicine for every taking time is also considered. In the medicine packaging device 3, the medicine package 81 is formed by heating and melting a part of a continuous long medicine package sheet provided in the medicine packaging device 3. A perforation is formed between them for easy separation.
 前記薬品分包装置3は、前記薬品分包装置3を制御する制御部31、及び前記薬包81に情報を印刷する分包プリンタ32を備える。前記制御部31は、CPU、ROM、及びRAMなどを備える。前記分包プリンタ32は、前記制御部31からの制御指示に従って、前記薬包81に、前記薬包81に収容される薬品を服用する服用者を示す服用者ID(服用者識別情報の一例)、前記薬包81に収容される薬品の服用時期、及び予め定められた配送先識別情報を含む第1配薬情報を印刷する。前記配送先識別情報は、前記薬包81の薬品の服用者が入居している前記老健施設Bを示す配送先ID又は配送先名などの情報であって、後述の服用者マスターに登録されている。なお、前記服用時期を示す文字に代えて、又は前記服用時期を示す文字と共に、前記服用時期ごとに予め定められた服用時期コードの数字(例えば2桁の数字)又は前記服用時期を示すピクトグラムなどの画像が前記薬袋81に印刷されることも考えられる。ここで、前記服用時期コードの数字は文字として印刷されてもよいが、前記薬品分包装置3が前記ピクトグラムを印刷する機能を有する場合には、前記制御部31がその機能を利用して、前記服用時期コードの数字の画像として予め登録された画像を前記ピクトグラムに代えて印刷することも考えられる。これにより、既存のシステムにおいて前記薬包81に前記服用時期コードの数字を印刷させることが可能である。 The medicine packaging apparatus 3 includes a control unit 31 that controls the medicine packaging apparatus 3 and a packaging printer 32 that prints information on the medicine package 81. The control unit 31 includes a CPU, a ROM, a RAM, and the like. According to the control instruction from the control unit 31, the packaging printer 32 takes a medicine ID (an example of a person identification information) indicating a medicine person taking a medicine contained in the medicine package 81 in the medicine package 81. The first medicine distribution information including the timing of taking medicines contained in the medicine package 81 and predetermined delivery destination identification information is printed. The delivery destination identification information is information such as a delivery destination ID or a delivery destination name indicating the health facility B in which a medicine taker of the medicine package 81 is occupying, and is registered in a later-described taker master. Yes. In addition, instead of the character indicating the dose time or together with the character indicating the dose time, a number (for example, a two-digit number) of a dose time code predetermined for each dose time or a pictogram indicating the dose time, etc. It is also conceivable that the image is printed on the medicine bag 81. Here, the number of the timing code may be printed as characters, but when the medicine packaging device 3 has a function of printing the pictogram, the control unit 31 uses the function, It is also conceivable to print an image registered in advance as a numeric image of the dosing time code instead of the pictogram. Thereby, in the existing system, it is possible to print the number of the dosing time code on the medicine package 81.
 特に、前記薬品分包装置3では、前記分包プリンタ32により、前記第1配薬情報を示す一次元コード又は二次元コード等のコード811(図4参照)が前記薬包81に印刷される。ここに、前記分包プリンタ32を用いて前記薬包81に前記第1配薬情報を印刷するときの前記制御部31が第1記録手段の一例である。なお、前記薬包81に貼付されるラベルなどの第1記録媒体に前記第1配薬情報が印刷されることも他の実施形態として考えられる。また、前記薬包81にICタグのような第1記録媒体が付されることも考えられる。この場合、前記薬品分包装置3が、前記第1記録媒体に前記第1配薬情報を記録するICリーダーライタのような記録手段を備える構成が考えられる。 In particular, in the medicine packaging device 3, a code 811 (see FIG. 4) such as a one-dimensional code or a two-dimensional code indicating the first medicine distribution information is printed on the medicine package 81 by the packaging printer 32. . Here, the controller 31 when the first medicine distribution information is printed on the medicine package 81 using the packaging printer 32 is an example of a first recording unit. In addition, it is also conceivable as another embodiment that the first medicine distribution information is printed on a first recording medium such as a label attached to the medicine package 81. It is also conceivable that a first recording medium such as an IC tag is attached to the medicine package 81. In this case, a configuration in which the medicine packaging device 3 includes recording means such as an IC reader / writer that records the first medicine distribution information on the first recording medium is conceivable.
 また、前記薬品分包装置3は、一の服用者が服用する薬品を服用時期ごとに一連の前記薬包81に連続して分包する服用者別分包処理と、予め定められた配薬グループに属する複数の服用者が服用する薬品を服用時期ごとに並べて一連の前記薬包81に連続して分包する時期別分包処理とを実行可能である。前記薬品分包装置3では、前記服用者別分包処理及び前記時期別分包処理のいずれが実行される場合でも、前記分包プリンタ32によって前記薬包81各々に前記コード811が印刷される。 Further, the medicine packaging device 3 includes a medicine-specific packaging process in which a medicine taken by a single user is continuously packaged in a series of the medicine packs 81 at each time of taking, and a predetermined medicine distribution. It is possible to perform a time-specific packaging process in which medicines taken by a plurality of users belonging to a group are arranged at each time of taking and are continuously packaged in the series of medicine packages 81. In the medicine packaging device 3, the code 811 is printed on each medicine package 81 by the packaging printer 32, regardless of whether the user-specific packaging process or the time-based packaging process is performed. .
 なお、前記時期別分包処理が実行される場合には、前記一連の薬包81を切り離すことなく配送することも考えられるため、前記分包プリンタ32により最初又は最後の前記薬包81のみに前記コード811が印刷されることも他の実施形態として考えられる。この場合、後述の収容時照合処理(図10参照)において、前記服用時期ごとに連なった前記薬包81のうち最初又は最後の前記薬包81に印刷された前記第1配薬情報が照合の対象となる。 When the time-specific packaging process is executed, the series of medicine packages 81 may be delivered without being separated, so that only the first or last medicine package 81 is delivered by the packaging printer 32. It is also conceivable as another embodiment that the code 811 is printed. In this case, in the collation process at the time of accommodation (see FIG. 10) described later, the first medicine distribution information printed on the first or last medicine pack 81 among the medicine packs 81 connected at each time of taking is collated. It becomes a target.
[プリンタ4]
 前記プリンタ4は、予め定められた配薬グループに属する複数の服用者の前記薬包81を同一服用時期ごとに纏めて収容する際に使用される薬袋82(配送容器の一例:図4参照)に貼付されるラベル821(第2記録媒体の一例:図4参照)に情報を印刷するために用いられる。具体的に、前記プリンタ4は、前記調剤支援装置1からの制御指示に従って、前記ラベル821に、前記薬袋82に収容される前記薬包81に対応する服用時期及び予め定められた配送先識別情報を含む第2配薬情報を印刷(記録)する。特に、前記プリンタ4は、前記ラベル821に、前記第2配薬情報を示す一次元コード又は二次元コード等のコード822(図4参照)を印刷する。そして、前記ラベル821は、前記薬袋82に貼付して用いられる。なお、前記配送先識別情報は、前記薬包81の薬品の服用者が入居している前記老健施設Bを示す情報であって、後述の服用者マスターに予め登録されている。
[Printer 4]
The printer 4 has a medicine bag 82 (an example of a delivery container: see FIG. 4) used when storing the medicine packs 81 of a plurality of users belonging to a predetermined medicine distribution group at the same time of administration. It is used for printing information on a label 821 (an example of a second recording medium: see FIG. 4) affixed to. Specifically, according to the control instruction from the dispensing support device 1, the printer 4 uses the label 821 to take a dose corresponding to the medicine pack 81 contained in the medicine bag 82 and predetermined delivery destination identification information. 2nd medicine distribution information including is printed (recorded). In particular, the printer 4 prints on the label 821 a code 822 (see FIG. 4) such as a one-dimensional code or a two-dimensional code indicating the second medicine distribution information. The label 821 is attached to the medicine bag 82 for use. The delivery destination identification information is information indicating the health facility B in which a medicine taker of the medicine package 81 is occupying, and is registered in advance in a later-described taker master.
 前記ラベル821は、前記薬袋82に前記第2配薬情報を記録するための手段の一例であり、前記プリンタ4によって前記薬袋82に前記第2配薬情報が直接印刷されることも他の実施形態として考えられる。また、前記薬袋82にICタグのような第2記録媒体が付されることも考えられる。この場合、前記調剤支援装置1が、前記第2記録媒体に前記第2配薬情報を記録するICリーダーライタのような記録手段を備える構成が考えられる。なお、前記プリンタ4は、前記調剤支援装置1から受信するプリントデータに従って、前記処方データに対応する処方箋を印刷するためにも利用される。 The label 821 is an example of a unit for recording the second medicine distribution information on the medicine bag 82, and the printer 4 may directly print the second medicine information on the medicine bag 82. Considered as a form. It is also conceivable that a second recording medium such as an IC tag is attached to the medicine bag 82. In this case, a configuration in which the dispensing support device 1 includes a recording unit such as an IC reader / writer that records the second medicine distribution information on the second recording medium is conceivable. The printer 4 is also used for printing a prescription corresponding to the prescription data in accordance with the print data received from the dispensing support device 1.
[調剤支援装置1]
 前記調剤支援装置1は、制御部11、データ記憶部12、通信インターフェース13、表示装置14、操作装置15、及びドライブ装置16などを備えるパーソナルコンピュータである。前記調剤支援装置1の単体を本発明に係る配薬支援システムとして捉えてもよい。また、前記調剤支援装置1には、前記調剤支援装置1に処方データを入力する電子カルテシステム又は処方入力端末などの上位システム(不図示)が前記ネットワークN1を介して接続されている。なお、前記調剤支援装置1において前記操作装置15を用いて処方データが入力可能な構成も考えられる。
[Dispensing support device 1]
The dispensing support device 1 is a personal computer including a control unit 11, a data storage unit 12, a communication interface 13, a display device 14, an operation device 15, a drive device 16, and the like. The single unit of the dispensing support device 1 may be regarded as a drug distribution support system according to the present invention. The dispensing support apparatus 1 is connected to a host system (not shown) such as an electronic medical record system or a prescription input terminal for inputting prescription data to the dispensing support apparatus 1 via the network N1. In addition, the structure which can input prescription data using the said operating device 15 in the said dispensing assistance apparatus 1 is also considered.
 前記制御部11は、CPU、ROM、及びRAM等を備える。前記CPUは、各種の制御プログラムに従って処理を実行することにより前記調剤支援装置1を制御するプロセッサーである。前記ROMは、前記CPUにより実行されるBIOS等のプログラムが予め記憶された不揮発性メモリである。前記RAMは、前記CPUによる各種の制御プログラムの展開及びデータの一時記憶に用いられる揮発性メモリ又は不揮発性メモリである。 The control unit 11 includes a CPU, a ROM, a RAM, and the like. The CPU is a processor that controls the dispensing support device 1 by executing processing according to various control programs. The ROM is a non-volatile memory in which programs such as BIOS executed by the CPU are stored in advance. The RAM is a volatile memory or a non-volatile memory used for development of various control programs and temporary storage of data by the CPU.
 前記データ記憶部12は、前記制御部11によって実行される各種のアプリケーションプログラム及び各種のデータを記憶するハードディスク又はSSD等の不揮発性の記憶手段である。具体的に、前記データ記憶部12には、後述の処方データ発行処理(図5参照)、収容時照合処理(図10参照)及び配送時照合処理(図11参照)などを前記制御部11に実行させるための調剤支援プログラムが記憶されている。 The data storage unit 12 is a non-volatile storage unit such as a hard disk or an SSD that stores various application programs and various data executed by the control unit 11. Specifically, the data storage unit 12 includes a prescription data issuing process (see FIG. 5), a collation process at the time of accommodation (see FIG. 10), a collation process at the time of delivery (see FIG. 11), etc. A dispensing support program for execution is stored.
 例えば、前記制御部11は、前記調剤支援プログラムに従って各種の処理を実行することにより、第2記録部111、判定部112、及び第1報知部113として機能する。ここに、前記第2記録部111、前記判定部112、及び前記第1報知部113として機能するときの前記制御部11が第2記録手段、判定手段、及び第1報知手段の一例である。 For example, the control unit 11 functions as the second recording unit 111, the determination unit 112, and the first notification unit 113 by executing various processes according to the dispensing support program. Here, the control unit 11 when functioning as the second recording unit 111, the determination unit 112, and the first notification unit 113 is an example of a second recording unit, a determination unit, and a first notification unit.
 前記第2記録部111は、前記プリンタ4を用いて、予め定められた前記老健施設B(配薬グループ)に属する複数の服用者の前記薬包81を同一服用時期ごとに収容する際に用いられる前記薬袋82に付される前記ラベル821に、前記服用時期及び前記老健施設Bの配送先識別情報を含む前記第2配薬情報である前記コード822を印刷(記録)する。 The second recording unit 111 is used to store the medicine packs 81 of a plurality of users belonging to the predetermined health facility B (medicine distribution group) at the same dosage time using the printer 4. On the label 821 attached to the medicine bag 82, the code 822 which is the second medicine distribution information including the time of taking and the delivery destination identification information of the health facility B is printed (recorded).
 前記判定部112は、前記薬包81から読み取られる前記第1配薬情報の前記服用時期及び前記配送先識別情報と前記薬袋82から読み取られる前記第2配薬情報の前記服用時期及び前記配送先識別情報とが一致するか否かを判定する。なお、前記第1配薬情報及び前記第2配薬情報の読み取りは前記読取端末2によって行われる。 The determination unit 112 includes the time of taking the first medicine distribution information read from the medicine package 81 and the delivery destination identification information and the time of taking the second medicine information read from the medicine bag 82 and the delivery destination. It is determined whether or not the identification information matches. The reading terminal 2 reads the first medicine distribution information and the second medicine distribution information.
 前記第1報知部113は、前記判定部112の判定結果を報知する。例えば、前記第1報知部113は、前記判定部112の判定結果が一致であるか否かを、前記読取端末2又は前記表示装置14に表示させる。なお、前記第1報知部113は、前記判定部112の判定結果が一致でない場合にのみエラーメッセージを表示させることも考えられる。 The first notification unit 113 notifies the determination result of the determination unit 112. For example, the first notification unit 113 causes the reading terminal 2 or the display device 14 to display whether the determination result of the determination unit 112 is the same. Note that the first notification unit 113 may display an error message only when the determination result of the determination unit 112 does not match.
 また、前記データ記憶部12には、薬品マスター、服用者マスター、薬剤師マスター、処方箋区分マスター、診療科マスター、及び病棟マスターなどの各種データベースも記憶されている。例えば、前記薬品マスターには、薬品コード、薬品名、JANコード(又はRSS)、薬瓶コード、区分(剤形:散薬、錠剤、水剤、外用薬など)、比重、薬品種(普通薬、毒薬、麻薬、劇薬、抗精神薬、治療薬など)、配合変化、賦形薬品、注意事項などの情報が含まれる。さらに、前記薬品マスターには、薬品ごとに発現するおそれのある副作用に関する副作用関連情報も含まれる。これにより、前記調剤支援装置1において、前記制御部11は、例えば副作用の内容が選択された場合に、その副作用の原因となっている可能性の高い薬品を前記副作用関連情報と前記処方データとに基づいて特定する被疑薬特定処理を実行することも可能である。また、前記服用者マスターには、服用者各々の服用者ID、氏名、性別、年齢、住所、既往歴、家族情報、診療科、及び入院病棟と共に、入居先の前記老健施設Bに対応する前記配送先識別情報などの情報が含まれる。なお、前記服用者とは、前記老健施設Bに入居している入居者、及び医療機関で診療を受けている患者を含む概念である。 The data storage unit 12 also stores various databases such as a medicine master, a user master, a pharmacist master, a prescription division master, a medical department master, and a ward master. For example, the medicine master includes a medicine code, a medicine name, a JAN code (or RSS), a medicine bottle code, a classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), specific gravity, kind of medicine (ordinary medicine, Information on poisoning, narcotics, powerful drugs, antipsychotics, therapeutics, etc.), formulation changes, excipients, and precautions. Further, the drug master includes side effect related information regarding side effects that may occur for each drug. Thereby, in the said dispensing assistance apparatus 1, when the content of the side effect is selected, for example, when the content of the side effect is selected, the control unit 11 can select the drug that is likely to cause the side effect as the side effect related information and the prescription data. It is also possible to execute a suspected drug identifying process that identifies based on the above. In addition, the taker master includes the taker ID, name, gender, age, address, medical history, family information, medical department, and hospital ward, along with the health facility B of the tenant. Information such as delivery destination identification information is included. In addition, the said taker is a concept including a resident who lives in the old health facility B and a patient who receives medical care at a medical institution.
 また、前記データ記憶部12は、処方データ記憶部121及び配薬管理情報記憶部122を有する。前記処方データ記憶部121は、前記上位システム(不図示)から取得する前記処方データをデータベース形式で記憶する。前記処方データには、例えば処方箋交付年月日、オーダーナンバー、処方区分、BCD、服用者ID、服用者名、服用者生年月日、薬品情報(薬品コード、薬品名、用量など)、剤形情報(内服、外用など)、用法情報(服用時期を含む)、診療種別(外来、入院など)、診療科などの情報が含まれる。 The data storage unit 12 includes a prescription data storage unit 121 and a medicine distribution management information storage unit 122. The prescription data storage unit 121 stores the prescription data acquired from the host system (not shown) in a database format. The prescription data includes, for example, prescription delivery date, order number, prescription classification, BCD, user ID, user name, user birth date, drug information (drug code, drug name, dose, etc.), dosage form Information such as information (internal use, external use, etc.), usage information (including time of taking), medical treatment type (outpatient, hospitalization, etc.), medical department, etc. are included.
 前記配薬管理情報記憶部122は、配送先識別情報と服用時期と服用者識別情報とが対応付けられた配薬管理情報D1を記憶する。ここに、図2は、前記配薬管理情報D1の一例を示す図である。図2に示すように、前記配薬管理情報D1では、配送日と、配送先識別情報である前記老健施設Bの配送先ID及び老健施設名と、服用時期と、前記服用者識別情報である前記服用者ID及び氏名とが対応付けて記憶されている。 The medicine distribution management information storage unit 122 stores medicine distribution management information D1 in which delivery destination identification information, dosage time, and user identification information are associated with each other. FIG. 2 is a diagram showing an example of the medicine distribution management information D1. As shown in FIG. 2, in the medicine distribution management information D1, the delivery date, the delivery destination ID and the name of the old facility B, which is the delivery destination identification information, the time of taking, and the user identification information are shown. The user ID and name are stored in association with each other.
 具体的に、前記制御部11は、前記上位システム(不図示)から入力される複数の服用者の処方データ及び前記服用者マスターに基づいて、前記配薬管理情報D1を生成する。なお、図2に示す前記配薬管理情報D1では、1日分の服用時期に対応する情報が示されているが、これに限定されない。例えば、前記制御部11は、複数日分又は1週間分など、前記薬局Aから前記老健施設Bに同時に配送される予め定められた任意の服用期間に対応する前記配薬管理情報D1を生成する。 Specifically, the control unit 11 generates the medicine distribution management information D1 based on prescription data of a plurality of users input from the host system (not shown) and the user master. In addition, in the said medicine distribution management information D1 shown in FIG. 2, the information corresponding to the taking time for one day is shown, However, It is not limited to this. For example, the control unit 11 generates the medicine distribution management information D1 corresponding to an arbitrary predetermined period of time that is simultaneously delivered from the pharmacy A to the health facility B, such as for a plurality of days or a week. .
 また、図2に示す前記配薬管理情報D1では、前記老健施設Bとして二つの老健施設B1及び老健施設B2が登録されている場合を例に挙げて説明するが、一つ又は三つ以上の前記老健施設Bが配送先として予め登録されていてもよい。さらに、本実施の形態では、前記老健施設Bが一つの配薬グループとして設定されている場合について説明するが、例えば前記老健施設Bにおいて複数の服用者が入居している部屋又はフロアを前記配薬グループとして設定することも可能である。 Moreover, in the said medicine distribution management information D1 shown in FIG. 2, although the case where two old health facilities B1 and old health facilities B2 are registered as the said old health facilities B is mentioned as an example, one or three or more The old health facility B may be registered in advance as a delivery destination. Furthermore, in the present embodiment, the case where the health facility B is set as one medicine distribution group will be described. For example, in the health facility B, a room or a floor in which a plurality of users are occupying is arranged. It can also be set as a medicine group.
 前記通信インターフェース13は、前記ネットワークN1を介して前記読取端末2、前記薬品分包装置3、及び前記プリンタ4との間で、予め定められた通信プロトコルに従って無線又は有線でデータ通信を実行するネットワークカード等を有する。前記表示装置14は、前記制御部11からの制御指示に従って各種の情報を表示する液晶ディスプレイ又は有機ELディスプレイなどの表示手段である。前記操作装置15は、前記調剤支援装置1に各種の情報を入力するためにユーザーによって操作される操作手段である。具体的に、前記操作装置15は、前記表示装置14の表示画面に従った各種の情報の入力操作を受け付けるキーボード及びマウス(ポインティングデバイス)を含む。 The communication interface 13 is a network that performs data communication between the reading terminal 2, the medicine packaging device 3, and the printer 4 via the network N1 in a wireless or wired manner according to a predetermined communication protocol. Have cards etc. The display device 14 is a display unit such as a liquid crystal display or an organic EL display that displays various types of information in accordance with control instructions from the control unit 11. The operation device 15 is an operation means operated by a user in order to input various information to the dispensing support device 1. Specifically, the operation device 15 includes a keyboard and a mouse (pointing device) that accept input operations of various information according to the display screen of the display device 14.
 前記ドライブ装置16は、前記調剤支援プログラムが記録されたコンピュータ読み取り可能な記録媒体17から前記調剤支援プログラムを読み取ることが可能である。前記記録媒体17は、CD、DVD、BD、又はUSBメモリなどである。そして、前記調剤支援装置1では、前記制御部11により、前記記録媒体17から前記ドライブ装置16で読み取られた前記調剤支援プログラムが前記データ記憶部12にインストールされる。 The drive device 16 can read the dispensing support program from a computer-readable recording medium 17 on which the dispensing support program is recorded. The recording medium 17 is a CD, DVD, BD, USB memory or the like. In the dispensing support device 1, the dispensing support program read by the drive device 16 from the recording medium 17 is installed in the data storage unit 12 by the control unit 11.
[読取端末2]
 前記読取端末2は、前記薬包81及び前記薬袋82に付されている前記コード811及び前記コード822から前記第1配薬情報及び前記第2配薬情報を読み取るバーコードリーダーなどの読取手段である。前記読取端末2により読み取られる前記第1配薬情報及び前記第2配薬情報は、前記調剤支援装置1に入力される。なお、前記薬包81又は前記薬袋82に前記第1配薬情報又は前記第2配薬情報が記録されるICタグなどの第1記録媒体又は第2記録媒体が付される場合、前記読取端末2は、前記第1記録媒体又は前記第2記録媒体から情報を読み取るICリーダーライタのような読取手段である。また、前記読取端末2は、前記コード811及び前記コード822から情報を読み取ることができるものであれば、携帯電話、スマートフォン、PDA、メディアプレーヤー、又はタブレット端末などの携帯端末であってもよい。
[Reading terminal 2]
The reading terminal 2 is a reading means such as a barcode reader for reading the first medicine distribution information and the second medicine distribution information from the code 811 and the code 822 attached to the medicine bag 81 and the medicine bag 82. is there. The first medicine distribution information and the second medicine distribution information read by the reading terminal 2 are input to the dispensing support device 1. In the case where the first recording medium or the second recording medium such as an IC tag on which the first medicine distribution information or the second medicine distribution information is recorded is attached to the medicine bag 81 or the medicine bag 82, the reading terminal Reference numeral 2 denotes reading means such as an IC reader / writer for reading information from the first recording medium or the second recording medium. The reading terminal 2 may be a portable terminal such as a mobile phone, a smartphone, a PDA, a media player, or a tablet terminal as long as it can read information from the code 811 and the code 822.
[配薬支援装置5]
 一方、前記配薬支援装置5は、制御部51、データ記憶部52、通信インターフェース53、表示装置54、操作装置55、及びドライブ装置56などを備えるパーソナルコンピュータである。
[Medicine distribution support device 5]
On the other hand, the medicine distribution support device 5 is a personal computer including a control unit 51, a data storage unit 52, a communication interface 53, a display device 54, an operation device 55, a drive device 56, and the like.
 前記制御部51は、CPU、ROM、及びRAM等を備える。前記CPUは、各種の制御プログラムに従って処理を実行することにより前記配薬支援装置5を制御するプロセッサーである。前記ROMは、前記CPUにより実行されるBIOS等のプログラムが予め記憶された不揮発性メモリである。前記RAMは、前記CPUによる各種の制御プログラムの展開及びデータの一時記憶に用いられる揮発性メモリ又は不揮発性メモリである。 The control unit 51 includes a CPU, a ROM, a RAM, and the like. The CPU is a processor that controls the medicine distribution support device 5 by executing processing according to various control programs. The ROM is a non-volatile memory in which programs such as BIOS executed by the CPU are stored in advance. The RAM is a volatile memory or a non-volatile memory used for development of various control programs and temporary storage of data by the CPU.
 前記データ記憶部52は、前記制御部51によって実行される各種のアプリケーションプログラム及び各種のデータを記憶するハードディスク又はSSD等の不揮発性の記憶手段である。具体的に、前記データ記憶部52には、後述の受取時照合処理(図12参照)及び配薬時照合処理(図13参照)などを前記制御部51に実行させるための配薬支援プログラムが記憶されている。 The data storage unit 52 is a non-volatile storage unit such as a hard disk or an SSD that stores various application programs and various data executed by the control unit 51. Specifically, in the data storage unit 52, there is a medicine distribution support program for causing the control unit 51 to execute a later-described receipt-time verification process (see FIG. 12), a drug-delivery verification process (see FIG. 13), and the like. It is remembered.
 例えば、前記制御部51は、前記配薬支援プログラムに従って各種の処理を実行することにより、表示制御部511、配送先判定部512、及び第2報知部513として機能する。ここに、前記表示制御部511、前記配送先判定部512、及び前記第2報知部513として機能するときの前記制御部51が表示制御手段、配送先判定手段、及び第2報知手段の一例である。 For example, the control unit 51 functions as a display control unit 511, a delivery destination determination unit 512, and a second notification unit 513 by executing various processes according to the medicine distribution support program. Here, the control unit 51 when functioning as the display control unit 511, the delivery destination determination unit 512, and the second notification unit 513 is an example of a display control unit, a delivery destination determination unit, and a second notification unit. is there.
 前記表示制御部511は、前記薬包81から前記第1配薬情報が読み取られた場合に前記第1配薬情報の前記服用者IDに対応する前記服用者の顔画像を前記データ記憶部52から読み出して表示する。具体的に、前記表示制御部511は、前記携帯端末6によって前記第1配薬情報が読み取られた場合に、前記マスター記憶部521に記憶されている後述の入居者マスターに基づいて前記服用者の顔画像を前記携帯端末6に表示させる。 When the first medicine distribution information is read from the medicine package 81, the display control section 511 displays the face image of the user corresponding to the user ID of the first medicine distribution information in the data storage section 52. Read from and display. Specifically, the display control unit 511, when the first medicine distribution information is read by the portable terminal 6, based on a resident master described later stored in the master storage unit 521, the user Are displayed on the portable terminal 6.
 前記配送先判定部512は、前記配送先において前記薬袋82から読み取られる前記第2配薬情報の前記配送先識別情報と前記配送先に対応する前記配送先識別情報とが一致するか否かを判定する。即ち、前記配送先判定部512は、前記配送先が前記薬袋82を配送するべき配送先として正しいか否かを判定する。 The delivery destination determination unit 512 determines whether or not the delivery destination identification information of the second medicine distribution information read from the medicine bag 82 at the delivery destination matches the delivery destination identification information corresponding to the delivery destination. judge. That is, the delivery destination determination unit 512 determines whether or not the delivery destination is correct as a delivery destination to which the medicine bag 82 should be delivered.
 前記第2報知部513は、前記配送先判定部512による判定結果を報知する。例えば、前記第2報知部513は、前記配送先判定部512の判定結果が一致であるか否かを、前記表示装置54又は前記読取端末7に表示させることが考えられる。なお、前記第2報知部513は、前記配送先判定部512の判定結果が一致でない場合にのみエラーメッセージを表示させることも考えられる。 The second notification unit 513 notifies the determination result by the delivery destination determination unit 512. For example, the second notification unit 513 may cause the display device 54 or the reading terminal 7 to display whether the determination result of the delivery destination determination unit 512 matches. Note that the second notification unit 513 may display an error message only when the determination result of the delivery destination determination unit 512 does not match.
 また、前記データ記憶部52は、マスター記憶部521及び変換情報記憶部522を有する。前記マスター記憶部521には、前記老健施設Bに入居している入居者について、入居者ID、入居者名、顔画像、病歴、又は薬歴などの情報を含む入居者マスターが記憶される。なお、前記顔画像は、入居者の外観を示す顔写真又は似顔絵などの画像として予め登録される。 The data storage unit 52 includes a master storage unit 521 and a conversion information storage unit 522. The master storage unit 521 stores a resident master including information such as a resident ID, a resident name, a face image, a medical history, or a medical history about the resident who is in the health facility B. The face image is registered in advance as an image such as a facial photograph or a portrait showing the resident's appearance.
 前記変換情報記憶部522には、前記薬局Aで管理されている前記服用者マスターと前記老健施設Bで管理されている前記入居者マスターとの互換を実現するために予め定められた変換情報が記憶されている。例えば、前記変換情報は、前記服用者IDと前記入居者IDとの対応関係を示す情報である。なお、前記服用者マスターにおける前記服用者IDが、前記老健施設Bに対応する前記配送先識別情報及び前記入居者IDを結合したものであることも考えられる。 In the conversion information storage unit 522, conversion information predetermined in order to realize compatibility between the user master managed in the pharmacy A and the tenant master managed in the health facility B is stored. It is remembered. For example, the conversion information is information indicating a correspondence relationship between the user ID and the resident ID. In addition, it is also considered that the taker ID in the taker master is a combination of the delivery destination identification information corresponding to the health facility B and the resident ID.
 これにより、前記配薬支援装置5では、前記制御部51が、前記薬局Aで管理されている前記服用者マスターにおける前記服用者IDを前記変換情報に基づいて前記入居者IDに変換することが可能である。従って、前記配薬支援システム10では、前記薬局A側のシステムと前記老健施設B側のシステムとを切り離して構成することが可能であり、前記老健施設B側の前記入居者マスターの情報を前記薬局A側に伝える必要がない。 Thereby, in the said medicine distribution assistance apparatus 5, the said control part 51 converts the said user ID in the said user master managed in the said pharmacy A into the said resident ID based on the said conversion information. Is possible. Therefore, in the medicine distribution support system 10, the system on the pharmacy A side and the system on the health facility B side can be separated from each other, and the information on the resident master on the health facility B side is obtained as described above. There is no need to tell pharmacy A.
 前記通信インターフェース53は、前記ネットワークN1を介して前記調剤支援装置1等との間で、予め定められた通信プロトコルに従って無線又は有線でデータ通信を実行するネットワークカード等を有する。前記表示装置54は、前記制御部51からの制御指示に従って各種の情報を表示する液晶ディスプレイ又は有機ELディスプレイなどの表示手段、及び前記制御部51からの制御指示に従って音声を出力するスピーカー等を備える端末表示手段の一例である。前記操作装置55は、前記配薬支援装置5に各種の情報を入力するためにユーザーによって操作される操作手段である。具体的に、前記操作装置55は、前記表示装置54の表示画面に従った各種の情報の入力操作を受け付けるキーボード及びマウス(ポインティングデバイス)を含む。 The communication interface 53 includes a network card or the like that performs data communication with the dispensing support device 1 or the like via the network N1 in a wireless or wired manner according to a predetermined communication protocol. The display device 54 includes a display unit such as a liquid crystal display or an organic EL display that displays various types of information according to a control instruction from the control unit 51, a speaker that outputs sound according to the control instruction from the control unit 51, and the like. It is an example of a terminal display means. The operation device 55 is an operation means operated by a user in order to input various information to the medicine distribution support device 5. Specifically, the operation device 55 includes a keyboard and a mouse (pointing device) that accept input operations of various information according to the display screen of the display device 54.
 前記ドライブ装置56は、前記配薬支援プログラムが記録されたコンピュータ読み取り可能な記録媒体57から前記配薬支援プログラムを読み取ることが可能である。前記記録媒体57は、CD、DVD、BD、又はUSBメモリなどである。そして、前記配薬支援装置5では、前記制御部51により、前記記録媒体57から前記ドライブ装置56で読み取られた前記配薬支援プログラムが前記データ記憶部52にインストールされる。 The drive device 56 can read the medicine distribution support program from a computer-readable recording medium 57 in which the medicine distribution support program is recorded. The recording medium 57 is a CD, DVD, BD, USB memory or the like. In the medicine distribution support device 5, the medicine distribution support program read by the drive device 56 from the recording medium 57 is installed in the data storage unit 52 by the control unit 51.
[携帯端末6]
 前記携帯端末6は、例えば携帯電話、スマートフォン、PDA、メディアプレーヤー、又はタブレット端末などであって、前記老健施設Bにおいて、前記薬袋82に収容された前記薬包81を服用者に配薬する配薬担当者によって持ち運ばれる。前記携帯端末6は、制御部61及びカメラ62を備える。
[Portable terminal 6]
The mobile terminal 6 is, for example, a mobile phone, a smart phone, a PDA, a media player, or a tablet terminal. In the old health facility B, the mobile terminal 6 distributes the medicine pack 81 accommodated in the medicine bag 82 to a user. Carried by a pharmacist. The portable terminal 6 includes a control unit 61 and a camera 62.
 前記制御部61は、CPU、RAM、及びROMなどを備え、前記携帯端末6を制御する。なお、前記携帯端末6では、前記制御部61により、予めインストールされたアプリケーションプログラムに従って各種の処理が実行される。前記カメラ62は、画像又は映像を撮影する撮影手段である。そして、前記制御部61は、前記カメラ62で撮影される画像又は映像に含まれる一次元コード又は二次元コードを読み取るコード読取機能を有する。具体的に、前記携帯端末6では、前記コード読取機能を用いて、前記薬包81及び前記薬袋82に印刷されている一次元コード又は二次元コードから情報を読み取ることが可能である。そして、前記制御部61は、前記カメラ62を用いて読み取った情報を前記配薬支援装置5に送信する。なお、前記携帯端末6は、各種の情報を表示する表示部及び各種の操作を受け付ける操作部なども備えている。 The control unit 61 includes a CPU, a RAM, a ROM, and the like, and controls the portable terminal 6. In the mobile terminal 6, various processes are executed by the control unit 61 according to an application program installed in advance. The camera 62 is a photographing means for photographing an image or a video. The control unit 61 has a code reading function for reading a one-dimensional code or a two-dimensional code included in an image or video captured by the camera 62. Specifically, the portable terminal 6 can read information from a one-dimensional code or a two-dimensional code printed on the medicine package 81 and the medicine bag 82 using the code reading function. Then, the control unit 61 transmits information read using the camera 62 to the medicine distribution support device 5. The mobile terminal 6 also includes a display unit that displays various types of information and an operation unit that receives various types of operations.
[読取端末7]
 前記読取端末7は、前記読取端末2と同様に、前記薬包81又は前記薬袋82などに印刷されている一次元コード又は二次元コードから情報を読み取るバーコードリーダーなどの読取手段である。そして、前記読取端末7により読み取られる情報は、前記配薬支援装置5に入力される。なお、前記薬包81又は前記薬袋82にICタグなどの記録媒体が付される場合、前記読取端末7は、前記記録媒体から情報を読み取るICリーダーライタのような読取手段である。なお、前記携帯端末6を前記読取端末7として利用し、前記読取端末7を省略することも可能である。
[Reading terminal 7]
The reading terminal 7 is a reading means such as a barcode reader that reads information from a one-dimensional code or a two-dimensional code printed on the medicine package 81 or the medicine bag 82, as in the case of the reading terminal 2. Information read by the reading terminal 7 is input to the medicine distribution support device 5. When a recording medium such as an IC tag is attached to the medicine package 81 or the medicine bag 82, the reading terminal 7 is a reading means such as an IC reader / writer that reads information from the recording medium. The portable terminal 6 can be used as the reading terminal 7 and the reading terminal 7 can be omitted.
[配薬作業の一例]
 続いて、図3及び図4を参照しつつ、前記配薬支援システム10が使用される前記薬局A及び前記老健施設Bにおいて実行される配薬作業のフローについて説明する。具体的に、図3に示すステップS1~S5は前記薬局Aで実行され、ステップS6~S7は前記老健施設Bで実行される。なお、図4は、前記薬局Aから前記老健施設Bの一例である前記老健施設B1及び前記老健施設B2に薬品が配送される場合の前記配薬作業のフローを模式的に示す図である。
[Example of drug distribution work]
Next, the flow of the drug distribution operation executed in the pharmacy A and the old health facility B where the drug distribution support system 10 is used will be described with reference to FIGS. 3 and 4. Specifically, steps S1 to S5 shown in FIG. 3 are executed at the pharmacy A, and steps S6 to S7 are executed at the health facility B. FIG. 4 is a diagram schematically showing a flow of the medicine distribution work when medicine is delivered from the pharmacy A to the health facility B1 and the health facility B2, which are examples of the health facility B.
<ステップS1>
 まず、前記調剤支援装置1では、前記制御部11が、前記操作装置15のユーザー操作に応じて、薬品を配送する前記老健施設Bを選択し、前記老健施設Bに対応する処方データを発行する処方データ発行処理を実行する(S1)。
<Step S1>
First, in the dispensing support device 1, the control unit 11 selects the old health facility B that delivers medicine in response to a user operation of the operating device 15 and issues prescription data corresponding to the old health facility B. A prescription data issuing process is executed (S1).
<ステップS2>
 そして、前記調剤支援装置1では、前記制御部11が、前記ステップS1で発行された前記処方データ各々に基づいて分包データを生成し、その分包データを前記薬品分包装置3に入力することにより、前記薬品分包装置3による自動調剤が開始される(S2)。これにより、図4に示すように、前記老健施設B各々に属する服用者が服用する薬品が収容された前記薬包81各々が得られる。
<Step S2>
And in the said dispensing assistance apparatus 1, the said control part 11 produces | generates packaging data based on each of the said prescription data issued by the said step S1, and inputs the packaging data into the said medicine packaging apparatus 3 Thus, automatic dispensing by the medicine packaging device 3 is started (S2). As a result, as shown in FIG. 4, each of the medicine packs 81 containing medicines taken by users who belong to each of the old health facilities B is obtained.
 また、前記ステップS2において、前記薬品分包装置3では、前記制御部31が、前記分包プリンタ32を用いて、図4に示すように、前記第1配薬情報を示す前記コード811を前記薬包81に印刷させる。前記第1配薬情報には、前記服用者ID、前記服用時期及び前記配送先識別情報が含まれる。なお、前記薬包81には、服用者名、服用日時、及び服用時期なども印刷される。 In step S2, in the medicine packaging device 3, the control unit 31 uses the packaging printer 32 to generate the code 811 indicating the first medicine distribution information as shown in FIG. The medicine package 81 is printed. The first medicine distribution information includes the user ID, the time of taking, and the delivery destination identification information. The medicine package 81 is also printed with the name of the user, the date and time of taking, and the time of taking.
 さらに、前記ステップS2において、前記制御部11は、前記プリンタ4を用いて、図4に示すように、前記第2配薬情報を示す前記コード822を、前記薬袋82に貼付される前記ラベル821に印刷させる。前記第2配薬情報には、前記服用時期及び前記配送先識別情報が含まれる。なお、前記薬袋82には、老健施設名、服用日時、及び服用時期なども印刷される。 Further, in the step S2, the control unit 11 uses the printer 4 to label the code 822 indicating the second medicine distribution information on the medicine bag 82 as shown in FIG. To print. The second medicine distribution information includes the dose time and the delivery destination identification information. The medicine bag 82 is also printed with the name of the old facility, the date and time of taking, and the time of taking.
<ステップS3>
 前記薬品分包装置3による調剤作業が完了すると、続いて、鑑査担当の薬剤師は、前記薬品分包装置3で調剤された薬品の鑑査を行う(S3)。なお、前記鑑査には、前記薬品分包装置3により調剤された薬品を撮像し、その撮像された画像に基づいて自動的に鑑査を行う画像鑑査システムが利用されることも考えられる。例えば、前記薬品分包処理において前記時期別分包処理が実行された場合、前記画像鑑査システムでは、老健施設単位で前記服用時期ごとに並べられた前記薬包81各々の画像が分割され、前記服用者単位で前記服用時期ごとに並べた鑑査用画像が生成される。そして、前記画像鑑査システムは、前記鑑査用画像に基づいて前記薬品分包装置3により調剤された薬品を鑑査する。
<Step S3>
When the dispensing operation by the medicine packaging device 3 is completed, the pharmacist in charge of inspection subsequently inspects the medicine dispensed by the medicine packaging device 3 (S3). In addition, it is also conceivable for the inspection to use an image inspection system that images the medicine dispensed by the medicine packaging device 3 and automatically inspects based on the captured image. For example, when the time-specific packaging process is executed in the medicine packaging process, the image inspection system divides the images of the medicine packages 81 arranged for each taking time in units of health facilities, An inspection image arranged for each dose time in units of users is generated. Then, the image inspection system inspects the medicine dispensed by the medicine packaging device 3 based on the inspection image.
<ステップS4>
 次に、配送担当者は、図4に示すように、前記老健施設B各々に配送するべき前記薬包81各々を前記薬包81の服用時期及び配送先に対応する前記薬袋82に収容する(S4)。このとき、配送担当者は、前記読取端末2を用いて、前記薬包81及び前記薬袋82各々から前記第1配薬情報及び前記第2配薬情報を読み取る。これにより、前記調剤管理装置1の制御部11は、後述の収容時照合処理において前記第1配薬情報と前記第2配薬情報とが一致するか否かを判定する。
<Step S4>
Next, as shown in FIG. 4, the person in charge of delivery accommodates each of the medicine packs 81 to be delivered to each of the health facilities B in the medicine bag 82 corresponding to the time of taking the medicine pack 81 and the delivery destination ( S4). At this time, the delivery person uses the reading terminal 2 to read the first medicine distribution information and the second medicine distribution information from the medicine bag 81 and the medicine bag 82, respectively. Thereby, the control part 11 of the said dispensing management apparatus 1 determines whether the said 1st medicine distribution information and the said 2nd medicine distribution information correspond in the below-mentioned accommodation time collation process.
<ステップS5>
 その後、配送担当者は、前記薬袋82各々を前記配送先に配送する(S5)。このとき、配送担当者は、前記読取端末2を用いて、前記薬袋82各々から前記第2配薬情報を読み取る。これにより、前記調剤管理装置1の制御部11は、後述の配送時照合処理において前記配送先に配送するべき前記薬袋82に漏れがあるか否かを判定する。
<Step S5>
Thereafter, the delivery person delivers each medicine bag 82 to the delivery destination (S5). At this time, the delivery person uses the reading terminal 2 to read the second medicine distribution information from each medicine bag 82. Thereby, the control part 11 of the said dispensing management apparatus 1 determines whether the said medicine bag 82 which should be delivered to the said delivery destination has a leak in the below-mentioned collation process at the time of delivery.
<ステップS6>
 次に、前記老健施設B各々では、前記薬局Aから前記薬袋82各々を受け取ると、配薬担当者が、前記読取端末7を用いて前記薬袋82のコード822から前記第2配薬情報を読み取る(S6)。これにより、前記配薬支援装置51の制御部51は、後述の薬品受取処理において、前記第2配薬情報に含まれる配送先識別情報と前記読取端末7が配置された前記老健施設Bの配送先識別情報とが一致するか否かを判定する。
<Step S6>
Next, in each of the old health facilities B, when each medicine bag 82 is received from the pharmacy A, a person in charge of medicine distribution reads the second medicine information from the code 822 of the medicine bag 82 using the reading terminal 7. (S6). Thereby, the control part 51 of the said medicine distribution assistance apparatus 51 is the delivery of the said health facility B where the delivery destination identification information contained in the said 2nd medicine distribution information and the said reading terminal 7 are arrange | positioned in the chemical | medical agent reception process mentioned later. It is determined whether or not the destination identification information matches.
<ステップS7>
 その後、前記老健施設Bの配薬担当者は、服用時期ごとに、その服用時期に対応する前記薬袋82に収容されている前記薬包81各々を入居者に配薬する(S7)。このとき、前記配薬作業では、複数の服用者の前記薬包81が前記服用時期ごとに纏めて前記薬袋82に収容されているため、配送先である前記老健施設Bでは、服用時期ごとに前記薬袋82から複数の服用者の前記薬包81を取り出して服用者各々に容易に投薬することが可能である。また、前記ステップS7において、配薬担当者は、前記携帯端末6を用いて前記薬包81各々から前記第1配薬情報を読み取る。これにより、前記配薬支援装置51の制御部51は、後述の配薬時照合処理において、前記第1配薬情報に含まれる前記服用者IDに基づいて前記服用者IDに対応する入居者の顔画像63を前記データ記憶部52の前記服用者情報記憶部521から読み出して前記携帯端末6に表示させる。
<Step S7>
Thereafter, the person in charge of medicine at the health facility B dispenses each medicine package 81 contained in the medicine bag 82 corresponding to the time of taking the medicine to the resident at every time of taking (S7). At this time, in the medicine distribution work, since the medicine packs 81 of a plurality of users are collectively stored in the medicine bag 82 for each time of taking, in the old facility B as a delivery destination, for each time of taking The medicine bags 81 of a plurality of users can be taken out from the medicine bag 82 and can be easily administered to each user. In step S <b> 7, the person in charge of medicine distribution reads the first medicine information from each medicine package 81 using the portable terminal 6. Thereby, the control part 51 of the said medicine distribution assistance apparatus 51 of the residents corresponding to the said user ID based on the said user ID contained in the said 1st medicine distribution information in the below-mentioned collation process at the time of medicine distribution. The face image 63 is read from the user information storage unit 521 of the data storage unit 52 and displayed on the portable terminal 6.
[配薬支援システム10で実行される各種の処理]
 以下、図5~図13を参照しつつ、前記配薬作業(図3参照)が実行される場合に、前記配薬支援システム10において実行される各種の処理の一例について説明する。なお、前記配薬支援システム10において実行される各種の処理の実行主体はここで説明するものに限らず、前記配薬支援システム10を構成する各種の装置の制御部により実行されればよい。
[Various processes executed by the drug distribution support system 10]
Hereinafter, with reference to FIGS. 5 to 13, examples of various processes executed in the medicine distribution support system 10 when the medicine distribution operation (see FIG. 3) is executed will be described. In addition, the execution subject of the various processes performed in the said medicine distribution assistance system 10 is not restricted to what is demonstrated here, What is necessary is just to be performed by the control part of the various apparatuses which comprise the said medicine distribution assistance system 10. FIG.
[処方データ発行処理]
 まず、図5を参照しつつ、前記ステップS1において前記調剤支援装置1の制御部11によって実行される処方データ発行処理について説明する。
[Prescription data issuance processing]
First, the prescription data issuing process executed by the control unit 11 of the dispensing support device 1 in the step S1 will be described with reference to FIG.
<ステップS11>
 ステップS11において、前記制御部11は、一又は複数の前記老健施設Bについて処方データの発行操作が行われたか否かを判断する。具体的に、前記制御部11は、前記調剤支援装置1における前記操作装置15のユーザー操作に応じて、一又は複数の前記老健施設Bを選択し、前記老健施設B各々の処方データの発行操作を受け付ける。そして、前記処方データの発行操作が行われると(S11:Yes)、処理がステップS12に移行する。なお、前記処方データの発行操作が行われるまでの間は(S11:No)、処理が前記ステップS11で待機する。
<Step S11>
In step S <b> 11, the control unit 11 determines whether or not a prescription data issuing operation has been performed for one or a plurality of the healthy facilities B. Specifically, the control unit 11 selects one or a plurality of the health facilities B according to a user operation of the operation device 15 in the dispensing support device 1, and issues a prescription data issue operation for each of the health facilities B. Accept. When the prescription data issuance operation is performed (S11: Yes), the process proceeds to step S12. Until the prescription data issuance operation is performed (S11: No), the process waits in step S11.
<ステップS12>
 ステップS12において、前記制御部11は、前記老健施設B各々に属する前記服用者各々の前記処方データを、当該服用者が属する老健施設単位で同一服用時期ごとに分解して並べた分包データを生成する。
<Step S12>
In step S12, the control unit 11 divides the prescription data of each of the users belonging to each of the old-age facilities B into pieces of package data obtained by disassembling and arranging them for each old-age facility belonging to the user. Generate.
 例えば、前記制御部11は、図6に示すように、「老健施設B1」及び「老健施設B2」ごとに属する複数の服用者の処方データをグループ化したグループ処方データを生成する。その後、前記制御部11は、図7に示すように、前記グループ処方データに基づいて、「老健施設B1」及び「老健施設B2」に属する服用者各々に対応する処方データを服用時期ごとに並び替えた分包データを生成する。また、前記分包データには、服用時期に対応する薬品が存在しない服用者についてもその旨を示すデータ(空データ)が含まれている。 For example, as shown in FIG. 6, the control unit 11 generates group prescription data obtained by grouping prescription data of a plurality of users belonging to “old health facility B1” and “old health facility B2”. Thereafter, as shown in FIG. 7, the control unit 11 arranges prescription data corresponding to each user belonging to “health care facility B1” and “health care facility B2” for each taking time based on the group prescription data. Generate the replaced parcel data. In addition, the packaging data includes data (empty data) indicating that a user who does not have a medicine corresponding to the time of taking does not.
<ステップS13>
 そして、ステップS13において、前記制御部11は、前記薬品分包装置3に前記分包データを出力する。これにより、前記薬品分包装置3では、前記分包データに従って後述の薬品分包処理(図8参照)が実行される。なお、前記調剤支援装置1が接続された前記プリンタ4等により前記分包データを示す一次元コード又は二次元コードなどを印刷出力することも他の実施形態として考えられる。これにより、前記薬品分包装置3では、前記印刷された用紙から前記分包データをハーコードリーダー等によって読み取ることにより、前記分包データに従った分包動作を行うことが可能である。
<Step S13>
In step S <b> 13, the control unit 11 outputs the packaging data to the medicine packaging device 3. Thereby, in the said medicine packaging apparatus 3, the medicine packaging process (refer FIG. 8) mentioned later according to the said packaging data is performed. In addition, it is also conceivable as another embodiment to print out a one-dimensional code or a two-dimensional code indicating the packaging data by the printer 4 or the like to which the dispensing support device 1 is connected. Thereby, in the said medicine packaging apparatus 3, it is possible to perform the packaging operation according to the said packaging data by reading the said packaging data from the said printed paper with a Harcode reader etc.
[薬品分包処理]
 次に、図8を参照しつつ、前記ステップS2において前記薬品分包装置3の制御部31によって実行される薬品分包処理について説明する。なお、本実施の形態では、前記薬品分包処理として前記時期別分包処理が実行される場合を例に挙げて説明するが、前記服用者別分包処理が実行されてもよい。
[Chemical packaging]
Next, the medicine packaging process executed by the control unit 31 of the medicine packaging apparatus 3 in step S2 will be described with reference to FIG. In the present embodiment, the case where the time-specific packaging process is executed as the medicine packaging process will be described as an example, but the user-specific packaging process may be executed.
<ステップS21>
 まず、ステップS21において、前記制御部31は、前記調剤支援装置1からの前記分包データの入力を待ち受ける(S21:No)。そして、前記分包データが入力されたと判断すると(S21:Yes)、前記制御部31は、処理をステップS22に移行させる。
<Step S21>
First, in step S21, the control unit 31 waits for input of the packaging data from the dispensing support device 1 (S21: No). When it is determined that the packaging data has been input (S21: Yes), the control unit 31 shifts the process to step S22.
<ステップS22>
 ステップS22において、前記制御部31は、前記分包データのうち一つ目の前記老健施設B1を分包対象として設定する。具体的に、図7に示した前記分包データが入力された場合、前記制御部11は、初めの前記ステップS22において、「老健施設B1」を分包対象として設定する。そして、二回目以降に前記ステップS22が実行された場合、前記制御部11は二つ目以降の前記病室を順に分包対象として設定する。即ち、図7に示した前記分包データが入力された場合、前記制御部31は、二回目の前記ステップS22において、「老健施設B2」を分包対象として設定する。
<Step S22>
In step S22, the control unit 31 sets the first healthy facility B1 in the packaging data as a packaging target. Specifically, when the packaging data shown in FIG. 7 is input, the control unit 11 sets “healthy facility B1” as a packaging target in the first step S22. And when said step S22 is performed after the 2nd time, the said control part 11 will set the said 2nd or later hospital room in order as a packaging object. That is, when the packaging data shown in FIG. 7 is input, the control unit 31 sets “old health facility B2” as a packaging target in the second step S22.
<ステップS23>
 ステップS23において、前記制御部31は、前記分包データのうち前記ステップS22で分包対象として選択された前記老健施設Bに対応する一つ目の服用時期を分包対象として分包を開始する。
<Step S23>
In step S23, the control unit 31 starts packaging using the first dose corresponding to the health facility B selected as the packaging target in step S22 in the packaging data as the packaging target. .
 具体的に、図7に示した前記分包データが入力されている場合、前記制御部31は、初めの前記ステップS23において、「老健施設B1」の「△月△日朝食後」の服用時期を分包対象として分包を開始する。そして、二回目以降に前記ステップS23が実行された場合、前記制御部31は、二つ目以降の前記服用時期について順に分包対象として分包を開始する。即ち、図7に示した前記分包データが入力されている場合、前記制御部31は、二回目の前記ステップS23において、「老健施設B1」の「△月△日昼食後」の服用時期を分包対象として分包を開始する。 Specifically, when the packaging data shown in FIG. 7 has been input, the control unit 31 takes the “Departure of △ month △ day after breakfast” of “healthy facility B1” in the first step S23. Start the packaging with the target of packaging. And when said step S23 is performed after the 2nd time, the said control part 31 will start the packaging as a packaging object in order about the said 2nd and subsequent dosing time. That is, when the packaging data shown in FIG. 7 is input, the control unit 31 determines the taking time of “Δ month Δ day after lunch” of “healthy facility B1” in the second step S23. Start packaging as the target of packaging.
 ここに、図9(A)は、図7に示した前記分包データに基づいて前記薬品分包処理が実行された場合の分包結果の一例を示す図である。図9(A)に示す分包結果では、同一の前記老健施設Bに属する複数の服用者が服用する薬品が服用時期ごとに連続して分包されている。具体的に、前記老健施設B1の服用者「湯山一郎」、「湯山二郎」、「湯山三郎」に対応する前記薬包81が、△月△日の朝食後、昼食後、夕食後ごとに連続して形成されている。なお、△月△日の後には、次の日である△月□日についても同様の形態で分包される。 Here, FIG. 9A is a diagram showing an example of the packaging result when the medicine packaging process is executed based on the packaging data shown in FIG. In the packaging result shown in FIG. 9 (A), medicines taken by a plurality of users belonging to the same old facility B are continuously packaged at every time of taking. Specifically, the medicine packs 81 corresponding to the users “Ichiro Yuyama”, “Jiro Yuyama”, and “Saburo Yuyama” of the health facility B1 are consecutive after every month after breakfast, lunch, and after dinner. Is formed. In addition, after △ month △ day, the next day △ month □ day is also packaged in the same manner.
 また、前記処方データに、前記薬包81に分包されない目薬、水剤、又は外用薬などの分包外薬品の情報(種類、使用時期など)が含まれる場合には、前記分包データに、前記薬品分包装置3で分包される薬品のデータに加えて前記分包外薬品の情報が含まれることが考えられる。この場合、前記制御部31は、前記分包外薬品の使用時期に対応する前記薬包81に、前記分包外薬品が存在する旨及び前記分包外薬品の内容などの情報を文字又はピクトグラム(画像)で印刷することが考えられる。これにより、前記薬包81の配薬時に前記分包外薬品の存在を容易に把握することができ、前記分包外薬品の使用忘れを抑制することができる。また、前記分包外薬品の使用時期に対応する前記薬包81が存在しない場合でも、前記制御部31が、空の前記薬包81を出力してその薬包81に前記分包外薬品が存在する旨及び前記分包外薬品の内容などの情報を文字又はピクトグラム(画像)で印刷することが考えられる。これにより、前記薬包81の服用時期と異なる時期に使用するべき前記分包外薬品が存在する場合でも、前記薬包81を参照することにより前記分包外薬品の存在を容易に把握することができ、前記分包外薬品の使用忘れを抑制することができる。 In addition, when the prescription data includes information (type, time of use, etc.) of non-packaged medicines such as eye drops, liquids, or external medicines that are not packaged in the package 81, the package data includes It is conceivable that information on the medicine outside the package is included in addition to the data on the medicine packaged by the medicine packaging device 3. In this case, the control unit 31 displays information such as the fact that the medicine outside the packaging is present in the medicine package 81 corresponding to the use time of the medicine outside the packaging and the contents of the medicine outside the packaging and the pictogram. It is possible to print with (image). Thereby, the presence of the medicine outside the package can be easily grasped when the medicine package 81 is dispensed, and forgetting to use the medicine outside the package can be suppressed. Further, even when the medicine package 81 corresponding to the use time of the medicine outside the package does not exist, the control unit 31 outputs the medicine package 81 that is empty, and the medicine outside the package contains the medicine package 81. It is conceivable to print information such as the presence and contents of the unpackaged medicine in characters or pictograms (images). Thereby, even when there is the unpackaged medicine to be used at a time different from the time when the medicine package 81 is taken, the presence of the unpackaged medicine can be easily grasped by referring to the medicine package 81. And forgetting to use the unpackaged medicine can be suppressed.
<ステップS24>
 次に、ステップS24において、前記制御部31は、前記分包データに含まれた前記服用者各々のデータについて当該服用時期に服用するべき薬品が存在するか否かを順に判断する。そして、前記制御部31は、当該データに服用時期に服用するべき薬品が存在しない場合、即ち当該データが空データである場合(S24:No)、処理をステップS241に移行させる。一方、当該データに服用時期に服用するべき薬品が存在している場合、即ち当該データが空データではない場合(S24:Yes)、処理をステップS25に移行させる。
<Step S24>
Next, in step S24, the control unit 31 sequentially determines whether or not there is a medicine to be taken at the time of taking the data of each of the users included in the packaging data. And the said control part 31 makes a process transfer to step S241, when the chemical | medical agent which should be taken at the time of taking does not exist in the said data, ie, the said data is empty data (S24: No). On the other hand, if there is a medicine to be taken at the time of taking in the data, that is, if the data is not empty data (S24: Yes), the process proceeds to step S25.
<ステップS25>
 ステップS25において、前記制御部31は、前記分包データに含まれた当該データについて分包動作を実行する。具体的に、前記制御部31は、前記分包プリンタ32により、服用者の氏名及び服用時期と前記第1配薬情報を示す前記コード811とを前記薬包81に印刷すると共に、当該データに対応する薬品を前記薬包81に分包する。
<Step S25>
In step S <b> 25, the control unit 31 performs a packaging operation on the data included in the packaging data. Specifically, the control unit 31 uses the packaging printer 32 to print the name and timing of the user and the code 811 indicating the first medicine distribution information on the medicine package 81, and to the data. The corresponding medicine is packaged in the medicine package 81.
<ステップS241>
 一方、ステップS241において、前記制御部31は、当該服用時期に服用するべき薬品が存在しない旨が前記分包プリンタ32により印刷された空の前記薬包81を作成する。具体的に、空の前記薬包81には、服用者の氏名及び服用時期と、前記コード811と、薬がない旨を示す情報(お薬はありません)とが印刷される。
<Step S241>
On the other hand, in step S241, the control unit 31 creates an empty medicine package 81 printed by the packaging printer 32 to the effect that there is no medicine to be taken at the time of taking. Specifically, the empty medicine package 81 is printed with the name and timing of the user, the code 811, and information indicating that there is no medicine (no medicine).
<ステップS26>
 そして、ステップS26において、前記制御部31は、前記ステップS23で開始された同一服用時期についての分包が終了したか否かを判断する。ここで、前記同一服用時期の分包が終了したと判断すると(S26:Yes)、前記制御部31は処理をステップS27に移行させる。一方、前記同一服用時期の分包が終了していないと判断すると(S26:No)、前記制御部31は処理を前記ステップS24に戻す。
<Step S26>
In step S26, the control unit 31 determines whether or not the packaging for the same dosing time started in step S23 is completed. Here, when it is determined that the packaging of the same dosing time has ended (S26: Yes), the control unit 31 shifts the process to step S27. On the other hand, if it is determined that the packaging at the same dose time has not ended (S26: No), the control unit 31 returns the process to step S24.
<ステップS27>
 ステップS27において、前記制御部31は、前記ステップS22で分包対象として設定された同一の前記老健施設Bについての全服用時期の分包が終了したか否かを判断する。ここで、前記全服用時期の分包が終了したと判断すると(S27:Yes)、前記制御部31は処理をステップS28に移行させる。一方、前記全服用時期の分包が終了していないと判断すると(S27:No)、前記制御部31は処理をステップS271に移行させる。
<Step S27>
In step S27, the control unit 31 determines whether or not the packaging of all the taking times for the same health facility B set as the packaging target in the step S22 is completed. Here, if it is determined that the all-packaging period has been finished (S27: Yes), the control unit 31 shifts the process to step S28. On the other hand, if it is determined that the all-packaging period packaging has not ended (S27: No), the control unit 31 shifts the process to step S271.
<ステップS271>
 ステップS271において、前記制御部31は、前記服用時期が切り替わるタイミングを明示するための分包の区切り処理を実行し、処理を前記ステップS23に戻す。例えば、前記区切り処理は、空の前記薬包81を一つ設けることである。これにより、当該薬品分包処理による分包結果として得られる前記薬包81が連続して形成された薬包シートにおいて服用時期の切り替わりのタイミングを容易に把握することができる。なお、空の前記薬包81には、その前に連なっている各薬包81の内容に関する検薬用、鑑査用の各種情報が印字されてもよい。また、前記区切り処理は、前記薬包81が連続して形成された薬包シートを一度切断することであってもよい。これにより、前記薬品分包装置3において、自動的に服用時期ごとの前記薬包81の連続体を得ることができる。なお、前記区切り処理を省略することも他の実施形態として考えられる。
<Step S271>
In step S271, the control unit 31 executes a package separation process for clearly indicating the timing at which the dosing time is switched, and returns the process to step S23. For example, the separation process is to provide one empty medicine package 81. Thereby, in the medicine package sheet in which the medicine package 81 obtained as a result of packaging by the medicine packaging process is continuously formed, it is possible to easily grasp the timing of changing the dosing time. The empty medicine pack 81 may be printed with various information for drug inspection and inspection related to the contents of each medicine pack 81 connected in front of it. Moreover, the said division | segmentation process may cut | disconnect the medicine package sheet | seat in which the said medicine package 81 was formed continuously once. Thereby, in the said medicine packaging apparatus 3, the continuous body of the said medicine package 81 for every taking time can be obtained automatically. It should be noted that omitting the separation process may be considered as another embodiment.
<ステップS28>
 そして、ステップS28では、前記分包データに含まれた全ての前記老健施設Bについての分包が終了したか否かを判断する。ここで、前記老健施設B各々の分包が終了したと判断すると(S28:Yes)、前記制御部31は一連の当該薬品分包処理を終了して処理を前記ステップS21に戻す。一方、前記老健施設B各々の分包が終了していないと判断すると(S28:No)、前記制御部31は処理を前記ステップS22に移行させ、次の前記老健施設Bについての分包動作を開始する。
<Step S28>
In step S28, it is determined whether or not the packaging for all the healthy facilities B included in the packaging data has been completed. Here, when it is determined that the packaging of each of the old health facilities B has been completed (S28: Yes), the control unit 31 terminates a series of the drug packaging processes and returns the process to the step S21. On the other hand, if it is determined that the packaging of each of the old health facilities B has not been completed (S28: No), the control unit 31 shifts the processing to the step S22, and performs the next packaging operation for the old health facilities B. Start.
 なお、本実施の形態では、前記薬品分包処理において前記時期別分包処理が実行される場合を例に挙げて説明したが、前記薬品分包処理において前記服用者別分包処理が実行されてもよい。ここに、図9(B)は、図6に示した前記グループ処方データに従って「老健施設B1」を対象に前記服用者別分包処理が実行された場合の分包結果を示す図である。図9(B)に示す分包結果では、一の服用者が服用する薬品が服用時期ごとに連続して分包されている。具体的に、図9(B)に示す例では、服用者「湯山一郎」の△月△日の朝食後、昼食後、夕食後、△月□日の朝食後、昼食後、夕食後のそれぞれに対応する前記薬包81が連続して形成されている。そして、服用者「湯山一郎」の後は、同一の前記老健施設B1に属する服用者「湯山二郎」についても同様に、服用時期ごとに対応する前記薬包81が連続して形成される。 In the present embodiment, the case where the time-specific packaging process is executed in the medicine packaging process has been described as an example. However, the user-specific packaging process is executed in the medicine packaging process. May be. Here, FIG. 9B is a diagram showing a packaging result when the individual packaging process is performed on the “old health facility B1” according to the group prescription data shown in FIG. In the packaging result shown in FIG. 9 (B), the medicine taken by one user is continuously packaged at every time of taking. Specifically, in the example shown in FIG. 9 (B), each of the user “Ichiro Yuyama” after △ month △ day breakfast, after lunch, after dinner, after △ month □ day breakfast, after lunch, and after dinner. The medicine packs 81 corresponding to are continuously formed. Then, after the user “Ichiro Yuyama”, for the user “Jiro Yuyama” belonging to the same old health facility B1, the medicine pack 81 corresponding to each dose time is continuously formed.
[収容時照合処理]
 続いて、図10のフローチャートを参照しつつ、前記ステップS3において前記調剤支援装置1の前記制御部11によって実行される収容時照合処理について説明する。
[Containment verification process]
Next, the housing time verification process executed by the control unit 11 of the dispensing support device 1 in step S3 will be described with reference to the flowchart of FIG.
 なお、前記服用者別分包処理が実行された場合には、前記ステップS3における前記薬包81の前記薬袋82への収容時に、前記薬包81各々が切り離されて前記薬袋82各々に収容される。一方、前記時期別分包処理が実行された場合には、前記ステップS3における前記薬包81の前記薬袋82への収容時に、前記薬包81各々を切り離して前記薬袋82各々に収容してもよいが、服用時期ごとに連なった複数の前記薬包81を切り離さずに前記薬袋82に収容してもよい。このような収容作業により、前記薬局Aでは、前記服用時期ごとに対応する複数の服薬者の前記薬包81が纏めて収容された前記薬袋82が複数準備される。 When the individual packaging process is performed, each medicine bag 81 is separated and accommodated in each medicine bag 82 when the medicine bag 81 is accommodated in the medicine bag 82 in step S3. The On the other hand, when the time-specific packaging process is performed, when the medicine pack 81 is accommodated in the medicine bag 82 in the step S3, each medicine bag 81 is separated and accommodated in each medicine bag 82. It is good, but you may accommodate in the said medicine bag 82, without separating the said several medicine package 81 continued for every taking time. By such a storing operation, the pharmacy A prepares a plurality of the medicine bags 82 in which the medicine packages 81 of a plurality of medicine users corresponding to each time of taking are collectively stored.
<ステップS31>
 ステップS31において、前記制御部11は、前記読取端末2によって、前記薬袋82の前記コード822から前記第2配薬情報が読み取られたか否かを判断する。ここで、前記制御部11は、前記第2配薬情報が読み取られたと判断すると(S31:Yes)、処理をステップS32に移行させる。一方、前記第2配薬情報が読み取られるまでの間は(S31:No)、処理が前記ステップS31で待機する。なお、前記制御部11は、前記薬包81の第1配薬情報と前記薬袋82の第2配薬情報との違いを、例えば前記第1配薬情報にのみ存在する前記服用者IDの有無に応じて判断可能である。もちろん、前記第1配薬情報及び前記第2配薬情報にその識別が可能な情報が含まれていてもよい。
<Step S31>
In step S <b> 31, the control unit 11 determines whether or not the second dispensing information has been read from the code 822 of the medicine bag 82 by the reading terminal 2. Here, if the said control part 11 judges that the said 2nd medicine distribution information was read (S31: Yes), it will transfer a process to step S32. On the other hand, until the second medicine distribution information is read (S31: No), the process waits at step S31. In addition, the said control part 11 is the presence or absence of the said user ID which exists only in the said 1st medicine distribution information, for example between the 1st medicine distribution information of the said medicine package 81, and the 2nd medicine distribution information of the said medicine bag 82 It can be determined according to Of course, information that can be identified may be included in the first drug distribution information and the second drug distribution information.
<ステップS32>
 ステップS32において、前記制御部11は、前記ステップS31で読み取られた前記薬袋82の第2配薬情報と前記配薬管理情報D1とに基づいて、同一の前記薬袋82に収容される薬包81として予め定められた一又は複数の前記薬包81を特定する。具体的に、前記制御部11は、前記配薬管理情報D1において前記配送先識別情報及び前記服用時期が前記第2配薬情報と同一である前記服用者IDの薬品が収容される前記薬包81を前記薬袋82に収容するべき前記薬包81として特定する。
<Step S32>
In step S32, the control unit 11 determines the medicine pack 81 accommodated in the same medicine bag 82 based on the second medicine distribution information and the medicine management information D1 of the medicine bag 82 read in step S31. One or a plurality of the medicine packs 81 determined in advance are specified. Specifically, the control unit 11 stores the medicine package containing the medicine of the user ID whose delivery destination identification information and the time of taking are the same as the second medicine information in the medicine management information D1. 81 is specified as the medicine pack 81 to be accommodated in the medicine bag 82.
<ステップS33>
 そして、ステップS33において、前記制御部11は、前記読取端末2によって、前記薬包81の前記コード811から前記第1配薬情報が読み取られたか否かを判断する。ここで、前記制御部11は、前記第1配薬情報が読み取られたと判断すると(S33:Yes)、処理をステップS34に移行させ、前記第1配薬情報が読み取られるまでの間は(S33:No)、前記ステップS33の判断を繰り返す。
<Step S33>
In step S <b> 33, the control unit 11 determines whether or not the first dispensing information has been read from the code 811 of the medicine package 81 by the reading terminal 2. Here, if the said control part 11 judges that the said 1st medicine distribution information was read (S33: Yes), it will transfer a process to step S34, and until the said 1st medicine distribution information is read (S33). : No), the determination in step S33 is repeated.
<ステップS34>
 ステップS34において、前記制御部11は、前記ステップS31で読み取られた前記第2配薬情報の前記配送先識別情報及び前記服用時期と前記ステップS33で読み取られた前記第1配薬情報の前記配送先識別情報及び前記服用時期とが一致するか否かを判定する。ここに、前記ステップS34は、前記制御部11の前記判定部112によって実行される処理である。また、前記ステップS34において、前記制御部11は、前記ステップS33で読み取られた前記第1配薬情報と、前記ステップS34における判定結果とを読取履歴として前記データ記憶部12に記憶させる。これにより、前記調剤支援装置1では、前記読取履歴を参照及び出力することが可能である。
<Step S34>
In step S34, the control unit 11 sends the delivery destination identification information and the dosing time of the second medicine information read in step S31 and the delivery of the first medicine information read in step S33. It is determined whether the previous identification information and the timing of taking are the same. Here, the step S34 is a process executed by the determination unit 112 of the control unit 11. In Step S34, the control unit 11 stores the first medicine distribution information read in Step S33 and the determination result in Step S34 in the data storage unit 12 as a reading history. Thereby, the dispensing support device 1 can refer to and output the reading history.
<ステップS35>
 そして、ステップS35において、前記制御部11は、前記ステップS34における判定結果を報知する。ここに、前記ステップS35は、前記制御部11の前記第1報知部113によって実行される処理である。具体的に、前記制御部11は、前記判定結果を前記表示装置14又は前記読取端末2に表示させることにより、前記判定結果をユーザーに報知する。これにより、ユーザーが前記判定結果を認識することができる。従って、複数の服用者の前記薬包81を服用時期ごとに纏めて前記薬袋82に収容して配送先に配送する配薬作業における人為的ミスが抑制される。なお、前記判定結果の報知方法は表示に限らず、音声又は発光態様などによって前記判定結果の報知が行われてもよい。
<Step S35>
In step S35, the control unit 11 notifies the determination result in step S34. Here, the step S35 is a process executed by the first notification unit 113 of the control unit 11. Specifically, the control unit 11 notifies the user of the determination result by causing the display device 14 or the reading terminal 2 to display the determination result. Thereby, the user can recognize the determination result. Therefore, human errors in a medicine distribution operation in which the medicine packages 81 of a plurality of users are collected at each time of taking and stored in the medicine bag 82 and delivered to a delivery destination are suppressed. Note that the determination result notification method is not limited to display, and the determination result notification may be performed by sound or a light emission mode.
<ステップS36>
 その後、ステップS36において、前記制御部11は、前記読取端末2による前記薬袋82に収容する前記薬包81からの前記第1配薬情報の読取作業を終了するか否かを判断する。具体的に、前記制御部11は、前記読取端末2に対するユーザーの継続操作、又は次の前記薬包81からの前記第1配薬情報の読取作業が行われた場合に、前記読取作業を終了しないと判断し(S36:No)、処理を前記ステップS33に移行させる。これにより、前記薬袋82に収容する前記薬包81各々からの前記第1配薬情報の読み取りが順に実行される。一方、前記制御部11は、前記読取端末2に対するユーザーの終了操作に応じて前記読取端末2から終了信号が入力された場合、又は前記ステップS31で読み取られた前記薬袋82と異なる前記薬袋82から前記第2配薬情報が読み取られた場合に、前記読取作業を終了すると判断し(S36:Yes)、処理をステップS37に移行させる。
<Step S36>
Thereafter, in step S <b> 36, the control unit 11 determines whether or not to end the reading operation of the first medicine distribution information from the medicine package 81 stored in the medicine bag 82 by the reading terminal 2. Specifically, the control unit 11 ends the reading operation when a user's continuous operation on the reading terminal 2 or a reading operation of the first medicine distribution information from the next medicine pack 81 is performed. It is determined not to do so (S36: No), and the process proceeds to step S33. Thereby, the reading of the first medicine distribution information from each of the medicine packs 81 accommodated in the medicine bag 82 is sequentially executed. On the other hand, the control unit 11 receives an end signal from the reading terminal 2 in response to a user's end operation on the reading terminal 2, or from the medicine bag 82 different from the medicine bag 82 read in the step S31. When the second medicine distribution information is read, it is determined that the reading operation is finished (S36: Yes), and the process is shifted to step S37.
<ステップS37>
 ステップS37において、前記制御部11は、前記配薬管理情報D1に基づいて、同一の前記薬袋82に収容するべき全ての前記薬包81から前記第1配薬情報が読み取られたか否かを判定する。ここに、前記ステップS37は、前記制御部11の前記判定部112によって実行される処理である。ここで、前記制御部11は、前記薬袋82に収容するべき全ての前記薬包81から前記第1配薬情報が読み取られたと判定すると(S37:Yes)、当該収容時照合処理を終了させて処理を前記ステップS31に戻す。なお、異なる前記薬袋82から前記第2配薬情報が読み取られることにより読取終了と判断した場合には、続く前記ステップS31以降において当該第2配薬情報に基づいて同様の処理が実行される。一方、前記制御部11は、前記薬袋82に収容するべき全ての前記薬包81から前記第1配薬情報が読み取られていないと判定すると(S37:No)、処理をステップS38に移行させる。
<Step S37>
In step S37, the control unit 11 determines whether or not the first medicine distribution information has been read from all the medicine packages 81 to be stored in the same medicine bag 82 based on the medicine distribution management information D1. To do. Here, the step S37 is a process executed by the determination unit 112 of the control unit 11. Here, if the said control part 11 determines with the said 1st medicine distribution information having been read from all the said medicine packs 81 which should be accommodated in the said medicine bag 82 (S37: Yes), it will complete | finish the said collation process at the time of accommodation. The process returns to step S31. In addition, when it is determined that the reading is completed by reading the second medicine information from the different medicine bag 82, the same processing is executed based on the second medicine information in the subsequent step S31. On the other hand, if the said control part 11 determines with the said 1st medicine distribution information not being read from all the said medicine packs 81 which should be accommodated in the said medicine bag 82 (S37: No), it will transfer a process to step S38.
<ステップS38>
 ステップS38において、前記制御部11は、前記ステップS37における判定結果を報知し、処理を前記ステップS33に戻す。具体的に、前記制御部11は、前記配薬管理情報D1に基づいて、前記薬袋82に収容するべき前記薬包81のうち前記ステップS33で読み取られていない前記薬包81が存在する旨、及びその未読取の前記薬包81の情報を前記表示装置14又は前記読取端末2に表示させる。これにより、前記薬袋82への前記薬包81の収容漏れが抑制される。例えば、前記制御部11は、前記薬袋82に収容するべき前記薬包81のうち前記ステップS33で読み取られていない前記薬包81に対応する服用者のID又は氏名などを前記服用時期と共に表示させる。
<Step S38>
In step S38, the control unit 11 notifies the determination result in step S37, and returns the process to step S33. Specifically, the control unit 11 indicates that there is the medicine pack 81 that has not been read in step S33 among the medicine packs 81 to be stored in the medicine bag 82 based on the medicine distribution management information D1. And the information of the unread medicine package 81 is displayed on the display device 14 or the reading terminal 2. Thereby, accommodation omission of the medicine bag 81 in the medicine bag 82 is suppressed. For example, the control unit 11 displays the ID or name of the user corresponding to the medicine pack 81 that has not been read in step S33 among the medicine packs 81 to be stored in the medicine bag 82 together with the time of taking the medicine. .
[配送時照合処理]
 続いて、図11のフローチャートを参照しつつ、前記ステップS5において前記調剤支援装置1の前記制御部11によって実行される配送時照合処理について説明する。
[Delivery verification process]
Next, the delivery verification process executed by the control unit 11 of the dispensing support device 1 in the step S5 will be described with reference to the flowchart of FIG.
<ステップS41>
 ステップS41において、前記制御部11は、前記読取端末2によって、前記配送先識別情報が入力されたか否かを判断する。具体的に、配送担当者は、前記読取端末2に対して、これから出荷する前記薬袋82の配送先である前記老健施設Bを示す前記配送先識別情報を入力する。また、配送担当者は、前記読取端末2を用いて、これから出荷する前記薬袋82が配送する際に収容されるコンテナなどの容器に予め付された前記配送先識別情報を読み取ることにより前記配送先識別情報を入力することも考えられる。ここで、前記制御部11は、前記配送先識別情報が入力されたと判断すると(S41:Yes)、処理をステップS42に移行させる。一方、前記配送先識別情報が入力されるまでの間は(S41:No)、処理が前記ステップS41で待機する。
<Step S41>
In step S <b> 41, the control unit 11 determines whether or not the delivery destination identification information has been input by the reading terminal 2. Specifically, the person in charge of delivery inputs the delivery destination identification information indicating the old facility B, which is the delivery destination of the medicine bag 82 to be shipped, to the reading terminal 2. Further, the delivery person uses the reading terminal 2 to read the delivery destination identification information previously attached to a container such as a container to be accommodated when the medicine bag 82 to be shipped is delivered. It is also possible to input identification information. Here, if the said control part 11 judges that the said delivery destination identification information was input (S41: Yes), it will transfer a process to step S42. On the other hand, until the delivery destination identification information is input (S41: No), the process waits in step S41.
<ステップS42>
 ステップS42において、前記制御部11は、前記ステップS41で入力された前記配送先識別情報と前記配薬管理情報D1とに基づいて、前記配送先識別情報が示す同一の前記老健施設Bに同時に配送するべき一又は複数の前記薬袋82を特定する。具体的に、前記制御部11は、前記配送先識別情報及び前記配送日が同一である前記薬袋82を前記老健施設Bに同時に配送するべき前記薬袋82として特定する。
<Step S42>
In step S42, the control unit 11 simultaneously delivers to the same old facility B indicated by the delivery destination identification information based on the delivery destination identification information and the medicine distribution management information D1 input in step S41. One or a plurality of the medicine bags 82 to be specified are specified. Specifically, the control unit 11 specifies the medicine bag 82 having the same delivery destination identification information and the same delivery date as the medicine bag 82 to be delivered to the health facility B at the same time.
<ステップS43>
 そして、ステップS43において、前記制御部11は、前記読取端末2によって、前記薬袋82の前記コード822から前記第2配薬情報が読み取られたか否かを判断する。ここで、前記制御部11は、前記第2配薬情報が読み取られたと判断すると(S43:Yes)、処理をステップS44に移行させ、前記第2配薬情報が読み取られるまでの間は(S43:No)、前記ステップS43の判断を繰り返す。
<Step S43>
In step S <b> 43, the control unit 11 determines whether or not the reading terminal 2 has read the second medicine distribution information from the code 822 of the medicine bag 82. Here, if the said control part 11 judges that the said 2nd medicine distribution information was read (S43: Yes), it will transfer a process to step S44 and will continue until the said 2nd medicine distribution information is read (S43). : No), the determination in step S43 is repeated.
<ステップS44>
 ステップS44において、前記制御部11は、前記ステップS41で入力された前記配送先識別情報と前記ステップS43で読み取られた前記第2配薬情報の前記配送先識別情報とが一致するか否かを判定する。ここに、前記ステップS44は、前記制御部11の前記判定部112によって実行される処理である。また、前記ステップS44において、前記制御部11は、前記ステップS43で読み取られた前記第2配薬情報と、前記ステップS44における判定結果とを読取履歴として前記データ記憶部12に記憶させる。これにより、前記調剤支援装置1では、前記読取履歴を参照及び出力することが可能である。
<Step S44>
In step S44, the control unit 11 determines whether or not the delivery destination identification information input in step S41 matches the delivery destination identification information of the second medicine distribution information read in step S43. judge. Here, the step S44 is a process executed by the determination unit 112 of the control unit 11. In Step S44, the control unit 11 stores the second medicine distribution information read in Step S43 and the determination result in Step S44 in the data storage unit 12 as a reading history. Thereby, the dispensing support device 1 can refer to and output the reading history.
<ステップS45>
 そして、ステップS45において、前記制御部11は、前記ステップS44における判定結果を報知する。ここに、前記ステップS45は、前記制御部11の前記第1報知部113によって実行される処理である。具体的に、前記制御部11は、前記判定結果を前記表示装置14又は前記読取端末2に表示させることにより、前記判定結果をユーザーに報知する。これにより、ユーザーが前記判定結果を認識することができる。従って、複数の服用者の前記薬包81を服用時期ごとに纏めて前記薬袋82に収容して配送先に配送する配薬作業における人為的ミスが抑制される。なお、前記判定結果の報知方法は表示に限らず、音声又は発光態様などによって前記判定結果の報知が行われてもよい。
<Step S45>
In step S45, the control unit 11 notifies the determination result in step S44. Here, the step S45 is a process executed by the first notification unit 113 of the control unit 11. Specifically, the control unit 11 notifies the user of the determination result by causing the display device 14 or the reading terminal 2 to display the determination result. Thereby, the user can recognize the determination result. Therefore, human errors in a medicine distribution operation in which the medicine packages 81 of a plurality of users are collected at each time of taking and stored in the medicine bag 82 and delivered to a delivery destination are suppressed. Note that the determination result notification method is not limited to display, and the determination result notification may be performed by sound or a light emission mode.
<ステップS46>
 その後、ステップS46において、前記制御部11は、前記読取端末2による同一の前記老健施設Bに配送する前記薬袋82からの前記第2配薬情報の読取作業を終了するか否かを判断する。具体的に、前記制御部11は、前記読取端末2に対するユーザーの継続操作、又は次の前記薬袋82からの前記第2配薬情報の読取作業が行われた場合に、前記読取作業を終了しないと判断し(S46:No)、処理を前記ステップS43に移行させる。これにより、同一の前記老健施設Bに配送する前記薬袋82各々からの前記第2配薬情報の読み取りが順に実行される。一方、前記制御部11は、前記読取端末2に対するユーザーの終了操作に応じて前記読取端末2から終了信号が入力された場合、又は前記ステップS41で入力された前記配送先識別情報とは異なる前記配送先識別情報が入力された場合に、前記読取作業を終了すると判断し(S46:Yes)、処理をステップS47に移行させる。
<Step S46>
Thereafter, in step S46, the control unit 11 determines whether or not to end the reading operation of the second medicine distribution information from the medicine bag 82 delivered to the same health facility B by the reading terminal 2. Specifically, the control unit 11 does not end the reading operation when a user's continuous operation on the reading terminal 2 or a reading operation of the second medicine distribution information from the next medicine bag 82 is performed. (S46: No), the process proceeds to step S43. Thereby, the reading of the second medicine distribution information from each of the medicine bags 82 delivered to the same health facility B is sequentially executed. On the other hand, the control unit 11 is different from the delivery destination identification information input in the case where an end signal is input from the reading terminal 2 in response to a user's end operation on the reading terminal 2, or in the step S41. When delivery destination identification information is input, it is determined that the reading operation is to be terminated (S46: Yes), and the process proceeds to step S47.
<ステップS47>
 ステップS47において、前記制御部11は、前記配薬管理情報D1に基づいて、前記配送先識別情報に対応する同一の前記老健施設Bに同時に配送するべき全ての前記薬袋82から前記第2配薬情報が読み取られたか否かを判定する。ここに、前記ステップS47は、前記制御部11の前記判定部112によって実行される処理である。ここで、前記制御部11は、前記老健施設Bに同時に配送するべき全ての前記薬袋82から前記第2配薬情報が読み取られたと判定すると(S47:Yes)、当該配送時照合処理を終了させて処理を前記ステップS41に移行させる。なお、異なる前記配送先識別情報の入力により読取終了と判断した場合には、続く前記ステップS41以降において当該配送先識別情報に基づいて同様の処理が実行される。一方、前記制御部11は、前記老健施設Bに同時に配送するべき全ての前記薬袋82から前記第2配薬情報が読み取られていないと判定すると(S47:No)、処理をステップS48に移行させる。
<Step S47>
In step S47, the control unit 11 performs the second medicine distribution from all the medicine bags 82 to be simultaneously delivered to the same health facility B corresponding to the delivery destination identification information based on the medicine management information D1. It is determined whether information has been read. Here, the step S47 is a process executed by the determination unit 112 of the control unit 11. Here, if the said control part 11 determines with the said 2nd medicine distribution information having been read from all the said medicine bags 82 which should be delivered to the said healthy facility B simultaneously (S47: Yes), the said collation process at the time of delivery will be complete | finished. Then, the process proceeds to step S41. If it is determined that the reading has been completed by inputting different delivery destination identification information, the same processing is executed based on the delivery destination identification information in subsequent step S41. On the other hand, if the said control part 11 determines with the said 2nd medicine distribution information not being read from all the said medicine bags 82 which should be delivered to the said healthy facility B simultaneously (S47: No), it will transfer a process to step S48. .
<ステップS48>
 ステップS48において、前記制御部11は、前記ステップS47における判定結果を報知し、処理を前記ステップS43に戻す。具体的に、前記制御部11は、前記配薬管理情報D1に基づいて、前記配送先識別情報に対応する前記老健施設Bに同時に配送するべき前記薬袋82のうち前記ステップS43で読み取られていない前記薬袋82が存在する旨、及びその未読取の前記薬袋82の情報を前記表示装置14又は前記読取端末2に表示させる。これにより、前記老健施設Bへの前記薬袋82の配送漏れが抑制される。例えば、前記制御部11は、前記配送先識別情報に対応する前記老健施設Bに同時に配送するべき前記薬袋82のうち前記ステップS43で読み取られていない前記薬袋82に対応する服用時期などを前記配送先識別情報と共に表示させる。
<Step S48>
In step S48, the control unit 11 notifies the determination result in step S47, and returns the process to step S43. Specifically, the control unit 11 is not read in step S43 among the medicine bags 82 to be delivered simultaneously to the health facility B corresponding to the delivery destination identification information based on the medicine distribution management information D1. The display device 14 or the reading terminal 2 displays information indicating that the medicine bag 82 exists and information about the medicine bag 82 that has not been read. Thereby, the delivery omission of the medicine bag 82 to the health facility B is suppressed. For example, the control unit 11 sends the dose time corresponding to the medicine bag 82 that has not been read in step S43 among the medicine bags 82 to be delivered to the health facility B corresponding to the delivery destination identification information at the same time. Displayed together with the previous identification information.
[受取時処理]
 次に、図12のフローチャートを参照しつつ、前記ステップS6において前記配薬支援装置5の制御部51によって実行される受取時処理の手順の一例について説明する。
[Processing upon receipt]
Next, an example of the procedure of the receiving process executed by the control unit 51 of the medicine distribution support apparatus 5 in the step S6 will be described with reference to the flowchart of FIG.
<ステップS51>
 ステップS51において、前記制御部51は、前記薬袋82から前記第2配薬情報が読み取られたか否かを判断する。ここで、前記薬袋82から前記第2配薬情報が読み取られるまでの間は(S51:No)、処理が前記ステップS51で待機する。一方、前記薬袋82から前記第2配薬情報が読み取られたと判断すると(S51:Yes)、処理はステップS52に移行する。
<Step S51>
In step S51, the control unit 51 determines whether or not the second medicine distribution information has been read from the medicine bag 82. Here, until the second medicine distribution information is read from the medicine bag 82 (S51: No), the process waits in step S51. On the other hand, if it is determined that the second medicine distribution information has been read from the medicine bag 82 (S51: Yes), the process proceeds to step S52.
<ステップS52>
 ステップS52において、前記制御部51は、前記ステップS51で読み取られた前記第2配薬情報に含まれる前記配送先識別情報と、前記配薬支援装置5が設置されている前記老健施設Bを示す情報として前記配薬支援装置5に予め登録された配送先識別情報とが一致するか否かを判定する。ここに、前記ステップS52は、前記制御部51の前記配送先判定部512によって実行される処理である。また、前記ステップS52において、前記制御部51は、前記ステップS51で読み取られた前記第2配薬情報と、前記ステップS52における判定結果とを読取履歴として前記データ記憶部52に記憶させる。これにより、前記配薬支援装置5では、前記読取履歴を参照及び出力することが可能である。
<Step S52>
In step S52, the control unit 51 indicates the delivery destination identification information included in the second medicine distribution information read in step S51 and the health facility B where the medicine distribution support device 5 is installed. It is determined whether or not the delivery destination identification information registered in advance in the medicine distribution support device 5 as information matches. Here, the step S52 is a process executed by the delivery destination determination unit 512 of the control unit 51. In step S52, the control unit 51 causes the data storage unit 52 to store the second medicine distribution information read in step S51 and the determination result in step S52 as a reading history. Thereby, the medicine distribution support device 5 can refer to and output the reading history.
<ステップS53>
 そして、ステップS53において、前記制御部51は、前記ステップS52における前記判定結果を報知する。具体的に、前記制御部51は、前記判定結果を前記表示装置54又は前記読取端末7に表示させる。ここに、前記ステップS53は、前記制御部51の前記第2報知部513によって実行される処理である。これにより、配薬担当者は、前記判定結果を確認することにより、前記老健施設Bが前記薬袋82の配送先として正しい旨を容易かつ確実に認識することができる。従って、前記薬袋82の誤配送が抑制される。
<Step S53>
In step S53, the control unit 51 notifies the determination result in step S52. Specifically, the control unit 51 displays the determination result on the display device 54 or the reading terminal 7. The step S53 is a process executed by the second notification unit 513 of the control unit 51. Thus, the person in charge of medicine distribution can easily and reliably recognize that the old health facility B is correct as the delivery destination of the medicine bag 82 by confirming the determination result. Accordingly, erroneous delivery of the medicine bag 82 is suppressed.
[配薬時照合処理]
 次に、図13のフローチャートを参照しつつ、前記ステップS7において前記配薬支援装置5の制御部51によって実行される配薬時照合処理の手順の一例について説明する。
[Matching process during drug distribution]
Next, an example of the procedure of the collation process at the time of drug distribution executed by the control unit 51 of the drug distribution support apparatus 5 in the step S7 will be described with reference to the flowchart of FIG.
<ステップS61>
 ステップS61において、前記制御部51は、前記薬包81から前記第1配薬情報が読み取られたか否かを判断する。ここで、前記薬包81から前記第1配薬情報が読み取られるまでの間は(S61:No)、処理が前記ステップS61で待機する。一方、前記薬包81から前記第1配薬情報が読み取られたと判断すると(S61:Yes)、処理はステップS62に移行する。
<Step S61>
In step S <b> 61, the control unit 51 determines whether or not the first medicine distribution information has been read from the medicine package 81. Here, until the first medicine distribution information is read from the medicine package 81 (S61: No), the process waits in the step S61. On the other hand, if it is determined that the first medicine distribution information has been read from the medicine package 81 (S61: Yes), the process proceeds to step S62.
<ステップS62>
 ステップS62において、前記制御部51は、前記ステップS61で読み取られた前記第1配薬情報に含まれる前記服用者IDと前記変換情報と前記入居者マスターとに基づいて前記服用者に対応する入居者を特定する。また、前記ステップS62において、前記制御部51は、前記ステップS61で読み取られた前記第1配薬情報と、前記ステップS62における特定結果とを読取履歴として前記データ記憶部52に記憶させる。これにより、前記配薬支援装置5では、前記読取履歴を参照及び出力することが可能である。
<Step S62>
In step S62, the control unit 51 moves in corresponding to the user based on the user ID, the conversion information, and the resident master included in the first medicine information read in step S61. Identify the person. In step S62, the control unit 51 stores the first medicine distribution information read in step S61 and the specific result in step S62 in the data storage unit 52 as a reading history. Thereby, the medicine distribution support device 5 can refer to and output the reading history.
<ステップS63>
 そして、ステップS63において、前記制御部51は、前記薬包81の服用時期と、前記ステップS62で特定された前記服用者に対応する入居者の氏名及び顔画像63と、を前記携帯端末6に表示させる(図4参照)。ここに、前記ステップS63は、前記制御部51の前記表示制御部511によって実行される処理である。これにより、配薬担当者は、前記入居者の顔画像63を確認することにより、前記入居者が前記薬包81の薬品を服用する服用者として正しい旨を容易かつ確実に認識することができるため、配薬担当者による配薬ミスが抑制される。また、前記配薬支援システム10の構成によれば、前記顔画像63を表示されることにより、前記入居者各々が当該入居者を識別するためのリストバンドなどを装着する必要がないため、前記老健施設Bの運営に好適である。なお、前記入居者マスターに、1人の前記入居者について表情又は撮影角度の異なる複数の前記顔画像63が予め登録されていることも他の実施形態として考えられる。これにより、配薬担当者が前記顔画像63各々に基づいて前記入居者をより正確に判断することができる。
<Step S63>
In step S63, the control unit 51 displays the time of taking the medicine package 81 and the name and face image 63 of the resident corresponding to the user specified in step S62 on the portable terminal 6. Display (see FIG. 4). The step S63 is a process executed by the display control unit 511 of the control unit 51. Thereby, the person in charge of medicine distribution can easily and reliably recognize that the resident is correct as a person taking the medicine of the medicine package 81 by checking the face image 63 of the resident. Therefore, medicine delivery mistakes by the person in charge of medicine delivery are suppressed. Further, according to the configuration of the medicine distribution support system 10, since the face image 63 is displayed, it is not necessary for each resident to wear a wristband or the like for identifying the resident. It is suitable for the operation of the old health facility B. In addition, it is also conceivable as another embodiment that a plurality of face images 63 having different facial expressions or photographing angles are registered in advance in the tenant master. Thereby, the medicine distribution person can judge the resident more accurately based on each of the face images 63.
[第2実施形態]
 前述したように、前記老健施設Bで実行される前記ステップS7の配薬作業では、配薬担当者により薬品と入居者とが照合されながら配薬が行われる。以下、本実施形態では、配薬担当者による薬品の配薬作業を支援することにより配薬時における人為的ミスの抑制を図る構成について説明する。
[Second Embodiment]
As described above, in the medicine distribution operation in step S7 executed in the old-age facility B, medicine distribution is performed while the medicine person in charge compares the medicine and the resident. Hereinafter, in the present embodiment, a configuration will be described in which an artificial mistake at the time of drug distribution is suppressed by supporting a drug distribution operation by a person in charge of drug distribution.
 まず、図14を参照しつつ、本実施形態に係る配薬支援システム100の構成について説明する。なお、前記配薬支援システム100について、前記配薬支援システム10(図1参照)と同様の構成には同じ符号を付しており、その説明を省略する。 First, the configuration of the drug distribution support system 100 according to the present embodiment will be described with reference to FIG. In addition, about the said medicine distribution assistance system 100, the same code | symbol is attached | subjected to the structure similar to the said medicine distribution assistance system 10 (refer FIG. 1), and the description is abbreviate | omitted.
 図14に示すように、前記調剤支援装置1は、USBポート18を備える。前記USBポート18は、USBメモリ19を着脱可能であって、前記USBメモリ19に対するデータの書き込み及び前記USBメモリ19からのデータの読み出しが可能である。なお、前記USBメモリ19に限らず、CD、DVD、BDなどの他の記録メディアを利用することも考えられる。 As shown in FIG. 14, the dispensing support device 1 includes a USB port 18. The USB port 18 is detachably attachable to the USB memory 19 and can write data to the USB memory 19 and read data from the USB memory 19. It should be noted that not only the USB memory 19 but also other recording media such as a CD, a DVD, and a BD may be used.
 また、前記調剤支援装置1では、前記制御部11が、前記調剤支援プログラムに従って各種の処理を実行することにより配薬データ出力部114、残薬情報入力部115、及び残薬通知部116として機能する。なお、前記配薬データ出力部114が配薬データ出力手段の一例、前記残薬情報入力部115が残薬情報入力手段の一例、前記残薬通知部116が残薬通知手段の一例である。 Moreover, in the said dispensing assistance apparatus 1, the said control part 11 functions as the medicine distribution data output part 114, the remaining medicine information input part 115, and the remaining medicine notification part 116 by performing various processes according to the said dispensing assistance program. To do. The drug distribution data output unit 114 is an example of a drug distribution data output unit, the residual drug information input unit 115 is an example of a residual drug information input unit, and the residual drug notification unit 116 is an example of a residual drug notification unit.
 前記配薬データ出力部114は、前記薬包81各々に薬品を分包する際に用いられ、前記処方データ記憶部121に記憶されている処方データに基づく配薬データを前記USBポート18に出力し、前記USBポート18から前記USBメモリ19に記録させることが可能である。特に、前記配薬データ出力部114は、前記配薬データを前記配薬グループの単位で出力することが可能である。具体的に、前記配薬データ出力部114は、前記操作装置15に対するユーザー操作により前記老健施設Bが指定された場合に、その老健施設Bに入居している入居者各々に対応する処方データを抽出し、その処方データに基づく配薬データを出力可能である。これにより、前記処方データのうち必要な処方データだけを容易に利用することが可能である。 The medicine distribution data output unit 114 is used when dispensing medicines into each medicine package 81, and outputs medicine distribution data based on prescription data stored in the prescription data storage unit 121 to the USB port 18. It is possible to record from the USB port 18 to the USB memory 19. In particular, the medicine distribution data output unit 114 can output the medicine distribution data in units of the medicine distribution group. Specifically, when the health facility B is designated by a user operation on the operation device 15, the medicine distribution data output unit 114 displays prescription data corresponding to each resident in the health facility B. Extraction and distribution data based on the prescription data can be output. Thereby, it is possible to easily use only necessary prescription data among the prescription data.
 そのため、前記調剤支援装置1の前記データ記憶部12には、施設マスター及び入居者マスターが記憶されており、前記配薬データ出力部114は、前記施設マスター及び前記入居者マスターに基づいて必要な前記処方データを抽出する。なお、前記配薬データ出力部114は、前記配薬データに前記施設マスター及び前記入居者マスターの情報の一部又は全部を付加して出力することも可能である。 Therefore, a facility master and a resident master are stored in the data storage unit 12 of the dispensing support device 1, and the medicine distribution data output unit 114 is necessary based on the facility master and the resident master. The prescription data is extracted. In addition, the said medicine distribution data output part 114 can also add and output a part or all of the information of the said facility master and the said tenant master to the said medicine distribution data.
 ここに、図15は、前記施設マスター及び前記入居者マスターの一例を示す図である。なお、前記施設マスター及び前記入居者マスター各々の登録作業は、例えば前記調剤支援装置1の初期設定又はマスターメンテナンスなどにおいて、前記調剤支援装置1の前記表示装置14及び前記操作装置15などを用いて行われる。 FIG. 15 is a diagram showing an example of the facility master and the resident master. The registration work of each of the facility master and the resident master is performed by using the display device 14 and the operation device 15 of the dispensing support device 1 in the initial setting or master maintenance of the dispensing support device 1, for example. Done.
 図15に示すように、前記施設マスターには、前記老健施設Bごとに対応する施設コード、施設名称、及び印字フォーマットが関連付けて記憶されている。前記施設コード及び前記施設名称は、前記老健施設Bを識別するための識別情報の一例であって、前記印字フォーマットは、前記薬品分包装置3において前記薬包81に印刷する項目のフォーマットの種類を識別するための情報である。なお、前記施設コードは、例えば前記配送先ID(図2参照)と同一である。 As shown in FIG. 15, the facility master stores a facility code, a facility name, and a print format corresponding to each of the old facilities B in association with each other. The facility code and the facility name are examples of identification information for identifying the health facility B, and the print format is the format type of items to be printed on the medicine package 81 in the medicine packaging device 3 It is information for identifying. The facility code is, for example, the same as the delivery destination ID (see FIG. 2).
 また、図15に示すように、前記入居者マスター各々は、前記施設マスターに登録されている前記老健施設B各々に関連付けて記憶される。具体的に、前記入居者マスターには、入居者ごとに対応する服用者ID、服用者名、入居者ID、グループ、及び印字フォーマットが記憶されている。前記服用者ID、前記服用者名、及び前記入居者IDは前記老健施設Bに入居する入居者を識別するための識別情報の一例である。特に、前記服用者IDは、前記薬局A側の前記調剤支援装置1などにおいて前記入居者(服用者)を識別するために予め登録される識別情報であり、前記入居者IDは、前記老健施設B側の前記配薬支援装置5などにおいて前記入居者を識別するために予め登録される識別情報である。例えば、前記マスター記憶部521に記憶されている前記入居者マスターが前記老健施設B側から前記薬局A側に提供されることにより、前記薬局A側で前記調剤支援装置1の前記入居者マスターに前記入居者IDが登録される。なお、前記入居者マスターにおける前記服用者IDと前記入居者IDとの対応関係は、前記配薬支援装置5で用いられる前記変換情報における前記服用者IDと前記入居者IDとの対応関係と同じである。 Further, as shown in FIG. 15, each of the tenant masters is stored in association with each of the old facility B registered in the facility master. Specifically, the resident master stores a occupant ID, a occupant name, a resident ID, a group, and a print format corresponding to each resident. The taker ID, the taker name, and the resident ID are examples of identification information for identifying a resident who enters the health facility B. In particular, the user ID is identification information registered in advance for identifying the resident (taker) in the dispensing support device 1 or the like on the pharmacy A side, and the resident ID is the health facility. This is identification information registered in advance in order to identify the resident in the medicine distribution support device 5 on the B side. For example, the resident master stored in the master storage unit 521 is provided from the health facility B side to the pharmacy A side, so that the pharmacy A side can provide the resident master of the dispensing support device 1 to the resident master. The resident ID is registered. In addition, the correspondence between the doser ID and the resident ID in the resident master is the same as the correspondence between the doser ID and the resident ID in the conversion information used in the medicine distribution support device 5. It is.
 また、前記グループは、前記老健施設Bにおける病棟、病室、又はフロアなどにより一連の配薬グループとして分類されたグループを識別するための識別情報である。なお、前記老健施設Bでは、入居者への配薬作業が前記グループごとに行われる。さらに、前記印字フォーマットは、前記薬品分包装置3において前記薬包81及び前記薬袋82などに印刷する項目及び配置などのフォーマットの種類を識別するための情報である。なお、前記入居者マスターに登録された前記印字フォーマットは、例えば前記施設マスターにおいて前記印字フォーマットが登録されている場合でも優先的に採用される。 Further, the group is identification information for identifying a group classified as a series of medicine distribution groups by a ward, a hospital room, a floor, or the like in the old-age facility B. In the old-age facility B, a medicine distribution operation to residents is performed for each group. Further, the print format is information for identifying the type of format such as items and arrangements to be printed on the medicine package 81 and the medicine bag 82 in the medicine packaging device 3. The print format registered in the resident master is preferentially adopted even when the print format is registered in the facility master, for example.
 このように構成された前記配薬支援システム100では、前記調剤支援装置1において、前記服用者IDと前記入居者IDとの対応関係を把握することが可能である。そのため、前記制御部11が、前記第1配薬情報に含まれる前記服薬者IDに代えて又は前記服薬者IDと共に、前記入居者IDを前記薬品分包装置3によって前記薬包81に印刷させることが考えられる。 In the medicine distribution support system 100 configured as described above, the dispensing support device 1 can grasp the correspondence between the user ID and the resident ID. Therefore, the control unit 11 causes the medicine packaging device 3 to print the resident ID on the medicine package 81 instead of the medicine person ID included in the first medicine distribution information or together with the medicine person ID. It is possible.
 また、前記残薬情報入力部115は、前記配薬支援装置5において後述の残薬情報出力部516によって出力される残薬情報を入力可能である。例えば、前記残薬情報入力部115は、前記ネットワークN1及び前記ネットワークN2などを介して、前記残薬情報の送信を前記配薬支援装置5に要求し、前記配薬支援装置5から送信される前記残薬情報を取得する。また、前記残薬情報入力部115は、前記USBメモリ19などの記録媒体から前記残薬情報を読み取って入力することも可能であり、前記配薬支援装置5からメールなどによって送信された前記残薬情報を入力することも可能である。 Further, the remaining medicine information input unit 115 can input the remaining medicine information output from the remaining medicine information output unit 516 described later in the medicine distribution support device 5. For example, the remaining medicine information input unit 115 requests the medicine distribution support apparatus 5 to transmit the remaining medicine information via the network N1, the network N2, and the like, and is transmitted from the medicine distribution support apparatus 5. The remaining medicine information is acquired. The remaining medicine information input unit 115 can also read and input the remaining medicine information from a recording medium such as the USB memory 19, and the remaining medicine information transmitted from the medicine distribution support apparatus 5 by e-mail or the like. It is also possible to enter drug information.
 前記残薬通知部116は、前記残薬情報入力部115により入力された前記残薬情報と前記処方データとに基づいて、前記処方データに含まれる処方薬として使用可能な残薬の情報を通知可能である。例えば、前記残薬通知部116は、前記処方データの発行処理(図4のステップS1)において、調剤対象の前記処方データで使用可能な残薬が存在する旨の注意喚起を表示することが可能である。なお、前記調剤支援装置1では、前記制御部11が、前記操作装置15のユーザー操作に応じて任意のタイミングで前記表示装置14などに前記残薬情報を表示させることも可能である。また、前記残薬通知部116は、前記残薬情報を前記調剤支援装置1に通信可能に接続された前記電子カルテシステム又は前記処方入力端末などの上位システム(不図示)に送信することも可能である。これにより、前記上位システムを使用する医師に前記残薬情報を通知して前記処方データの修正などを促すことができ、薬品の無駄を抑制することが可能である。なお、前記薬局A側の薬剤師が、前記調剤支援装置1で表示される前記残薬情報を参照し、残薬の量を医師に連絡して、新たな処方入力時に残薬を除いた処方入力を促すこと、又は入力済みの処方から残薬を除く修正(再発行)を促すことが可能である。 The remaining medicine notification unit 116 notifies information on remaining medicines that can be used as prescription drugs included in the prescription data based on the remaining medicine information and the prescription data input by the remaining medicine information input unit 115. Is possible. For example, the remaining medicine notification unit 116 can display a warning that there is a remaining medicine that can be used in the prescription data to be dispensed in the prescription data issuance process (step S1 in FIG. 4). It is. In the dispensing support device 1, the control unit 11 can display the remaining medicine information on the display device 14 or the like at an arbitrary timing in accordance with a user operation of the operation device 15. The remaining medicine notification unit 116 can also transmit the remaining medicine information to a higher-level system (not shown) such as the electronic medical record system or the prescription input terminal connected to the dispensing support device 1 so as to be communicable. It is. Accordingly, it is possible to notify the doctor using the host system of the remaining medicine information and prompt the correction of the prescription data, etc., and suppress waste of medicine. The pharmacist at the pharmacy A side refers to the remaining medicine information displayed on the dispensing support device 1, notifies the doctor of the amount of the remaining medicine, and inputs the prescription without removing the remaining medicine when inputting a new prescription. Or correction (reissue) to remove the remaining medicine from the prescription that has already been entered.
 一方、図14に示すように、前記配薬支援装置5は、USBポート58を備える。前記USBポート58は、前記USBメモリ19が着脱可能であり、前記USBメモリ19に対するデータの書き込み及び前記USBメモリ19からのデータの読み出しが可能である。 On the other hand, as shown in FIG. 14, the medicine distribution support device 5 includes a USB port 58. The USB memory 19 can be attached to and removed from the USB port 58, and data can be written to and read from the USB memory 19.
 また、前記配薬支援装置5では、前記データ記憶部52に配薬データ記憶部523が含まれる。前記配薬データ記憶部523には、前記調剤支援装置1から出力され、前記USBポート58によって前記USBメモリ19から読み出される前記配薬データが記憶される。 Also, in the medicine distribution support device 5, the data storage unit 523 is included in the data storage unit 52. The medicine distribution data storage unit 523 stores the medicine distribution data output from the dispensing support device 1 and read from the USB memory 19 by the USB port 58.
 また、前記配薬支援装置5では、前記制御部51が、前記配薬支援プログラムに従って各種の処理を実行することにより配薬データ入力部514、服薬完了入力部515、及び残薬情報出力部516として機能する。なお、前記配薬データ入力部514が配薬データ入力手段の一例、前記服薬完了入力部515が服薬完了入力手段の一例、前記残薬情報出力部516が残薬情報出力手段の一例である。 Moreover, in the said medicine distribution assistance apparatus 5, the said control part 51 performs various processes according to the said medicine distribution assistance program, and thereby, a medicine distribution data input part 514, a medication completion input part 515, and a remaining medicine information output part 516 Function as. The drug distribution data input unit 514 is an example of a drug distribution data input unit, the drug completion input unit 515 is an example of a drug completion input unit, and the remaining drug information output unit 516 is an example of a residual drug information output unit.
 前記配薬データ入力部514は、前記調剤支援装置1により出力された前記配薬データを、薬品の配送先である前記老健施設Bに設けられた前記配薬支援装置5に入力することが可能である。具体的に、前記配薬データ入力部514は、前記操作装置55のユーザー操作に応じて、前記USBポート58に接続される前記USBメモリ19から前記配薬データを読み出すことにより前記配薬データを前記配薬支援装置5に入力する。 The medicine distribution data input unit 514 can input the medicine distribution data output by the dispensing support device 1 to the medicine distribution support device 5 provided in the old health facility B which is a medicine delivery destination. It is. Specifically, the medicine distribution data input unit 514 reads out the medicine distribution data by reading out the medicine distribution data from the USB memory 19 connected to the USB port 58 in response to a user operation of the operation device 55. Input to the medicine distribution support device 5.
 前記服薬完了入力部515は、前記表示装置54又は前記携帯端末6により後述の入居者一覧画面211(図23参照)に表示された服用者ごとの服薬完了の入力操作を受け付ける。具体的に、前記服薬完了入力部515は、前記操作装置55又は前記携帯端末6に対する前記服用者の服薬完了の入力操作を受け付ける。 The medication completion input unit 515 accepts a medication completion input operation for each user displayed on the resident list screen 211 (see FIG. 23) described later by the display device 54 or the mobile terminal 6. Specifically, the medication completion input unit 515 accepts an input operation of the medication completion of the user for the operation device 55 or the mobile terminal 6.
 前記残薬情報出力部516は、前記服用者が服用しなかった残薬に関する残薬情報の入力操作を受け付けると共に、前記残薬情報を出力可能である。具体的に、前記残薬情報出力部516は、前記操作装置55又は前記携帯端末6に対する前記残薬情報の入力操作を受け付ける。そして、前記残薬情報出力部516は、前記残薬情報を前記データ記憶部52に記憶すると共に、前記ネットワークN1及び前記ネットワークN2などを介して前記調剤支援装置1に送信出力する。 The remaining medicine information output unit 516 can receive the remaining medicine information input operation regarding the remaining medicine that the user has not taken, and can output the remaining medicine information. Specifically, the remaining medicine information output unit 516 receives an input operation of the remaining medicine information with respect to the operation device 55 or the portable terminal 6. Then, the remaining medicine information output unit 516 stores the remaining medicine information in the data storage unit 52 and transmits and outputs it to the dispensing support apparatus 1 via the network N1, the network N2, and the like.
 また、前記配薬支援装置5では、前記制御部11が前記操作装置55又は前記携帯端末6のユーザー操作に応じて初期設定情報として前記老健施設B及び入居者の情報を登録可能である。ここに、図16は施設登録画面の一例を示す図、図17は入居者登録画面の一例を示す図である。 Further, in the medicine distribution support device 5, the control unit 11 can register the information about the old facility B and the resident as initial setting information according to the user operation of the operation device 55 or the mobile terminal 6. FIG. 16 shows an example of the facility registration screen, and FIG. 17 shows an example of the resident registration screen.
 図16に示すように、前記制御部11は、前記操作装置55のユーザー操作に応じて、施設コード及び施設名称を登録するための施設登録画面を表示させる。前記施設登録画面では、前記施設コード及び前記施設名称が入力された後、登録キーが操作されることにより、それらの情報が施設マスターとして前記マスター記憶部521に記憶される。なお、前記施設コード及び前記施設名称は、前記調剤支援装置1の前記施設マスター(図15参照)に登録される施設コード及び施設名称と同じである。 As shown in FIG. 16, the control unit 11 displays a facility registration screen for registering a facility code and a facility name in response to a user operation of the operation device 55. In the facility registration screen, after the facility code and the facility name are input, a registration key is operated, and the information is stored in the master storage unit 521 as a facility master. The facility code and the facility name are the same as the facility code and the facility name registered in the facility master (see FIG. 15) of the dispensing support device 1.
 また、図17に示すように、前記制御部11は、前記操作装置55のユーザー操作に応じて、入居者の情報を登録するための入居者登録画面を表示させる。具体的に、前記入居者登録画面では、入居者ID、入居者の名前、仮名、生年月日、性別、管理区分、グループ、部屋コード、コメント、及び顔画像(写真)の入力が可能である。前記管理区分では、例えば、薬品の服用を自己で管理する自己管理であるか否かなどが選択される。前記管理区分には、服薬時の配薬及び服薬の有無の確認が必要である「服薬確認要」、所定期間の薬品が服用者に預けられ、服薬時の配薬は不要であるが服薬の有無の確認が必要である「服薬確認要(自己管理)」、及び所定期間の薬品が服用者に預けられ、服薬時の配薬及び服用の確認が共に不要である「服薬確認不要(自己管理)」などが含まれる。前記コメントには、入居者について注意すべき事項などが任意に記載可能であり、前記コメントは後述の入居者確認画面213(図25参照)に表示可能である。また、顔画像(写真)の入力手法としては、予め撮影された写真を一覧から選択して取り込む取込入力、及び入居者の情報を登録する際に前記携帯端末6の前記カメラ62を用いて撮影する撮影入力がある。そして、前記入居者登録画面では、入居者の情報が入力された後、登録キーが操作されることによりそれらの情報が前記入居者マスターとして前記マスター記憶部521に記憶される。なお、入居者の情報に含まれる入居者ID、入居者の名前(仮名)、及びグループなどは、前記調剤支援装置1の前記入居者マスター(図15参照)に登録される入居者ID、服用者名、及びグループと同じである。また、前記入居者登録画面において、データキーが操作された場合には、前記制御部11は、その後の操作に応じて入居者の情報のインポート又はエクスポートを実行する。 Further, as shown in FIG. 17, the control unit 11 displays a resident registration screen for registering resident information in response to a user operation of the operation device 55. Specifically, the tenant ID, tenant name, pseudonym, date of birth, gender, management classification, group, room code, comment, and face image (photograph) can be input on the tenant registration screen. . In the management category, for example, it is selected whether or not self-management for self-administration of medicines is performed. In the above management category, it is necessary to confirm the dispensing at the time of taking medicine and the presence or absence of taking medicine, the medicine for the prescribed period is entrusted to the user, and the dispensing at the time of taking is not required, but “Medication confirmation required (self-management)”, which requires confirmation of presence / absence, and medication for a specified period of time have been entrusted to the user, and both dispensing and confirmation of medication are not required. ) "Etc. In the comment, matters to be noted about the resident can be arbitrarily described, and the comment can be displayed on a resident confirmation screen 213 (see FIG. 25) described later. In addition, as an input method of a face image (photograph), the camera 62 of the portable terminal 6 is used when registering a resident information by inputting a capture input by selecting a photograph taken in advance from a list. There is a shooting input to shoot. In the resident registration screen, after the resident information is input, the registration key is operated, and the information is stored in the master storage unit 521 as the resident master. The resident ID, resident name (kana), group, etc. included in the resident information are the resident ID registered in the resident master (see FIG. 15) of the dispensing support device 1 and the dose. The same as the name and group. In addition, when the data key is operated on the resident registration screen, the control unit 11 imports or exports resident information according to the subsequent operation.
 以下、このように構成された前記配薬支援システム100において実行される各種の処理について説明する。なお、前記配薬支援システム100においても、前記薬品分包処理(図8参照)、前記収容時照合処理(図10参照)、前記配送時照合処理(図11参照)、及び前記受取時処理(図12参照)などが実行される。 Hereinafter, various processes executed in the medicine distribution support system 100 configured as described above will be described. Also in the medicine distribution support system 100, the medicine packaging process (see FIG. 8), the collation process at the time of accommodation (see FIG. 10), the collation process at the time of delivery (see FIG. 11), and the process at the time of receiving ( Etc.) are executed.
[処方データの発行処理]
 まず、図18を参照しつつ、前記配薬支援システム100で実行される前記処方データ発行処理について説明する。なお、前記処方データの発行処理について、図5で説明した処理手順と同様の処理手順については同じ符号を付しており、その説明を省略する。
[Prescription data issuance process]
First, the prescription data issuing process executed by the medicine distribution support system 100 will be described with reference to FIG. In addition, about the issuing process of the said prescription data, the same code | symbol is attached | subjected about the process procedure similar to the process procedure demonstrated in FIG. 5, and the description is abbreviate | omitted.
<ステップS111>
 図18に示すように、前記ステップS11において前記処方データの発行操作が行われると、続くステップS111において、前記制御部11は、前記残薬情報を入力するための残薬情報入力処理を実行する。ここに、前記ステップS111は、前記制御部11の前記残薬情報入力部115によって実行される。
<Step S111>
As shown in FIG. 18, when the operation for issuing the prescription data is performed in step S11, in step S111, the control unit 11 executes a remaining medicine information input process for inputting the remaining medicine information. . Here, the step S111 is executed by the remaining medicine information input unit 115 of the control unit 11.
 例えば、前記ステップS111では、前記制御部11が、前記ネットワークN1及び前記ネットワークN2などを介して前記配薬支援装置5に前記残薬情報の送信を要求する。そして、前記制御部11は、前記配薬支援装置5から前記ネットワークN1及び前記ネットワークN2などを介して送信される前記残薬情報を受信する。なお、前記配薬支援装置5から予め設定された期間ごと又は予め定められたタイミングで自動的に前記残薬情報が前記ネットワークN1及び前記ネットワークN2などを介して送信され、前記残薬情報入力部115が前記残薬情報を取得することも考えられる。また、前記配薬支援装置5において前記USBメモリ19などの記録媒体に前記残薬情報が記録され、前記調剤支援装置1において前記USBメモリ19などの記録媒体から前記残薬情報が読み出されることも考えられる。これにより、前記ネットワークN1及び前記ネットワークN2を介した連携を伴うことなく前記残薬情報を前記調剤支援装置1で活用することが可能となる。 For example, in step S111, the control unit 11 requests the medicine distribution support apparatus 5 to transmit the remaining medicine information via the network N1, the network N2, and the like. And the said control part 11 receives the said remaining medicine information transmitted via the said network N1, the said network N2, etc. from the said medicine distribution assistance apparatus 5. FIG. Note that the remaining medicine information is automatically transmitted from the medicine distribution support device 5 via the network N1, the network N2, and the like automatically every predetermined period or at a predetermined timing. It is also conceivable that 115 acquires the remaining medicine information. In addition, the remaining medicine information is recorded on a recording medium such as the USB memory 19 in the medicine distribution support device 5, and the remaining medicine information is read from the recording medium such as the USB memory 19 in the dispensing support device 1. Conceivable. Thereby, it becomes possible to utilize the said remaining medicine information with the said dispensing assistance apparatus 1 without accompanying via the said network N1 and the said network N2.
<ステップS112>
 次に、ステップS112において、前記制御部11は、前記ステップS111で取得した前記残薬情報と前記処方データとに基づいて、前記処方データに含まれる処方薬として使用可能な残薬の情報を通知する。ここに、前記ステップ112は、前記制御部11の前記残薬通知部116によって実行される。また、前記制御部11は、前記ステップS112において、前記処方データにおける処方日が、前記残薬情報に含まれる残薬の有効期限内であるか否かを判断し、前記有効期限内であるか否かを前記表示装置14などに表示させることも考えられる。
<Step S112>
Next, in step S112, the control unit 11 notifies information on a remaining medicine that can be used as a prescription medicine included in the prescription data based on the remaining medicine information and the prescription data acquired in step S111. To do. Here, the step 112 is executed by the remaining medicine notification unit 116 of the control unit 11. Moreover, the said control part 11 judges whether the prescription date in the said prescription data is in the expiration date of the remaining medicine contained in the said remaining medicine information in the said step S112, and is it in the said expiration date? It is also possible to display whether or not the display device 14 or the like is displayed.
 例えば、前記ステップS112では、前記制御部11が、前記残薬情報と前記処方データとに基づいて、前記処方データのうち前記残薬情報において残薬として存在するため分包が不要な薬品を判断する。そして、前記残薬として存在する薬品の情報を前記表示装置14などに表示させる。これにより、前記表示装置14を参照する薬剤師などが、前記残薬を利用可能である旨を容易に認識することが可能であり、例えば医師への前記処方データの修正照会を行うことにより薬品の無駄を抑制することが可能になる。具体的には、前記残薬情報を確認した上で服用日数又は服用回数などが調整されることが考えられる。 For example, in step S112, the control unit 11 determines a medicine that does not need to be packaged because it exists as a remaining medicine in the remaining medicine information in the prescription data based on the remaining medicine information and the prescription data. To do. And the information of the medicine which exists as the said remaining medicine is displayed on the said display apparatus 14 grade | etc.,. Thereby, it is possible for a pharmacist or the like referring to the display device 14 to easily recognize that the remaining medicine can be used. For example, by making a correction inquiry of the prescription data to a doctor, It becomes possible to suppress waste. Specifically, it is considered that the number of days taken or the number of times taken is adjusted after confirming the remaining medicine information.
 なお、このとき医師が、前記処方データから前記残薬を使用可能な服用時期又は薬品を除いた場合には、前記残薬を使用することが前提になるため、前記老健施設Bに配送される薬品が不足した状態となる。そこで、例えば前記ステップS12における前記分包データの生成時に、前記残薬の存在により分包対象から除かれた薬品についても空の前記薬包81が発行されるように前記分包データが生成されることが考えられる。具体的には、前記分包データのうち前記残薬の存在により分包対象から除かれた薬品に対応する分包データに、その服用時期と、その服用時期に使用する残薬を特定するための残薬特定情報(例えば、服用時期など)とが含まれることが考えられる。 At this time, when the doctor removes the remaining time from which the remaining medicine can be used or the medicine from the prescription data, it is assumed that the remaining medicine will be used, and therefore, it is delivered to the health facility B. The drug is in short supply. Therefore, for example, when the packaging data is generated in step S12, the packaging data is generated so that an empty medicine package 81 is also issued for a medicine removed from the packaging target due to the presence of the remaining medicine. It can be considered. Specifically, in the packaging data corresponding to the medicine removed from the packaging target due to the presence of the remaining medicine in the packaging data, to specify the taking time and the remaining medicine to be used at the taking time It is conceivable that the remaining medicine specifying information (for example, the time of taking) is included.
 そして、前記薬品分包装置3では、残薬を使用する前記服用時期及び前記残薬特定情報が空の前記薬包81に印刷される。例えば、空の前記薬包81には、「△月△日夕食後は、○月○日夕食後の薬品を服用して下さい」などのメッセージが表示されることが考えられる。これにより、前記老健施設Bでは、空の前記薬包81を参照することにより前記服用時期ごとに使用するべき残薬を判断することが可能である。なお、前記残薬が使用可能であるか否かの判断は、前記服用時期ごとに行われること、即ち前記薬包81の単位で行われることが考えられる。これにより、前記薬包81内の薬品と残薬として残っている薬品とを合わせて服用する必要がなく、配薬ミスの発生を抑制することができる。また、前記分包データの生成時に、分包対象から除かれた薬品に関する情報が前記操作装置15の操作入力によって入力されることが考えられる。さらに、前記調剤支援装置1の前記制御部11が、前記残薬を使用する旨の修正が医師によって行われた場合に、その修正前後の前記処方データに基づいて、分包対象から除かれた薬品の服用時期などを判断することも考えられる。 In the medicine packaging device 3, the time of taking the remaining medicine and the remaining medicine specifying information are printed on the empty medicine package 81. For example, it is conceivable that a message such as “please take medicine after dinner for △ month and △ day after dinner” is displayed on the empty medicine package 81. Thereby, in the old health facility B, it is possible to determine the remaining medicine to be used at each time of taking by referring to the empty medicine package 81. In addition, it can be considered that the determination as to whether or not the remaining medicine can be used is performed at each time of taking, that is, performed in units of the medicine package 81. Thereby, it is not necessary to take the medicine in the medicine package 81 and the medicine remaining as the remaining medicine together, and the occurrence of a medicine distribution mistake can be suppressed. Further, it is conceivable that information related to the medicine removed from the packaging target is input by the operation input of the operation device 15 when the packaging data is generated. Furthermore, when the doctor 11 made a correction to use the remaining medicine, the control unit 11 of the dispensing support device 1 was excluded from the target for packaging based on the prescription data before and after the correction. It may be possible to determine when to take medicine.
<ステップS14>
 その後、ステップS14において、前記制御部11は、前記老健施設B側で利用される配薬データの出力操作を待ち受ける(S14:No側)。具体的に、前記制御部11は、前記操作装置15に対するユーザー操作によって前記配薬データの出力操作が実行されたか否かを判断する。ここで、前記配薬データの出力操作が行われたと判断すると(S14:Yes側)、処理はステップS15に移行する。
<Step S14>
Thereafter, in step S14, the control unit 11 waits for an operation of outputting medicine distribution data used on the side of the old facility B (S14: No side). Specifically, the control unit 11 determines whether or not an operation for outputting the medicine distribution data has been executed by a user operation on the operation device 15. Here, if it is determined that the operation of outputting the medicine distribution data has been performed (S14: Yes side), the process proceeds to step S15.
<ステップS15>
 ステップS15において、前記制御部11は、前記ステップS11で発行操作が行われた前記処方データに基づいて前記配薬データを生成し、前記配薬データを前記USBポート18に出力して前記USBメモリ19に記録する。即ち、前記制御部11は、前記処方データ及び前記分包データと同様に、前記配薬グループである前記老健施設B又は前記グループなどの単位で前記配薬データを出力する。これにより、前記薬包81及び前記薬袋82等と共に前記USBメモリ19を前記配薬支援装置5に配送することにより、前記USBメモリ19に記憶されている前記配薬データを前記配薬支援装置5で利用し、配薬担当者による配薬作業の効率化及び配薬ミスの抑制を図ることが可能となる。また、前記ステップS11で発行操作が行われた前記処方データを対象として前記配薬データが生成されるため、前記配薬データを生成するための抽出条件などを再度設定する手間が軽減され、また、調剤対象であって前記処方データと異なる前記配薬データが生成されることが防止される。
<Step S15>
In step S15, the control unit 11 generates the medicine distribution data based on the prescription data subjected to the issuing operation in step S11, and outputs the medicine distribution data to the USB port 18 to output the USB memory. 19 is recorded. That is, the control unit 11 outputs the medicine distribution data in units of the old health facility B or the group which is the medicine distribution group, similarly to the prescription data and the packaging data. As a result, the USB memory 19 is delivered to the medicine distribution support device 5 together with the medicine package 81 and the medicine bag 82, etc., and the medicine distribution data stored in the USB memory 19 is transferred to the medicine distribution support device 5. This makes it possible to improve the efficiency of drug distribution work by the person in charge of drug distribution and to suppress drug distribution mistakes. In addition, since the medicine distribution data is generated for the prescription data for which the issuing operation has been performed in step S11, it is possible to reduce time and effort for setting again the extraction conditions for generating the medicine distribution data, The dispensing data different from the prescription data, which is a subject of dispensing, is prevented.
 前記配薬データには、入居者ID、入居者(服用者)名、グループ、仮名、薬品コード(YJコード)、薬品名、服用日、服用時期(用法)、用量、剤形、一包化区分、副作用関連情報、及び頓服の1日最大用量(最大回数)などが含まれる。ここに、前記一包化区分は、同じ前記薬包81内に分包される薬品を識別するための区分である。前記副作用関連情報は、薬品の添付文書に記載されている副作用に関する情報、又は前記薬局Aなどにおいて予め薬品に対応付けて任意に登録された副作用に関する情報などである。なお、前記配薬支援システム100では、前記薬局A側の前記調剤支援装置1においても前記配薬支援装置5側で管理される入居者ID及びグループなどの情報が前記入居者マスターに登録される。そのため、前記制御部11は、前記入居者マスターを参照して前記入居者ID及び前記グループなどの情報を前記配薬データに付加して出力することが可能である。これにより、複数の前記薬局Aと複数の前記老健施設Bとの間で薬品の授受が行われる場合でも、前記配薬支援装置5が、前記配薬データに基づいて入居者を特定することが可能である。なお、前記配薬データに前記服用者IDが含まれており、前記老健施設B各々において前記配薬支援装置5が前記服用者IDと前記入居者IDとの対応関係(前記変換情報)に基づいて前記服用者IDに対応する入居者を判断することも他の実施形態として考えられる。 The drug distribution data includes the resident ID, resident (taker) name, group, pseudonym, drug code (YJ code), drug name, date taken, time taken (usage), dose, dosage form, and package. Includes categories, side-effect related information, and daily maximum dose (maximum frequency). Here, the one-packing section is a section for identifying medicines packaged in the same medicine package 81. The side effect related information is information about side effects described in a package insert of medicines, or information about side effects arbitrarily registered in advance in association with medicines in the pharmacy A or the like. In the medicine distribution support system 100, information such as a resident ID and a group managed on the medicine distribution support apparatus 5 side is also registered in the resident master in the dispensing support apparatus 1 on the pharmacy A side. . Therefore, the control unit 11 can add the information such as the resident ID and the group to the medicine distribution data by referring to the resident master and output the information. Thereby, even when medicine is exchanged between a plurality of the pharmacies A and a plurality of the health facilities B, the medicine distribution support device 5 may identify a resident based on the medicine distribution data. Is possible. In addition, the said user ID is contained in the said medicine distribution data, and the said medicine distribution support apparatus 5 is based on the correspondence (the said conversion information) of the said user ID and the said tenant ID in each of the said healthy facilities B. It is also conceivable as another embodiment to determine the resident corresponding to the user ID.
 ここに、図19は、前記老健施設B1で利用される配薬データの一例を示す図である。図19に示すように、前記配薬データには、前記分包データ(図6参照)に加えて、入居者ID、入居者(服用者)名、グループ、剤形、一包化区分が含まれている。なお、前記一包化区分について、図19に示す例では、「湯山一郎」の医薬品M1と医薬品M3とは共に一包化区分が「1」であり同じ前記薬包81に分包されることが示されており、「湯山三郎」の医薬品M7と医薬品M8とは一包化区分が「1」、「2」であって異なる前記薬包81に分包されることを示している。また、図19では省略しているが、前述したように、前記配薬データには、副作用関連情報及び頓服の1日最大用量(最大回数)なども含まれる。 Here, FIG. 19 is a diagram showing an example of medicine distribution data used in the old health facility B1. As shown in FIG. 19, in addition to the packaging data (see FIG. 6), the medicine distribution data includes a tenant ID, a tenant (taker) name, a group, a dosage form, and a package classification. It is. In the example shown in FIG. 19, the medicine M1 and medicine M3 of “Yuyama Ichiro” are both “1” in the packaging classification and are packaged in the same medicine package 81 in the example shown in FIG. The medicine M7 and the medicine M8 of “Yuyama Saburo” have the package classification “1” and “2” and are divided into different medicine packages 81. Although omitted in FIG. 19, as described above, the drug distribution data includes side effect related information, daily maximum dose (maximum number of times), and the like.
 なお、前記USBメモリ19は、前記配薬データの移動に利用される記録媒体の一例であって、前記USBメモリ19に代えて他のフラッシュメモリ又はハードディスクドライブなどの各種の記録媒体を用いることが可能である。また、本実施形態では、前記USBメモリ19のような記録媒体を用いて前記配薬データを移動可能な構成について説明するが、前記配薬データを前記配薬支援装置5に伝達することができればその手法はこれに限らない。例えば、前記配薬データ出力部114が、前記配薬データを前記通信インターフェース13に出力し、前記通信インターフェース13からインターネット等の前記ネットワークN1を通じて前記配薬支援装置5に送信出力な構成も考えられる。なお、前記配薬データ出力部114は、前記配薬データに対応する前記処方データを前記配薬支援装置5に送信出力することが可能な構成も考えられる。 The USB memory 19 is an example of a recording medium used for moving the medicine distribution data, and various recording media such as other flash memories or hard disk drives may be used instead of the USB memory 19. Is possible. In the present embodiment, a configuration in which the medicine distribution data can be moved using a recording medium such as the USB memory 19 will be described. However, if the medicine distribution data can be transmitted to the medicine distribution support device 5. The method is not limited to this. For example, a configuration in which the medicine distribution data output unit 114 outputs the medicine distribution data to the communication interface 13 and is transmitted from the communication interface 13 to the medicine distribution support apparatus 5 through the network N1 such as the Internet is also conceivable. . In addition, the structure which can transmit and output the said prescription data corresponding to the said medicine distribution data to the said medicine distribution assistance apparatus 5 is also considered for the said medicine distribution data output part 114. FIG.
 さらに、前記制御部11は、前記調剤支援装置1及び前記配薬支援装置5が前記ネットワークN1及び前記ネットワークN2などを介して通信可能に接続されたサーバーなどの記憶部に前記配薬データを出力して記憶させることも考えられる。即ち、前記調剤支援装置1及び前記配薬支援装置5がクラウド上で前記配薬データを共有する構成が考えられる。これにより、前記配薬支援装置5の前記制御部51は、前記サーバーなどの記憶部から前記配薬データを読み出して入力することが可能となる。また、前記薬品分包装置3において服用時期各々に対応する前記薬包81が連続する前記薬包シートが服用者ごとに出力され、その薬包シートに検薬用の情報が印刷される前記薬包81が付加される場合などには、その薬包81に当該服用者に関する前記配薬データを示す一次元コード又は二次元コードなどのコードが印刷出力されることが考えられる。これにより、前記配薬支援装置5において、前記制御部51が、前記検薬用の前記薬包81から前記コードを読み取ることにより、服用者ごとに前記配薬データを入力することが可能となる。なお、前記コードは、前記薬包81に限らず、例えば前記薬包81と共に配送される紙媒体に印刷されることも考えられる。前記コードに含まれる前記配薬データには、当該服用者に対応する今回の前記配薬データにおける最初の服用時期である服用開始時期及び最後の服用時期を示す服用終了時期も含まれる。また、前記配薬データに代えて当該服用者に対応する前記処方データ(例えば、薬品名、用法、用量、服用開始日、服用終了日など)が前記検薬用の前記薬包81に印刷出力される前記コードに含まれることも考えられる。 Further, the control unit 11 outputs the drug distribution data to a storage unit such as a server to which the dispensing support device 1 and the drug distribution support device 5 are communicably connected via the network N1, the network N2, and the like. It is also possible to memorize it. That is, a configuration in which the dispensing support device 1 and the medicine distribution support device 5 share the medicine distribution data on the cloud is conceivable. Thereby, the said control part 51 of the said medicine distribution assistance apparatus 5 can read and input the said medicine distribution data from memory | storage parts, such as the said server. In addition, the medicine package in which the medicine package 81 corresponding to each time of taking in the medicine packaging apparatus 3 is output for each user and the information for medicine is printed on the medicine sheet. When 81 is added, it is conceivable that a code such as a one-dimensional code or a two-dimensional code indicating the medicine distribution data related to the user is printed on the medicine pack 81. Thereby, in the medicine distribution support device 5, the control unit 51 can input the medicine distribution data for each user by reading the code from the medicine pack 81 for the medicine. Note that the code is not limited to the medicine package 81 but may be printed on a paper medium delivered together with the medicine package 81, for example. The drug distribution data included in the code includes a dose start time that is the first dose time and a dose end time that indicates the last dose time in the current drug distribution data corresponding to the user. In addition, the prescription data (for example, drug name, usage, dose, start date of taking, end date of taking, etc.) corresponding to the user is printed out on the medicine pack 81 for the medicine instead of the medicine distribution data. It may be included in the code.
 また、前記調剤支援装置1では、前述したように残薬の使用を前提とする前記処方データに基づいて前記分包データが生成された場合には、前記制御部11が、その残薬の服用時期と新たな服用時期との関係を示す前記残薬特定情報を含む前記配薬データを出力することが考えられる。そして、前記配薬支援装置5では、前記制御部51が、残薬に対応する前記薬包81に付されている前記コード811が読み取られた場合に、前記残薬特定情報を参照して前記薬包81に対応する服用時期を新たな服用時期として認識する。これにより、残薬を使用する場合にも、前記配薬支援システム100において、前記薬包81に対応する服用時期及び入居者などを照合すること、又は前記入居者の服用の有無などを管理することが可能となる。 Moreover, in the said dispensing assistance apparatus 1, when the said packaging data are produced | generated based on the said prescription data on the assumption of use of a remaining medicine as mentioned above, the said control part 11 takes the remaining medicine. It is conceivable to output the medicine distribution data including the remaining medicine specifying information indicating the relationship between the time and the new taking time. And in the said medicine distribution assistance apparatus 5, when the said code | cord | chord 811 attached | subjected to the said medicine package 81 corresponding to the remaining medicine is read, the said control part 51 refers to the said remaining medicine specific information, and the said The taking time corresponding to the medicine package 81 is recognized as a new taking time. Thereby, even when the remaining medicine is used, in the medicine distribution support system 100, the time of taking corresponding to the medicine package 81, the resident, and the like are managed, or the presence or absence of the resident is managed. It becomes possible.
 なお、ここでは、図18に示した処方データ発行処理において前記分包データが出力されるタイミングで前記配薬データが出力可能な構成について説明したが、前記制御部11は、前記配薬データを、任意のタイミングで前記操作装置15の操作などに応じて出力することも可能である。具体的に、前記制御部11は、前記処方データ記憶部121に記憶されている前記処方データのうち出力対象となる処方データを抽出するための抽出条件の設定操作を待ち受ける。例えば、前記調剤支援装置1では、前記制御部11が、前記操作装置15に対する設定開始操作に応じて、前記表示装置14に前記抽出条件を設定するための設定画面を表示する。そして、前記制御部11は、前記設定画面に従った前記操作装置15の操作に応じて前記抽出条件を設定する。例えば、前記施設コード、前記施設名称、前記グループ、前記服用者ID、前記服用者名、及び前記入居者IDのうち一又は複数の条件が設定可能である。ここで、前記抽出条件が設定されたと判断すると、前記制御部11は、前記処方データ記憶部121に記憶されている前記処方データに基づいて前記抽出条件に対応する前記配薬データを生成する。 In addition, although the structure which can output the said distribution data at the timing at which the said packaging data is output in the prescription data issuing process shown in FIG. 18 was demonstrated here, the said control part 11 is the said distribution data. It is also possible to output in accordance with the operation of the operating device 15 at an arbitrary timing. Specifically, the control unit 11 waits for an extraction condition setting operation for extracting prescription data to be output from the prescription data stored in the prescription data storage unit 121. For example, in the dispensing support device 1, the control unit 11 displays a setting screen for setting the extraction condition on the display device 14 in response to a setting start operation on the operation device 15. And the said control part 11 sets the said extraction conditions according to operation of the said operating device 15 according to the said setting screen. For example, one or more conditions can be set among the facility code, the facility name, the group, the user ID, the user name, and the resident ID. If it is determined that the extraction condition is set, the control unit 11 generates the medicine distribution data corresponding to the extraction condition based on the prescription data stored in the prescription data storage unit 121.
 具体的に、前記施設コードが選択された場合には、前記処方データ記憶部121に記憶されている前記処方データから、前記施設コードに対応する前記老健施設Bに入居している服用者各々の処方データが抽出される。また、前記抽出条件として前記グループが選択された場合には、前記処方データ記憶部121に記憶されている前記処方データから、前記グループに属する服用者各々の処方データが抽出される。そして、前記制御部11は、前記処方データのうち予め定められた一部又は全部の項目を前記配薬データとして抽出する。これにより、前記処方データのうち前記配薬データとして不要な情報を省略することによりデータ量を減少させ、又は前記服用者の個人情報の利用を最小限に抑制しつつ前記処方データを利用することが可能である。その後、前記制御部11は、前記ステップS15と同様に前記配薬データを出力する。これにより、前記調剤支援装置1では、前記処方データの発行タイミングに限らず任意のタイミングで前記配薬データを出力することが可能である。 Specifically, when the facility code is selected, from each of the prescription data stored in the prescription data storage unit 121, each of the users occupying the old health facility B corresponding to the facility code Prescription data is extracted. Further, when the group is selected as the extraction condition, prescription data for each user belonging to the group is extracted from the prescription data stored in the prescription data storage unit 121. And the said control part 11 extracts the one part or all item predetermined among the said prescription data as said medicine distribution data. Thereby, by omitting unnecessary information as the drug distribution data in the prescription data, the data amount is reduced, or the prescription data is used while minimizing the use of personal information of the user. Is possible. Then, the said control part 11 outputs the said medicine distribution data similarly to the said step S15. Thereby, in the said dispensing assistance apparatus 1, it is possible to output the said medication distribution data not only at the issue timing of the said prescription data but at arbitrary timing.
[配薬時照合処理]
 次に、図20のフローチャートを参照しつつ、前記配薬支援システム100において前記配薬支援装置5の制御部51によって実行される配薬時照合処理について説明する。
[Matching process during drug distribution]
Next, referring to the flowchart of FIG. 20, the collating process during dispensing executed by the control unit 51 of the medicine distribution assistance apparatus 5 in the medicine distribution assistance system 100 will be described.
<ステップS81>
 ステップS81において、前記制御部51は、前記操作装置55又は前記携帯端末6に対して予め定められた配薬開始操作が行われたか否かを判断する。ここで、前記配薬開始操作が行われたと判断すると、処理がステップS82に移行し、前記配薬開始操作が行われていない場合には、処理がステップS811に移行する。
<Step S81>
In step S <b> 81, the control unit 51 determines whether a predetermined medicine distribution start operation has been performed on the operation device 55 or the mobile terminal 6. If it is determined that the medicine distribution start operation has been performed, the process proceeds to step S82. If the medicine distribution start operation has not been performed, the process proceeds to step S811.
 ところで、前記配薬開始操作では、予め定めた職員などの配薬担当者のログイン操作が行われることが考えられる。この場合、前記データ記憶部52には、前記配薬担当者各々の識別コード及びパスワードなどが設定されていることが考えられる。例えば、前記制御部51は、前記配薬開始操作が行われた後、前記読取端末7によって前記配薬担当者が有する名札などに記載された一次元コード又は二次元コード等のコードが読み取られ、そのコードの情報が前記配薬担当者の識別コードと一致する場合に、その配薬担当者をログインさせることが考えられる。さらに、前記制御部51は、前記識別コードが読み取られた後、その識別コードに対応する前記パスワードが入力された場合に、そのパスワードを照合してから前記配薬担当者をログインさせることも考えられる。これにより、前記制御部51は、前記配薬担当者ごとに当該配薬時照合処理で表示させる情報を制限すること、又は前記配薬担当者ごとに当該配薬時照合処理で表示させる入居者の範囲(例えば自己担当の入居者のみ)を変更することなどが可能になる。 By the way, in the medicine distribution start operation, it is conceivable that a login operation of a person in charge of medicine distribution such as a predetermined staff is performed. In this case, it is conceivable that an identification code, a password, and the like of each person in charge of medicine distribution are set in the data storage unit 52. For example, after the medicine distribution start operation is performed, the control unit 51 reads a code such as a one-dimensional code or a two-dimensional code written on a name tag or the like possessed by the person in charge of medicine by the reading terminal 7. When the information on the code matches the identification code of the person in charge of medicine distribution, the person in charge of medicine distribution may be logged in. Further, when the password corresponding to the identification code is input after the identification code is read, the control unit 51 may consider logging in the person in charge of dispensing the medicine after verifying the password. It is done. Thereby, the said control part 51 restrict | limits the information displayed by the said collation process at the time of a medicine distribution for every said person in charge of medicine distribution, or the resident to display by the said collation process at the time of medicine distribution for every said medicine distributor It is possible to change the range (for example, only the resident who is in charge).
<ステップS811~S812>
 ステップS811~ステップS812では、前記調剤支援装置1から出力された前記配薬データを入力するための入力処理が実行される。ここに、前記ステップS811~S812は、前記配薬データ入力部514によって実行される。
<Steps S811 to S812>
In steps S811 to S812, an input process for inputting the medicine distribution data output from the dispensing support device 1 is executed. The steps S811 to S812 are executed by the medicine distribution data input unit 514.
 具体的に、まずステップS811において、前記制御部51は、前記配薬データの入力タイミングを待ち受ける(S811:No側)。例えば、前記制御部51は、前記USBメモリ19が前記USBポート58に装着され、前記操作装置55に対するユーザー操作が行われた場合に、前記配薬データの入力タイミングであると判断する。また、前記制御部51は、前記通信インターフェース53により前記ネットワークN2などを介して前記配薬データが受信された場合にも、前記配薬データの入力タイミングであると判断する。そして、前記配薬データの入力タイミングが到来したと判断すると(S811:Yes側)、処理はステップS812に移行する。 Specifically, first, in step S811, the control unit 51 waits for an input timing of the medicine distribution data (S811: No side). For example, when the USB memory 19 is attached to the USB port 58 and a user operation is performed on the operation device 55, the control unit 51 determines that the timing of inputting the medicine distribution data is reached. The control unit 51 also determines that it is the timing for inputting the medicine distribution data even when the medicine distribution data is received by the communication interface 53 via the network N2 or the like. And if it judges that the input timing of the said medicine distribution data has arrived (S811: Yes side), a process will transfer to step S812.
 ステップS812において、前記制御部51は、前記配薬データを前記調剤支援装置1に入力する。例えば、前記制御部51は、当該配薬時照合処理を実行するために必要な情報を予め定められたデータベース形式に従って前記配薬データ記憶部523に記憶する。これにより、前記配薬支援装置5では、前記調剤支援装置1における調剤時に用いられていた前記配薬データを利用して各種の処理を実行することが可能となる。 In step S812, the control unit 51 inputs the medicine distribution data to the dispensing support device 1. For example, the control unit 51 stores information necessary for executing the drug distribution matching process in the drug distribution data storage unit 523 in accordance with a predetermined database format. Thereby, in the said medicine distribution assistance apparatus 5, it becomes possible to perform various processes using the said medicine distribution data used at the time of the dispensing in the said dispensing assistance apparatus 1. FIG.
<ステップS82>
 一方、前記ステップS81において、前記操作装置55又は前記携帯端末6に対して予め定められた配薬開始操作が行われたと判断した場合、続くステップS82において、前記制御部51は配薬担当者が配薬時に参照する初期画面210(第1表示画面の一例)を表示させる。具体的に、前記制御部51は、前記操作装置55により前記配薬開始操作が行われた場合には、前記表示装置54に前記初期画面210を表示させる。また、前記制御部51は、前記携帯端末6により前記配薬開始操作が行われた場合には、前記携帯端末6の表示部に前記初期画面210を表示させる。なお、これ以降の処理についても同様に、前記操作装置55による操作は前記表示装置54の表示に反映され、前記携帯端末6における操作は前記携帯端末6の表示部の表示に反映される。
<Step S82>
On the other hand, in step S81, when it is determined that a predetermined medicine distribution start operation has been performed on the operation device 55 or the portable terminal 6, in the subsequent step S82, the controller 51 determines that the person in charge of medicine distribution has performed. An initial screen 210 (an example of a first display screen) to be referred to when dispensing is displayed. Specifically, the control unit 51 displays the initial screen 210 on the display device 54 when the medicine distribution start operation is performed by the operation device 55. Moreover, the said control part 51 displays the said initial screen 210 on the display part of the said portable terminal 6, when the said medicine distribution start operation is performed by the said portable terminal 6. FIG. Similarly, in the subsequent processing, the operation by the operation device 55 is reflected on the display of the display device 54, and the operation on the mobile terminal 6 is reflected on the display of the display unit of the mobile terminal 6.
 ここに、図21は、前記初期画面210の一例である。図21に示すように、前記制御部51は、前記配薬データに基づいて、これから服用する服用時期を選択するための選択キーが表示される。具体的に、図21に示す例では、前記制御部51が、本日に対応する服用時期が選択候補として前記初期画面210に表示される。前記初期画面210では、朝食、昼食、夕食ごとに「前」、「後」、「間」がツリー表示されており、配薬担当者が目的の服用時期を見つけやすい。なお、前記初期画面210の前段で服用日時が選択可能な構成も他の実施形態として考えられる。 FIG. 21 shows an example of the initial screen 210. As shown in FIG. 21, the control unit 51 displays a selection key for selecting a dose time to be taken based on the medicine distribution data. Specifically, in the example shown in FIG. 21, the control unit 51 displays the dosing time corresponding to today on the initial screen 210 as a selection candidate. In the initial screen 210, “before”, “after”, and “between” are displayed in a tree for each of breakfast, lunch, and dinner, so that the person in charge of drug distribution can easily find the intended time of taking. In addition, the structure which can select a dosing date in the front | former stage of the said initial screen 210 is also considered as other embodiment.
 また、図21に示すように、前記制御部51は、前記初期画面210において、服用すべき薬品が存在する服用時期と、服用すべき薬品が存在しない服用時期とを異なる表示態様で表示させる。これにより、配薬担当者は、服用時期ごとにおける服用すべき薬品の存在の有無を容易に判断することが可能である。なお、図21における服用時期の背景模様の違いが表示態様に差があることを示している。例えば、服用すべき薬品が存在する服用時期(図21の夕食後、夕食間など)はハイライト表示し、服用すべき薬品が存在しない服用時期(図21の朝食前、朝食後、朝食間など)はハイライト表示しないことが考えられる。また、服用すべき薬品が存在する服用時期の表示色と、服用すべき薬品が存在しない服用時期の表示色とが異なることも考えられる。さらに、服用すべき薬品が存在する服用時期の表示サイズが大きく、服用すべき薬品が存在しない服用時期の表示サイズが小さいことも考えられる。 Further, as shown in FIG. 21, the control unit 51 causes the initial screen 210 to display in different display modes the dosing time when there is a medicine to be taken and the dosing time when there is no medicine to be taken. Thereby, the person in charge of medicine distribution can easily determine the presence or absence of a medicine to be taken at each time of taking. In addition, the difference in the background pattern of the dosing time in FIG. 21 indicates that there is a difference in the display mode. For example, the time when the medicine to be taken is present (after dinner in FIG. 21, between dinner, etc.) is highlighted, and the time when the medicine to be taken is not present (before breakfast, after breakfast, between breakfast, etc. in FIG. 21). ) May not be highlighted. It is also conceivable that the display color of the medication time when there is a medicine to be taken and the display color of the medication time when there is no medicine to be taken are different. Furthermore, it is conceivable that the display size of the dosing time when there is a medicine to be taken is large and the display size of the dosing time when there is no medicine to be taken is small.
 さらに、図21に示すように、前記制御部51は、前記初期画面210において、現在時刻に最も近い服用時期を他の服用時期とは異なる表示態様で表示させることが考えられる。これにより、配薬担当者による服用時期の選択ミスを抑制すると共に、選択する服用時期を探す手間を軽減することができる。なお、このような表示処理を実現するため、前記配薬支援装置5では、前記データ記憶部52に、服用時期ごとに対応する服用時期名、服用時刻、服用時期コード、及び服用区分などの服用時期情報が予め記憶されている。これにより、前記制御部51は、前記服用時期情報に基づいて、現時点で服用するべき服用時期を判断することが可能である。前記服用時期コードは、前記薬包81に印刷される前記服用時期コードと同じ内容を示す情報であり、前記調剤支援装置1及び前記配薬支援装置5において共通で用いられる統一された情報である。なお、前記制御部51は、前記配薬支援装置5の初期設定などにおいてユーザー操作に応じて前記服用時期情報を変更可能である。 Furthermore, as shown in FIG. 21, it is conceivable that the control unit 51 causes the initial screen 210 to display the dosing time closest to the current time in a display mode different from other dosing times. Thereby, while the selection mistake of the taking time by the medicine distribution person in charge is suppressed, the effort which searches for the taking time to select can be reduced. In order to realize such display processing, the medicine distribution support device 5 stores the dose name corresponding to each dose time, the dose time, the dose time code, and the dose category in the data storage unit 52. Time information is stored in advance. Thereby, the said control part 51 can determine the dosing time which should be taken at this time based on the said dosing time information. The medication time code is information indicating the same content as the medication time code printed on the medicine package 81, and is unified information used in common in the dispensing support device 1 and the medicine distribution support device 5. . In addition, the said control part 51 can change the said dosing time information according to user operation in the initial setting of the said medicine distribution assistance apparatus 5, etc.
 ところで、図21では、服用時期がツリー表示された初期画面210が示されているが、服用時期を選択するための初期画面210の他の例として、例えば図22に示すように、服用時期各々が個別に配列して表示されることも考えられる。さらに、前記制御部51が、前記操作装置55又は前記携帯端末6の操作に応じて、前記初期画面210における前記服用時期各々の表示位置、表示サイズ、及び表示色を予め任意に設定可能な構成が考えられる。また、前記制御部51が、前記操作装置55又は前記携帯端末6の操作に応じて、前記初期画面210に表示される前記服用時期の種類を予め任意に設定可能な構成も考えられる。これにより、例えばユーザーが前記初期画面210を任意にカスタマイズして自己にとって見やすい画面構成にすること、又は前記初期画面210における不要な情報の表示を排除することが可能である。 Incidentally, in FIG. 21, an initial screen 210 in which the dosing time is displayed as a tree is shown. As another example of the initial screen 210 for selecting the dosing time, for example, as shown in FIG. It is also conceivable that the symbols are arranged and displayed individually. Further, the control unit 51 can arbitrarily arbitrarily set the display position, the display size, and the display color of each of the dosing times on the initial screen 210 in accordance with the operation of the operation device 55 or the mobile terminal 6. Can be considered. A configuration is also conceivable in which the control unit 51 can arbitrarily set in advance the type of dosing time displayed on the initial screen 210 in accordance with the operation of the operation device 55 or the mobile terminal 6. Accordingly, for example, the user can arbitrarily customize the initial screen 210 to make it easy to see for the user, or can eliminate unnecessary information display on the initial screen 210.
 また、前記老健施設Bでは、特定の前記薬局Aのみならず他の薬局からも薬品が持ち込まれ、その薬品の配薬の管理が行われることが考えられる。そのため、前記配薬支援装置5では、前記制御部51が、複数の前記薬局Aから取得する前記配薬データを合成することも可能である。また、前記配薬支援装置5では、前記制御部51が、前記操作装置55又は前記携帯端末6の操作に応じて前記配薬データを任意に入力可能な構成が考えられる。具体的に、前記制御部51は、前記操作装置55の操作に応じて、入居者、医療機関、医師、用法(服用時期)、薬品の種類、用量、及びコメントなどの情報を登録するための登録画面を表示させ、その登録画面に入力された情報を前記配薬データとして入力する。 Also, in the old health facility B, it is conceivable that medicines are brought in not only from the specific pharmacy A but also from other pharmacies, and the distribution of the medicine is managed. Therefore, in the medicine distribution support device 5, the control unit 51 can synthesize the medicine distribution data acquired from the plurality of pharmacies A. Moreover, in the said medicine distribution assistance apparatus 5, the said control part 51 can consider the structure which can input the said medicine distribution data arbitrarily according to operation of the said operation apparatus 55 or the said portable terminal 6. FIG. Specifically, the control unit 51 registers information such as a resident, a medical institution, a doctor, a usage (medication time), a medicine type, a dose, and a comment according to the operation of the operation device 55. A registration screen is displayed, and information input on the registration screen is input as the medicine distribution data.
<ステップS83>
 そして、ステップS83において、前記制御部51は、服用対象となる服用時期の選択を待ち受ける(S83:No側)。ここで、服用時期が選択されたと判断すると(S83:Yes側)、処理がステップS84に移行する。
<Step S83>
In step S83, the control unit 51 waits for selection of a dosing time to be taken (S83: No side). If it is determined that the dosing time has been selected (S83: Yes side), the process proceeds to step S84.
 具体的に、前記制御部51は、前記初期画面210における服用時期を選択するための操作が前記操作装置55又は前記携帯端末6の操作部によって行われた場合に服用時期が選択されたと判断する。また、前記制御部51は、前記携帯端末6又は前記読取端末7により、服用時期ごとに対応する前記薬包81が収容された配薬ボックスに予め付されている服用時期を示す一次元コード又は二次元コード等のコードが読み取られた場合に、その服用時期が選択されたと判断することが考えられる。 Specifically, the control unit 51 determines that the dosing time has been selected when an operation for selecting the dosing time on the initial screen 210 is performed by the operation device 55 or the operation unit of the mobile terminal 6. . In addition, the control unit 51 uses the portable terminal 6 or the reading terminal 7 to display a one-dimensional code indicating a dosing time attached in advance to a medicine box containing the medicine pack 81 corresponding to each dosing time. When a code such as a two-dimensional code is read, it may be determined that the taking time has been selected.
 ところで、前記配薬支援システム100が、複数の服用者の各服用時期に対応する前記薬包81などの薬品を各服用時期に対応する前記配薬ボックスに自動的に収容する自動収容装置を備える構成も考えられる。これにより、複数の服用者に処方される薬品が服用時期ごとに纏めて前記配薬ボックスに自動的に収容されるため、前記薬局A又は前記老健施設Bで前記薬包81を前記配薬ボックスに収容する手間が省略される。なお、前記自動収容装置は、前記薬品分包装置3に搭載されるものであってもよい。ところで、前記配薬ボックスは、例えば区画された複数の収容部を備えるボックスであるが、所謂ブリスターパックであってもよい。前記ブリスターパックとは、一面が開放された包装領域を複数有する包装部材を平板状の部材に接合することにより閉鎖された複数の包装部が形成される収容部材である。また、前記ブリスターパックでは、前記包装部各々を容易に切り離すための切り取り点線(ミシン目)が形成されている。 By the way, the medicine distribution support system 100 includes an automatic accommodation device that automatically accommodates medicines such as the medicine package 81 corresponding to each time taken by a plurality of users in the medicine distribution box corresponding to each time taken. Configuration is also conceivable. As a result, medicines prescribed to a plurality of users are automatically stored in the medicine box at every time of taking, so that the medicine package 81 is placed in the medicine box 81 at the pharmacy A or the old facility B. The time and labor required for storage in the container is omitted. The automatic storage device may be mounted on the medicine packaging device 3. By the way, although the said medicine distribution box is a box provided with the some accommodating part divided, for example, what is called a blister pack may be sufficient. The blister pack is an accommodating member in which a plurality of closed packaging parts are formed by joining a packaging member having a plurality of packaging regions with one side open to a flat plate-like member. Further, in the blister pack, a cut dotted line (perforation) for easily separating each of the packaging parts is formed.
 ここで、前記制御部51は、前記ステップS83で選択された服用時期が、前記配薬支援装置5で計時される現在日時に対応する適正な服用時期であるか否かを判断し、適正でない場合にその旨を報知可能である。具体的に、前記配薬支援装置5では、前記服用時期ごとに対応する服用時刻又は服用時間帯が予め設定されて前記データ記憶部52に記憶されている。例えば、服用時期「昼食後」に対応する服用時刻が「13時」に設定され、服用時期「昼食間」に対応する服用時刻が「15時」に設定され、服用時期「夕食前」に対応する服用時間帯が「18時」に設定されていることが考えられる。この場合、前記制御部51は、現在時刻が、前記ステップS83で選択された前記服用時期に対応する前記服用時刻から前後30分のような所定の許容範囲内であるか否かを判断することが考えられる。なお、現在時刻には、例えば前記配薬支援装置5のシステムクロックとして計時されている時刻、又は前記ネットワークN2などを介して所定の時刻報知機関から取得可能な時刻が用いられる。また、服用時期「昼食後」に対応する服用時間帯が「12時30分~13時」に設定され、服用時期「昼食間」に対応する服用時間帯が「15時~16時」に設定され、服用時期「夕食前」に対応する服用時間帯が「18時30分~19時」に設定されていることが考えられる。この場合、前記制御部51は、現在時刻が、前記ステップS83で選択された前記服用時期に対応する前記服用時間帯であるか否かを判断することが考えられる。 Here, the control unit 51 determines whether or not the dosing time selected in step S83 is an appropriate dosing time corresponding to the current date and time counted by the medicine distribution support device 5, and is not appropriate. In such cases, it is possible to notify the fact. Specifically, in the medicine distribution support device 5, a taking time or a taking time zone corresponding to each taking time is set in advance and stored in the data storage unit 52. For example, the taking time corresponding to the taking time “after lunch” is set to “13:00”, the taking time corresponding to the taking time “between lunch” is set to “15:00”, and the taking time “before dinner” is supported. It is conceivable that the taking time zone to be set is “18:00”. In this case, the control unit 51 determines whether or not the current time is within a predetermined allowable range such as 30 minutes before and after the dosing time corresponding to the dosing time selected in step S83. Can be considered. In addition, as the current time, for example, a time measured as a system clock of the medicine distribution support device 5 or a time that can be acquired from a predetermined time notification organization via the network N2 or the like is used. In addition, the time period corresponding to the dose period “after lunch” is set to “12:30 to 13:00”, and the time period corresponding to the dose period “between lunch” is set to “15:00 to 16:00” Therefore, it is conceivable that the taking time zone corresponding to the taking time “before dinner” is set to “18:30 to 19:00”. In this case, it is conceivable that the control unit 51 determines whether or not the current time is in the dosing time zone corresponding to the dosing time selected in step S83.
 さらに、前記制御部51が、前記初期画面210において選択される服用時期と、前記携帯端末6又は前記読取端末7で読み取られた前記配薬ボックスに付された一次元コード又は二次元コード等のコードの服用時期とを照合可能であり、照合結果が不一致である場合にその旨を報知可能な構成も考えられる。この場合、前記配薬支援装置5では、前記制御部51が、前記操作装置55の操作に応じて、例えば服用日時、服用時期、及びグループなどの前記配薬ボックスに貼付する情報を含む一次元コード又は二次元コード等のコードを任意のプリンタによってラベルなどに印刷可能であることが考えられる。また、前記制御部51が、前記初期画面210の表示前に選択される服用日時と、前記携帯端末6又は前記読取端末7で読み取られた前記配薬ボックスに付された前記コードの服用日時とを照合可能であり、照合結果が不一致である場合にその旨を報知可能な構成も考えられる。同じく、前記制御部51が、前記初期画面210に表示されるグループと、前記携帯端末6又は前記読取端末7で読み取られた前記配薬ボックスに付された前記コードのグループとを照合可能であり、照合結果が不一致である場合にその旨を報知可能な構成も考えられる。 Further, the control unit 51 may select a dose time selected on the initial screen 210 and a one-dimensional code or a two-dimensional code attached to the medicine box read by the portable terminal 6 or the reading terminal 7. A configuration is also conceivable in which it is possible to collate with the timing of taking the code, and to notify that when the collation results do not match. In this case, in the medicine distribution support device 5, the control unit 51 includes one-dimensional information including information to be pasted on the medicine distribution box such as a medication date and time, a medication time, and a group according to the operation of the operation device 55. It is conceivable that a code such as a code or a two-dimensional code can be printed on a label or the like by an arbitrary printer. In addition, the control unit 51 may select the date and time of taking before the initial screen 210 is displayed, and the date and time of taking the code attached to the medicine box read by the mobile terminal 6 or the reading terminal 7. Can be collated, and when the collation results do not match, a configuration that can notify that fact is also conceivable. Similarly, the control unit 51 can collate the group displayed on the initial screen 210 with the group of codes attached to the medicine box read by the portable terminal 6 or the reading terminal 7. A configuration is also conceivable in which, when the collation results do not match, that fact can be notified.
<ステップS84>
 ステップS84において、前記制御部51は、入居者の一覧が表示される入居者一覧画面211(第2表示画面の一例)を前記表示装置54又は前記携帯端末6の表示部に表示させる。ここに、図23は、前記入居者一覧画面211の一例を示す図である。具体的に、前記制御部51は、前記マスター記憶部521に記憶されている前記入居者マスターと前記配薬データ記憶部523に記憶されている前記配薬データとに基づいて前記入居者一覧画面211を表示させる。
<Step S84>
In step S <b> 84, the control unit 51 displays a resident list screen 211 (an example of a second display screen) on which a resident list is displayed on the display device 54 or the display unit of the mobile terminal 6. FIG. 23 is a diagram showing an example of the resident list screen 211. Specifically, the control unit 51 is configured to display the resident list screen based on the resident master stored in the master storage unit 521 and the medicine distribution data stored in the medicine distribution data storage unit 523. 211 is displayed.
 特に、図23に示すように、前記制御部51は、前記入居者一覧画面211において、前記ステップS83で選択されたと判断した服用時期に服用する薬品が存在する入居者と、その服用時期に服用する薬品が存在しない入居者とを異なる表示態様で表示させる。即ち、前記制御部51は、前記ステップS81~S84を実行することにより、前記入居者各々と前記服用時期各々との関係を表示させることが可能である。ここに、係る表示処理は前記表示制御部511によって実行され、前記表示制御部511が処方表示手段の一例である。特に、前記ステップS81~S82において前記服用時期を選択するための前記初期画面210を表示させるときの前記表示制御部511が第1表示処理手段の一例であり、前記ステップS83~S84において前記初期画面210における前記服用時期の選択に応じて前記服用時期における前記入居者各々の配薬の要否を表示する前記入居者一覧画面211を表示するときの前記表示制御部511が第2表示処理手段の一例である。 In particular, as shown in FIG. 23, the control unit 51 uses the resident list screen 211 for a resident who has a medicine to be taken at the taking time determined to have been selected at the step S83, and is taken at the taking time. The resident who does not have the medicine to be displayed is displayed in a different display mode. That is, the control unit 51 can display the relationship between each resident and each time of taking by executing the steps S81 to S84. Here, the display processing is executed by the display control unit 511, and the display control unit 511 is an example of a prescription display unit. In particular, the display control unit 511 when displaying the initial screen 210 for selecting the dosing time in the steps S81 to S82 is an example of a first display processing unit. In the steps S83 to S84, the initial screen is displayed. The display control unit 511 when displaying the tenant list screen 211 that displays whether or not each tenant needs to dispense medicine at the dosing time according to the selection of the dosing time in 210 is a second display processing unit. It is an example.
 これにより、配薬担当者は、前記初期画面210及び前記入居者一覧画面211を用いて、服用時期各々において服用すべき薬品が存在する入居者を容易に判断することが可能である。なお、図23における入居者の背景模様の違いが表示態様に差があることを示している。例えば、服用すべき薬品が存在する入居者(「湯山一郎」など)はハイライト表示し、服用すべき薬品が存在しない入居者(「湯山三郎」など)はハイライト表示しないことが考えられる。また、服用すべき薬品が存在する入居者の表示色と、服用すべき薬品が存在しない入居者の表示色とが異なることも考えられる。さらに、服用すべき薬品が存在する入居者の表示サイズが大きく、服用すべき薬品が存在しない入居者の表示サイズが小さいことも考えられる。 Thereby, the person in charge of medicine distribution can easily determine the resident who has the medicine to be taken at each time of taking, using the initial screen 210 and the resident list screen 211. In addition, the difference in the background pattern of the resident in FIG. 23 indicates that there is a difference in the display mode. For example, a resident who has a medicine to be taken (such as “Ichiro Yuyama”) may be highlighted, and a resident who has no medicine to be taken (such as “Saburo Yuyama”) may not be highlighted. It is also conceivable that the display color of a resident who has a medicine to be taken is different from the display color of a resident who has no medicine to be taken. Furthermore, the display size of a resident who has a medicine to be taken is large, and the display size of a resident who has no medicine to be taken may be small.
 また、前記入居者一覧画面211では、入居者の服薬の状況に関するステータス情報として、前述した前記服用時期に服用すべき薬品の有無の他に、「未服薬」、「服薬済」、「外出」、「未服薬完了」、「自己管理確認無」、「自己管理未確認」、「自己管理確認済」、「仕事中」、「服薬不能」、「入院中」などの情報が表示されることも考えられる。即ち、前記入居者一覧画面211では、これらの複数のステータス情報が、異なる配色又は表示サイズなどの異なる表示態様で表示可能である。 Further, in the resident list screen 211, as status information regarding the resident's medication status, in addition to the presence / absence of a medicine to be taken at the above-mentioned taking time, “not taking”, “done”, “going out” , "Non-medicine completed", "No self-management confirmed", "Self-managed unconfirmed", "Self-managed confirmed", "Working", "Unable to take medication", "In hospital", etc. Conceivable. That is, on the resident list screen 211, the plurality of status information can be displayed in different display modes such as different color schemes or display sizes.
 例えば、図23に示す例では、「湯山八郎」が「服薬完了」に対応する表示態様で表示されており、「湯山九郎」などの入居者は「未服薬」に対応する表示態様で表示されている。これにより、配薬担当者が、選択した服用時期における配薬の要否を入居者ごとに容易に判断することが可能である。また、図23に示す例では、「湯山七太」が「外出」に対応する表示態様で表示されており、配薬担当者は、「湯山七太」が外出中又は外泊中などであるために配薬が不要である旨を容易に判断することが可能である。ここで、入居者各々の外出の有無などのステータス情報は、前記制御部51により、前記操作装置55又は前記携帯端末6の操作部などの操作に応じて予め前記マスター記憶部521の前記入居者マスターの一部として記憶されることが考えられる。 For example, in the example shown in FIG. 23, “Yuyama Hachiro” is displayed in a display mode corresponding to “completion of medication”, and a resident such as “Yuyama Kuro” is displayed in a display mode corresponding to “Non-medication”. ing. Thereby, it is possible for the person in charge of medicine distribution to easily determine for each resident whether or not the medicine is required at the selected dose time. In the example shown in FIG. 23, “Yuyama Shichita” is displayed in a display mode corresponding to “Outing”, and the person in charge of dispensing is “Yuyama Shichita” being out or staying overnight. It is possible to easily determine that no medicine is required. Here, status information such as whether or not each resident has gone out is preliminarily stored in the resident of the master storage unit 521 by the control unit 51 according to the operation of the operation unit 55 or the operation unit of the mobile terminal 6. It can be stored as part of the master.
 なお、「仕事中」は、前記入居者が仕事に出ていることを示し、「服薬不能」は、前記入居者が服用困難な健康状態であることを示し、「入院中」は、前記入居者が病院に入院中であることを示す。また、「未服薬完了」は、服用者が薬品を服薬していないがその薬品が残薬として処理されて服薬が完了状態になっていることを示す。さらに「自己管理確認無」は、服用者に所定期間の薬品を予め預けて服用者を自己管理する場合であってその服薬の有無の確認の必要がないことを示す。一方、「自己管理未確認」、「自己管理確認済」は、服用者に所定期間の薬品を予め預けて服用者を自己管理するがその服薬の有無の確認の必要があることを示し、「自己管理未確認」は、まだ服薬が確認されていないことを示し、「自己管理確認済」は、既に服薬が確認されてその旨の入力操作が行われていることを示す。 “At work” indicates that the resident is at work, “Unable to take medication” indicates that the resident is in a difficult health state, and “In hospital” indicates that the resident Indicates that the person is hospitalized. In addition, “not taking medicine” indicates that the user has not taken the medicine but the medicine has been processed as a remaining medicine and the medicine has been completed. Further, “No self-confirmation confirmation” indicates that it is necessary to self-manage the user by preliminarily depositing the medicine for a predetermined period of time and it is not necessary to confirm the presence or absence of the medicine. On the other hand, “Self-managed unconfirmed” and “Self-managed confirmed” indicate that the patient is self-managed by prescribing the medicine for a predetermined period in advance, but the presence or absence of the medicine needs to be confirmed. “Unconfirmed management” indicates that the medication has not yet been confirmed, and “Self-administered confirmed” indicates that the medication has already been confirmed and an input operation to that effect has been performed.
 図23に示す前記入居者一覧画面211では、同一画面に表示されない入居者はスクロールによって表示可能であり、前記入居者一覧画面211における入居者の表示順は例えば五十音順又はアルファベット順などである。また、前記制御部51は、前記入居者一覧画面211における「全員」の操作キーの選択に応じて、前記入居者一覧画面211における入居者の表示を、未服用の入居者のみが表示される状態と入居者全員が表示される状態とに交互に切換可能である。さらに、前記制御部51は、前記入居者一覧画面211における「完了」の操作キーの選択に応じて前記入居者一覧画面211に表示中の入居者についてステータス情報を「未服薬完了」の状態に変更し、その服用時期に対応する未服用の薬品(薬包81)を残薬情報として前記データ記憶部52に記憶することが考えられる。また、前記制御部51は、前記残薬情報を前記データ記憶部52に蓄積して記憶する際、前記残薬情報の合計を算出することなく、前記薬包81に収容された錠剤の状態をそのままの情報として記憶する。例えば、ある入居者の薬品として1錠及び0.5錠(半錠)の薬品が薬包81に分包されており、その薬包81が3回分残っている場合、前記データ記憶部52では、4.5錠ではなく、1.5錠×3の情報が前記残薬情報として記憶される。 In the resident list screen 211 shown in FIG. 23, the resident who is not displayed on the same screen can be displayed by scrolling, and the display order of the resident in the resident list screen 211 is, for example, in alphabetical order or alphabetical order. is there. In addition, according to the selection of the “all” operation key on the resident list screen 211, the control unit 51 displays the resident display on the resident list screen 211 only for unoccupied residents. It is possible to alternately switch between a state and a state where all residents are displayed. Further, the control unit 51 changes the status information of the tenant currently displayed on the tenant list screen 211 to the state of “untreated medicine” in response to the selection of the “complete” operation key on the tenant list screen 211. It is conceivable to change and store the medicine (medicine package 81) that has not been taken corresponding to the taking time in the data storage unit 52 as the remaining medicine information. In addition, when the remaining medicine information is accumulated and stored in the data storage section 52, the control unit 51 calculates the state of the tablets contained in the medicine package 81 without calculating the total of the remaining medicine information. Store it as it is. For example, when one pill and 0.5 tablet (half tablet) are packed in a medicine pack 81 as a medicine of a certain resident, and the medicine pack 81 remains three times, the data storage unit 52 , Information of 1.5 tablets × 3 instead of 4.5 tablets is stored as the remaining medicine information.
 ところで、前記配薬支援システム100では、前記入居者マスター(図15参照)及び前記入居者登録画面(図17参照)に示したように、前記入居者を複数のグループに分類することも可能である。この場合、前記制御部51は、前記入居者一覧画面211を前記グループごとに表示させることが他の実施形態として考えられる。ここに、図24は、前記入居者各々をグループごとに表示させる場合の入居者一覧画面211の一例を示す図である。 By the way, in the medicine distribution support system 100, as shown in the resident master (see FIG. 15) and the resident registration screen (see FIG. 17), the resident can be classified into a plurality of groups. is there. In this case, it is conceivable as another embodiment that the control unit 51 displays the resident list screen 211 for each group. FIG. 24 is a diagram showing an example of a resident list screen 211 when each resident is displayed for each group.
 図24に示す前記入居者一覧画面211では、各グループに対応するタブが表示されており、前記タブが選択された場合にそのタブのグループに属する入居者の一覧が表示される。なお、この場合も図23に示した前記入居者の表示態様は、前記入居者一覧画面211と同様であるため説明を省略する。また、前述したように、前記配薬ボックスに付された前記コードが前記グループを示す情報を含む場合、前記制御部51は前記携帯端末6又は前記読取端末7によって読み取られた前記コードが示す前記グループに対応する前記入居者一覧画面211を表示させることが考えられる。また、前記制御部51が、前記図24における前記入居者一覧画面211で選択された前記タブのグループと、前記携帯端末6又は前記読取端末7によって前記配薬ボックスから読み取られる前記コードが示すグループとが一致しているか否かを照合可能であり、照合結果が不一致である場合にその旨を報知可能な構成も考えられる。 In the resident list screen 211 shown in FIG. 24, tabs corresponding to each group are displayed. When the tab is selected, a list of residents belonging to the group of the tab is displayed. In this case as well, the display mode of the resident shown in FIG. 23 is the same as that of the resident list screen 211, and the description thereof will be omitted. Further, as described above, when the code attached to the medicine distribution box includes information indicating the group, the control unit 51 indicates the code read by the mobile terminal 6 or the reading terminal 7. It is conceivable to display the resident list screen 211 corresponding to the group. In addition, the control unit 51 includes the group of the tab selected on the resident list screen 211 in FIG. 24 and the group indicated by the code read from the medicine box by the portable terminal 6 or the reading terminal 7. It is possible to collate whether or not and match, and when the matching result does not match, a configuration that can notify that fact is also conceivable.
<ステップS85>
 次に、ステップS85において、前記制御部51は、服用対象となる入居者の選択を待ち受ける(S85:No側)。ここで、入居者が選択されたと判断すると(S85:Yes側)、処理がステップS86に移行する。
<Step S85>
Next, in step S85, the control unit 51 waits for selection of a resident to be taken (S85: No side). If it is determined that a resident has been selected (S85: Yes side), the process proceeds to step S86.
 具体的に、前記制御部51は、前記入居者一覧画面211における入居者を選択するための操作が前記操作装置55又は前記携帯端末6の操作部によって行われた場合に入居者が選択されたと判断する。また、前記制御部51は、前記携帯端末6又は前記読取端末7により、例えば入居者が所有する名札、リストバンド、又は前記薬包81に付された一次元コード又は二次元コード等のコードが読み取られた場合に、そのコードが示す入居者IDに対応する入居者が選択されたと判断することが考えられる。さらに、前記制御部51が、前記入居者一覧画面211において選択される入居者と、前記携帯端末6又は前記読取端末7で読み取られた前記コードが示す入居者とを照合可能であり、照合結果が不一致である場合にその旨を報知可能な構成も考えられる。 Specifically, the control unit 51 determines that a resident is selected when an operation for selecting a resident on the resident list screen 211 is performed by the operation unit 55 or the operation unit of the portable terminal 6. to decide. In addition, the control unit 51 receives a code such as a name tag, a wristband, or a one-dimensional code or a two-dimensional code attached to the medicine package 81 owned by a resident by the portable terminal 6 or the reading terminal 7. When it is read, it may be determined that the resident corresponding to the resident ID indicated by the code has been selected. Furthermore, the control unit 51 can collate the tenant selected on the tenant list screen 211 with the tenant indicated by the code read by the mobile terminal 6 or the reading terminal 7, and the collation result If there is a mismatch, a configuration that can notify that is also conceivable.
 なお、前記ステップS85において、前記制御部51は、前記入居者一覧画面211におけるメニューキーが操作された場合には、前記表示装置54又は前記携帯端末6の表示を前記配薬開始操作が行われる前のメニュー画面などに戻す。また、前記制御部51は、戻るキーが操作された場合には、前記表示装置54又は前記携帯端末6の表示を前記初期画面210に戻す。 In step S85, when the menu key on the resident list screen 211 is operated, the control unit 51 performs the medicine distribution start operation to display the display device 54 or the portable terminal 6. Return to the previous menu screen. In addition, when the return key is operated, the control unit 51 returns the display of the display device 54 or the mobile terminal 6 to the initial screen 210.
<ステップS86>
 ステップS86において、前記制御部51は、前記ステップS85で選択されたと判断した入居者を確認するための入居者確認画面213を前記表示装置54又は前記携帯端末6の表示部に表示させる。具体的に、前記制御部51は、前記マスター記憶部521に記憶されている前記入居者マスター及び前記配薬データに基づいて入居者の情報及び服薬する薬品の情報などを前記入居者確認画面213に表示させる。ここに、図25は、前記入居者確認画面213の一例を示す図である。
<Step S86>
In step S86, the control unit 51 causes the display device 54 or the display unit of the portable terminal 6 to display a resident confirmation screen 213 for confirming the resident determined to have been selected in step S85. Specifically, the control unit 51 displays the resident information, information on medicines to be taken, and the like based on the resident master and the medicine distribution data stored in the master storage unit 521. To display. FIG. 25 is a diagram showing an example of the resident confirmation screen 213.
 図25に示すように、前記入居者確認画面213では、入居者の情報として、入居者の名前、顔画像(写真)、及びコメントが表示されている。また、前記入居者確認画面213では、配薬データのうち用法及び薬品情報が表示されている。これにより、配薬担当者は、配薬対象となる入居者及び薬品などの適否を容易に把握することが可能である。また、前記入居者確認画面213には、確認キー、取消キー、未服用キーが表示される。前記確認キーは、入居者が適切であることを確認したことを入力するための操作キーである。前記取消キーは、前記入居者の選択を解除して前記表示装置54又は前記携帯端末6の表示部の表示を前記入居者一覧画面211に戻すための操作キーである。前記未服用キーは、前記入居者が薬品を服用しなかった場合の未服薬理由を入力して未服薬のまま完了させるための操作キーである。なお、前記配薬確認データが前記処方データそのものの一部又は全部である場合には、実際に調剤された後の薬品の内容(例えば分包状態など)が把握できないことも考えられ、この場合、前記制御部51は、前記入居者確認画面213における薬品情報の表示を省略することが考えられる。 As shown in FIG. 25, in the resident confirmation screen 213, the resident's name, face image (photograph), and comment are displayed as the resident information. In addition, on the resident confirmation screen 213, usage and medicine information is displayed in the distribution data. Thereby, the person in charge of medicine distribution can easily grasp the suitability of the residents and medicines to be medicines. In addition, on the resident confirmation screen 213, a confirmation key, a cancel key, and an unused key are displayed. The confirmation key is an operation key for inputting that the resident has confirmed that it is appropriate. The cancel key is an operation key for canceling the resident selection and returning the display on the display device 54 or the mobile terminal 6 to the resident list screen 211. The non-medicine key is an operation key for inputting the reason for non-medication when the resident does not take the medicine and completing the medicine without taking the medicine. In addition, when the drug distribution confirmation data is a part or all of the prescription data itself, it may be impossible to grasp the contents of the medicine (for example, packaging state) after actually dispensing. The control unit 51 may omit displaying medicine information on the resident confirmation screen 213.
 さらに、前記データ記憶部52に薬品各々について注意すべき副作用に関する前記副作用関連情報を含む薬品マスターなどが記憶されており、前記入居者確認画面213では、前記入居者が服用する薬品の前記副作用関連情報が表示されることが考えられる。また、前記制御部51が、前記ネットワークN1を通じて前記調剤支援装置1にアクセスし、前記調剤支援装置1に記憶されている前記薬品マスターを参照して前記薬品の前記副作用関連情報を表示することも考えられる。これにより、配薬担当者は、前記入居者への配薬時に前記副作用関連情報を参照して前記入居者の状態について注意すべき事項を容易に把握することができ、例えば前記入居者の異常などを早期発見することが可能となる。また、前記入居者確認画面213では、前記服用時期を識別するための情報として、前記服用時期を示す文字に代えて、又は前記服用時期と共に前記服用時期コードが表示されることも考えられる。これにより、配薬担当者は、前記薬包81にも前記服用時期コードが印刷されている場合にその服用時期コードを参照して服用時期を容易に確認することが可能となる。さらに、前記入居者確認画面213では、前記入居者の服薬に関する前記ステータス情報(「未服薬」、「服薬済」、「外出」、「未服薬完了」、「自己管理確認無」、「自己管理未確認」、「自己管理確認済」、「仕事中」、「服薬不能」、又は「入院中」など)が表示されることも考えられる。なお、前記薬品マスターに薬品各々の写真などの薬品画像データが含まれている場合には、前記制御部51は、前記薬品画像データを前記入居者確認画面213で表示させることも可能である。 In addition, the data storage unit 52 stores a drug master including the side effect related information on the side effects to be noted for each drug, and the resident confirmation screen 213 stores the side effect related to the drug taken by the resident. Information may be displayed. Further, the control unit 51 may access the dispensing support device 1 through the network N1 and display the side effect related information of the drug by referring to the medicine master stored in the dispensing support device 1. Conceivable. Thereby, the person in charge of the medicine can easily grasp the matters to be careful about the state of the resident with reference to the side effect related information at the time of the medicine to the resident, for example, the abnormality of the resident Etc. can be detected early. In addition, on the resident confirmation screen 213, as the information for identifying the taking time, the taking time code may be displayed instead of the character indicating the taking time or together with the taking time. Thereby, the person in charge of medicine distribution can easily check the medication time by referring to the medication time code when the medication time code is also printed on the medicine package 81. Further, on the resident confirmation screen 213, the status information regarding the resident's medication (“unmedicated”, “medicine completed”, “going out”, “unmedicated”, “no self-management confirmation”, “self-management”) "Unconfirmed", "Self-confirmed confirmed", "Working", "Unable to take medication", "In hospital", etc.) may be displayed. When the medicine master includes medicine image data such as a photograph of each medicine, the control unit 51 can display the medicine image data on the resident confirmation screen 213.
<ステップS87>
 続いて、ステップS87において、前記制御部51は確認操作を待ち受ける(S87:No側)。ここで、前記確認操作が行われたと判断すると、処理はステップS871に移行し、前記確認操作が行われていない場合には、処理がステップS88に移行する。
<Step S87>
Subsequently, in step S87, the control unit 51 waits for a confirmation operation (S87: No side). If it is determined that the confirmation operation has been performed, the process proceeds to step S871. If the confirmation operation has not been performed, the process proceeds to step S88.
 具体的に、前記制御部51は、前記入居者確認画面213の前記確認キーが操作された場合に前記確認操作が行われたと判断する。このとき、前記制御部51は、前記確認キーの操作に応じて入居者IDを入力するための入力画面を表示させ、その入力画面において入力される入居者IDを前記入居者確認画面213に表示されている入居者に対応する入居者IDと照合し、照合結果が不一致である場合にその旨を報知可能な構成も考えられる。例えば、前記照合結果が不一致である場合、前記制御部51は、前記表示装置54又は前記携帯端末6にエラーメッセージを表示させた後、表示画面を前記入居者一覧画面211に戻す。 Specifically, the control unit 51 determines that the confirmation operation has been performed when the confirmation key on the resident confirmation screen 213 is operated. At this time, the control unit 51 displays an input screen for inputting a resident ID according to the operation of the confirmation key, and displays the resident ID input on the input screen on the resident confirmation screen 213. A configuration is also conceivable in which it is possible to collate with a resident ID corresponding to a resident who is informed, and to notify the fact when the collation result is inconsistent. For example, when the collation results do not match, the control unit 51 displays an error message on the display device 54 or the mobile terminal 6 and then returns the display screen to the resident list screen 211.
 さらに、前記制御部51は、前記ステップS86で前記入居者確認画面213を表示する前に、前記確認キーの操作に応じて入居者IDを入力するための入力画面を表示させ、その入力画面において入力される入居者IDを前記ステップS85で選択された入居者に対応する入居者IDと照合することも考えられる。この場合、前記制御部51は、照合結果が一致である場合は処理を前記ステップS86に移行させて前記入居者確認画面213を表示させ、照合結果が不一致である場合にその旨を報知することが考えられる。なお、前記制御部51が、前記入居者一覧画面211において選択される入居者と、前記携帯端末6又は前記読取端末7で読み取られた前記コードが示す入居者とを照合する構成でも同様に、照合結果が一致であることが確認された後に前記入居者確認画面213を表示させることが考えられる。 Further, the control unit 51 displays an input screen for inputting a resident ID in accordance with the operation of the confirmation key before displaying the resident confirmation screen 213 in the step S86. It is also conceivable to collate the entered resident ID with the resident ID corresponding to the resident selected in step S85. In this case, if the collation result is coincident, the control unit 51 shifts the processing to step S86 to display the resident confirmation screen 213, and notifies that fact when the collation result is inconsistent. Can be considered. Similarly, in the configuration in which the control unit 51 collates the tenant selected on the tenant list screen 211 with the tenant indicated by the code read by the portable terminal 6 or the reading terminal 7, It can be considered that the resident confirmation screen 213 is displayed after it is confirmed that the collation results are the same.
 また、前記制御部51は、前記薬包81に付された前記コード811が前記携帯端末6又は前記読取端末7によって読み取られ、そのコード811が示す入居者が、前記入居者確認画面213に表示されている入居者と一致する場合に前記確認操作が行われたと判断することも考えられる。なお、前記入居者が一致しない場合、前記制御部51は、前記表示装置54又は前記携帯端末6にエラーメッセージを表示させた後、表示画面を前記入居者一覧画面211に戻す。ところで、前記携帯端末6又は前記読取端末7による前記薬包81の読取確認を徹底するため、前記入居者確認画面213における前記確認キーの表示を省略することも他の実施形態として考えられる。 Further, the control unit 51 reads the code 811 attached to the medicine package 81 by the mobile terminal 6 or the reading terminal 7, and the resident indicated by the code 811 is displayed on the resident confirmation screen 213. It is also conceivable to determine that the confirmation operation has been performed when it coincides with a resident who has been admitted. If the tenants do not match, the control unit 51 displays an error message on the display device 54 or the portable terminal 6 and then returns the display screen to the tenant list screen 211. By the way, in order to thoroughly check the reading of the medicine package 81 by the portable terminal 6 or the reading terminal 7, it is possible to omit the display of the confirmation key on the resident confirmation screen 213 as another embodiment.
<ステップS871>
 ステップS871において、前記制御部51は、入居者への投薬開始を促すメッセージを前記表示装置54又は前記携帯端末6に表示させる。そして、配薬担当者は、入居者に対して前記薬包81を配薬する。なお、前記入居者確認画面213に、入居者の管理区分として自己管理であるか否かの情報が表示されることも考えられる。これにより、配薬担当者は、前記薬包81の配薬時に入居者の管理区分を容易に判断することができる。
<Step S871>
In step S871, the control unit 51 causes the display device 54 or the portable terminal 6 to display a message prompting the resident to start medication. Then, the person in charge of medicine distribution distributes the medicine package 81 to the resident. In addition, it is also conceivable that information indicating whether or not the tenant management screen is self-managed as the tenant management category is displayed. Thereby, the person in charge of medicine distribution can easily determine the management classification of the resident at the time of medicine distribution of the medicine package 81.
<ステップS872>
 また、ステップS872において、前記制御部51は、前記配薬データ記憶部523に記憶されている前記配薬データに関連付けて、前記入居者確認画面213に表示された前記入居者への配薬結果として「服薬完了」を記録し、処理を前記ステップS81に戻す。これにより、次に前記入居者一覧画面211が表示される場合、既に服用が完了した服用時期については服薬が不要であることを示す表示態様で入居者の名前が表示されることになる。ここに、前記ステップS87、S871、S872において、前記確認操作を前記入居者各々の服薬完了の入力操作として受け付ける処理は、前記服薬完了入力部515によって実行される。なお、前記ステップS87が省略されることも考えられる。即ち、前記薬包81に付された前記コードが読み取られて入居者が選択された場合に(S85:Yes側)、前記入居者確認画面213が表示されると共に(S86)、前記コードによって識別される前記入居者の前記薬包81の服用時期の服用完了が自動的に記録されることも考えられる(S872)。
<Step S872>
In step S872, the control unit 51 associates the medicine distribution data stored in the medicine distribution data storage unit 523 with the result of medicine distribution to the resident displayed on the resident confirmation screen 213. "Medication complete" is recorded, and the process returns to step S81. Thereby, when the resident list screen 211 is displayed next, the resident's name is displayed in a display mode indicating that no medication is required for the time when the medication has already been taken. Here, in the steps S87, S871, and S872, the process for accepting the confirmation operation as an input operation for completing the medication of each resident is performed by the medication completion input unit 515. Note that the step S87 may be omitted. That is, when the code attached to the medicine package 81 is read and a resident is selected (S85: Yes side), the resident confirmation screen 213 is displayed (S86) and identified by the code. It is also conceivable that the completion of taking the medicine package 81 of the resident is recorded automatically (S872).
<ステップS88>
 また、ステップS88において、前記制御部51は、前記未服用キーの操作を待ち受ける(S88:No側)。ここで、前記未服用キーが操作されたと判断すると、処理はステップS881に移行し、前記未服用キーが操作されていない場合には、処理がステップS89に移行する。なお、前記制御部51は、前記未服用キーが操作された場合には、「未服用で良いか?」などの確認メッセージを表示させることも考えられる。
<Step S88>
In step S88, the control unit 51 waits for an operation of the non-taking key (S88: No side). Here, if it is determined that the non-administration key has been operated, the process proceeds to step S881, and if the non-administration key has not been operated, the process proceeds to step S89. The control unit 51 may display a confirmation message such as “Can I take it?” When the non-taken key is operated.
<ステップS881>
 ステップS881において、前記制御部51は、図26に示すように、前記入居者が薬品を服用しなかった未服薬理由を入力するための未服薬入力画面214を前記入居者確認画面213上にポップアップで表示させた後、前記未服薬入力に入力される未服薬理由を、前記配薬データ記憶部523に記憶されている前記配薬データに関連付けて記憶させる。例えば、前記未服薬理由の入力は、図26に示すように、予め登録された未服薬理由の一覧が表示され、その未服薬理由を選択することによって行われる。ここで、前記未服薬理由は、プルダウン形式で表示される予め定められた複数の候補から選択によって入力可能であることも考えられる。なお、前記未服薬理由としては、例えば外出中、就寝、又は服用拒否などが考えられる。また、前記制御部51は、前記配薬データ記憶部523に記憶されている前記配薬データに関連付けて、前記入居者確認画面213に表示された前記入居者への配薬結果として「未服薬完了」を記録する。これにより、次に前記入居者一覧画面211が表示される場合、既に服薬しなかった未服薬理由が入力された服用時期については服薬が不要であることを示す表示態様で入居者の名前が表示されることになる。
<Step S881>
In step S881, as shown in FIG. 26, the control unit 51 pops up on the resident confirmation screen 213 a non-medicine input screen 214 for inputting the reason for non-medicine that the resident did not take medicine. After being displayed, the reason for non-medication input in the non-medicine input is stored in association with the drug distribution data stored in the drug distribution data storage unit 523. For example, as shown in FIG. 26, the reason for not taking medication is entered by displaying a list of pre-registered reasons for taking medication and selecting the reason for not taking medication. Here, it is conceivable that the reason for not taking the medicine can be input by selecting from a plurality of predetermined candidates displayed in a pull-down format. Examples of the reasons for not taking the drug include going out, sleeping, or refusal to take. In addition, the control unit 51 associates the drug distribution data stored in the drug distribution data storage unit 523 with the result of the drug distribution to the resident displayed on the resident confirmation screen 213 as “untreated drug”. Record Completed. Accordingly, when the resident list screen 211 is displayed next time, the name of the resident is displayed in a display mode indicating that no medication is required for the time of taking the reason for not taking medication already entered. Will be.
 ところで、入居者が外出(仕事、外泊、入院など)する予定が予め決まっていることも考えられる。そのため、前記配薬支援装置5では、入居者の未服薬の予定を入力可能な構成が考えられる。具体的に、図27は、入居者の未服薬の予定を入力するための予定入力画面215の一例を示す図である。図27に示すように、前記予定入力画面215では、前記操作装置55又は前記携帯端末6の操作によって、任意の日程が選択され、予め登録された服用時期が選択されると共に、未服薬理由が入力される。なお、図27には、前記予定入力画面215上で2014年3月12日~14日が選択された状態が示されている。このようにして未服薬の予定が入力されている場合、前記制御部51は、前記未服薬キーが操作されたときに(S88:Yes側)、前記ステップS881における未服薬理由の入力処理を省略して、既登録である未服用の予定の情報を表示させることが考えられる。また、前記制御部51は、未服用の予定が入力されている場合には、前記入居者一覧画面211において未服薬完了である旨を表示させることにより、その入居者の服薬の確認作業を省略させることも考えられる。 By the way, it is conceivable that the resident is scheduled to go out (work, stay overnight, hospitalization, etc.) in advance. Therefore, the medicine distribution support device 5 may be configured such that a resident's schedule of medications can be input. Specifically, FIG. 27 is a diagram illustrating an example of a schedule input screen 215 for inputting a plan of a resident who has not taken medication. As shown in FIG. 27, on the schedule input screen 215, an arbitrary schedule is selected by operating the operation device 55 or the portable terminal 6, a pre-registered dosing time is selected, and the reason for not taking the drug is shown. Entered. FIG. 27 shows a state in which March 12-14, 2014 is selected on the schedule input screen 215. When the non-medicine schedule is input in this way, the control unit 51 omits the non-medicine reason input process in step S881 when the non-medicine key is operated (S88: Yes side). Then, it is conceivable to display information on an already registered schedule that has not been taken. In addition, when an unscheduled schedule has been input, the control unit 51 displays the fact that the medicine has not been taken on the resident list screen 211, thereby omitting the confirmation work of the resident. It is possible to make it.
<ステップS882>
 そして、ステップS882において、前記制御部51は、前記入居者確認画面213に表示された前記入居者が服薬しなかった残薬に関する残薬情報として、前記入居者が服薬するべきであった薬品の情報を前記入居者の情報(配薬データなど)と共に出力する。ここに、係る処理は前記残薬情報出力部516によって実行される。
<Step S882>
In step S882, the control unit 51 sets the medicine that the resident should have taken as the remaining medicine information regarding the remaining medicine that the resident has not taken, which is displayed on the resident confirmation screen 213. Information is output together with the resident information (such as drug distribution data). This processing is executed by the remaining medicine information output unit 516.
 具体的に、前記ステップS882において、前記制御部51は、前記残薬情報を前記通信インターフェース53に出力し、前記通信インターフェース53からインターネット等の前記ネットワークN2を通じて前記調剤支援装置1に送信出力することが考えられる。また、前記残薬情報を前記調剤支援装置1に伝達することができればその手法はこれに限らず、例えば前記制御部51が、前記USBポート58を介して前記USBメモリ19に記録出力することも考えられる。これにより、前記調剤支援装置1では、次の薬品の処方時に医師又は薬剤師などが前記残薬情報を参照することが可能となり、例えば処方する薬品の無駄を防止することができる。なお、前記残薬情報は、前記データ記憶部52にも記憶される。これにより、前記配薬支援装置5又は前記携帯端末6においても前記残薬情報を参照することが可能になる。 Specifically, in the step S882, the control unit 51 outputs the remaining medicine information to the communication interface 53, and transmits the remaining medicine information to the dispensing support device 1 through the network N2 such as the Internet. Can be considered. In addition, if the remaining medicine information can be transmitted to the dispensing support device 1, the method is not limited to this. For example, the control unit 51 may record and output the USB memory 19 via the USB port 58. Conceivable. Thereby, in the said dispensing assistance apparatus 1, a doctor or a pharmacist can refer to the said remaining medicine information at the time of the prescription of the next chemical | medical agent, for example, and can prevent the waste of the chemical | medical agent to prescribe. The remaining medicine information is also stored in the data storage unit 52. Thereby, it becomes possible to refer to the remaining medicine information also in the medicine distribution support device 5 or the portable terminal 6.
<ステップS89>
 なお、ステップS89において、前記制御部51は、前記取消キーの操作を待ち受ける(S89:No側)。ここで、前記取消キーが操作されたと判断すると(S89:Yes側)、処理は前記ステップS84に移行して前記入居者一覧画面211が再表示される。なお、前記取消キーが操作されていない場合には(S89:No側)、処理が前記ステップS87に移行する。
<Step S89>
In step S89, the control unit 51 waits for an operation of the cancel key (S89: No side). If it is determined that the cancel key has been operated (S89: Yes side), the process proceeds to step S84, and the resident list screen 211 is displayed again. If the cancel key is not operated (S89: No side), the process proceeds to step S87.
 以上、説明したように、前記配薬支援システム100では、前記配薬データが前記調剤支援装置1から前記配薬支援装置5に提供されることにより、前記配薬支援装置5において実行される前記配薬時照合処理などにおいて前記配薬データを考慮した表示及び操作を実現することが可能になる。これにより、配薬担当者による入居者への配薬作業を効率的に実行することが可能になると共に、配薬担当者の配薬ミスを抑制することができる。 As described above, in the drug distribution support system 100, the drug distribution support device 100 executes the drug distribution support device 5 by providing the drug distribution data from the dispensing support device 1 to the drug distribution support device 5. It is possible to realize display and operation in consideration of the drug distribution data in the collating process at the time of drug distribution. Thereby, while it becomes possible to perform the medicine distribution work to the tenant by the person in charge of medicine distribution efficiently, the medicine person in charge of medicine distribution can be suppressed.
[その他の機能]
 なお、前記配薬支援システム100では、前記配薬データが前記配薬支援装置5に提供されることにより、下記のような他の機能も実現可能である。
[Other features]
In the drug distribution support system 100, the following other functions can be realized by providing the drug distribution data to the drug distribution support device 5.
[副作用情報入力機能]
 例えば、前記制御部51は、前記入居者確認画面213に、前記入居者の健康状態又は副作用の状態などを任意に入力可能であることが考えられる。この場合、前記制御部51は、前記入居者確認画面213の表示スペースを考慮して、予め定められた複数の項目をプルダウン形式で入力可能であることが考えられる。特に、前記制御部51は、前記副作用関連情報と前記配薬データとに基づいて当該入居者が服用する薬品に対応する副作用の候補を絞り込んで表示させることも考えられる。これにより、前記老健施設B側では、前記候補から選択することにより前記副作用の入力を容易に行うことが可能である。また、前記制御部51は、前記入居者の健康状態又は副作用の状態などの入力開始キーを前記入居者確認画面213に表示させ、その入力開始キーの操作に応じて前記入居者確認画面213から副作用情報入力画面216をポップアップで表示させることも考えられる。ここに、図28は、前記副作用情報入力画面216の一例を示す図である。また、前記制御部51は、前記入居者確認画面213とは別のメニュー画面などにおいて、副作用情報を入力する所定の操作が行われた場合に、図29に示すように、入居者名、写真、副作用情報、及びコメントなどが表示される入居者状態画面217を表示させ、前記入居者状態画面217における副作用情報の入力操作が行われた場合に前記副作用情報入力画面216をポップアップで表示させることも考えられる。なお、前記副作用情報入力画面216は、入居者ごとに予め任意のコメント情報を入力するためにも用いられる。
[Side effect information input function]
For example, it is conceivable that the control unit 51 can arbitrarily input the health status or side effect status of the resident on the resident confirmation screen 213. In this case, it is considered that the control unit 51 can input a plurality of predetermined items in a pull-down format in consideration of the display space of the resident confirmation screen 213. In particular, the control unit 51 may narrow down and display side effect candidates corresponding to medicines taken by the resident based on the side effect related information and the medicine distribution data. Thereby, the side of the old health facility B can easily input the side effect by selecting from the candidates. In addition, the control unit 51 displays an input start key such as the health status or side effect status of the resident on the resident confirmation screen 213, and the resident confirmation screen 213 displays the input start key according to the operation of the input start key. It is also conceivable to display the side effect information input screen 216 in a pop-up. FIG. 28 is a diagram showing an example of the side effect information input screen 216. In addition, when a predetermined operation for inputting side effect information is performed on a menu screen or the like different from the resident confirmation screen 213, the control unit 51, as shown in FIG. The side effect information and the comment are displayed on the resident status screen 217, and when the side effect information input operation is performed on the resident status screen 217, the side effect information input screen 216 is displayed in a pop-up. Is also possible. The side effect information input screen 216 is also used for inputting arbitrary comment information in advance for each resident.
 そして、前記制御部51は、前記副作用情報入力画面216で前記入居者の健康状態又は副作用の状態などに関する副作用情報が入力された場合には、その副作用情報を前記データ記憶部52に記憶させると共に、前記通信インターフェース53により前記調剤支援装置1に送信することが考えられる。なお、前記副作用情報が前記USBメモリ19などの記録媒体に記録され、前記USBメモリ19が前記調剤支援装置1又は前記上位システム(不図示)などに接続されることによって前記調剤支援装置1又は前記上位システム(不図示)などに前記副作用情報が入力されることも考えられる。これらの構成によれば、例えば医師が前記入居者の診察を行う際に、前記入居者の健康状態又は副作用の状態などの副作用情報を前記配薬支援装置5又は前記携帯端末6などで参照することが可能となる。 When the side effect information related to the resident's health status or side effect status is input on the side effect information input screen 216, the control unit 51 stores the side effect information in the data storage unit 52. It can be considered that the communication interface 53 transmits the information to the dispensing support device 1. The side effect information is recorded on a recording medium such as the USB memory 19, and the USB memory 19 is connected to the dispensing support device 1 or the upper system (not shown) or the like, so that the dispensing support device 1 or the It is also conceivable that the side effect information is input to a host system (not shown) or the like. According to these configurations, for example, when a doctor examines the resident, side effect information such as a health condition or a side effect state of the resident is referred to by the medicine distribution support device 5 or the portable terminal 6. It becomes possible.
 また、前記制御部51が、前記副作用情報と前記副作用関連情報とに基づいて発現している副作用の原因となっている可能性の高い被疑薬を特定して表示可能であることも考えられる。ここで、前記薬品マスターに薬品各々の写真などの薬品画像データが含まれている場合には、前記制御部51は、前記被疑薬の前記薬品画像データを前記入居者確認画面213で表示させることも可能である。これにより、例えば複数の薬品が一包化されている前記薬包81から前記被疑薬を抜き出す際の人為的ミスが抑制される。 It is also conceivable that the control unit 51 can identify and display a suspected drug that is likely to cause a side effect that is expressed based on the side effect information and the side effect related information. Here, when the medicine master includes medicine image data such as a photograph of each medicine, the control unit 51 displays the medicine image data of the suspected medicine on the resident confirmation screen 213. Is also possible. Thereby, for example, an artificial mistake when extracting the suspected drug from the medicine pack 81 in which a plurality of medicines are packaged is suppressed.
 さらに、前記調剤支援装置1に送信されることにより、薬局側でも前記入居者の健康状態又は副作用の状態などの情報を容易に把握することができる。特に、前記調剤支援装置1では、前記制御部11によって前記副作用情報を前記上位システム(不図示)に送信可能であることが考えられる。これにより、前記入居者の薬品を処方する医師も前記上位システム(不図示)において前記副作用情報を参照することが可能であり、病院(医師)、薬局(薬剤師)、及び老健施設(配薬担当者)が密接に連携した医療システムが実現される。 Furthermore, by transmitting the information to the dispensing support device 1, the pharmacy can easily grasp information such as the health status or side effect status of the resident. In particular, in the dispensing support device 1, it is conceivable that the side effect information can be transmitted to the host system (not shown) by the control unit 11. Thereby, the doctor prescribing the resident's medicine can also refer to the side effect information in the host system (not shown), and the hospital (doctor), pharmacy (pharmacist), and health facility (in charge of drug distribution) Medical system in close cooperation.
 さらに、前記調剤支援装置1又は前記上位システム(不図示)などで前記副作用情報を参照することが可能であるため、例えば前記入居者の次の処方データに基づく調剤時に、薬剤師が前記副作用情報に基づいて特定の薬品の調剤を省略することが可能である。また、前記調剤支援装置1において、前記制御部11が、自動的に前記副作用情報の対象となっている薬品を調剤対象から除外して前記分包データなどを生成することも考えられる。なお、前記副作用情報として、前記副作用の発現により服用が中止された日時又は未服用の薬品量などが含まれている場合には、前記調剤支援装置1において、前記制御部11が、前記副作用情報に基づいて未服用の薬品及び残量を特定し、次の前記分包データの生成時に前記未服用の薬品の処方量から前記残量を除いて前記分包データを生成することも考えられる。なお、前記薬局A側の薬剤師が、前記調剤支援装置1で表示される前記副作用情報を参照し、副作用の原因となっている可能性のある被疑薬を医師に連絡して、新たな処方入力時に前記被疑薬を除いた処方入力を促すこと、又は入力済みの処方から前記被疑薬を除く修正(再発行)を促すことが可能である。また、未服用の薬品量を医師に連絡して、新たな処方入力時に前記未服用の薬品量を除いた処方入力を促すこと、又は入力済みの処方から前記未服用の薬品量を除く修正(再発行)を促すことも可能である。 Furthermore, since the side effect information can be referred to by the dispensing support device 1 or the host system (not shown), for example, a pharmacist can use the side effect information at the time of dispensing based on the next prescription data of the resident. On the basis of it, it is possible to dispense with the dispensing of certain chemicals. Moreover, in the said dispensing assistance apparatus 1, it is also considered that the said control part 11 automatically excludes the chemical | medical agent used as the object of the said side effect information from a dispensing object, and produces | generates the said packaging data. Note that when the side effect information includes the date and time when the medication was stopped due to the occurrence of the side effect or the amount of medicine not taken, the control unit 11 in the dispensing support device 1 It is also conceivable to identify the medicine and the remaining amount that have not been taken based on the above, and to generate the packaging data by excluding the remaining amount from the prescription amount of the medicine that has not been taken at the next generation of the packaging data. In addition, the pharmacist at the pharmacy A side refers to the side effect information displayed on the dispensing support device 1 and informs the doctor of the suspected drug that may cause the side effect, and inputs a new prescription. Occasionally, it is possible to prompt a prescription input excluding the suspected drug, or to prompt a correction (reissue) to remove the suspected drug from the prescription already entered. In addition, inform the doctor about the amount of medicines that have not been taken, and prompt the patient to enter a prescription that excludes the amount of medicines that have not been taken when entering a new prescription, or correct the amount of medicines that have not been taken from the prescription that has already been entered ( (Reissue) can be encouraged.
[配薬ボックス開閉機能]
 また、服用時期ごとに対応する前記薬包81が収容される収容部を備え、前記収容部ごとに開閉制御が可能な配薬ボックスが前記配薬支援装置5と通信可能に接続されて用いられることが考えられる。この場合、前記制御部51は、前記配薬データに基づいて、服用時期が到来しないとその服用時期に対応する薬品を取り出すことができないように前記配薬ボックスにおける前記収容部各々の開閉を制御することが考えられる。これにより、前記入居者に対する配薬ミスを抑制することができる。
[Dispensing box opening and closing function]
In addition, a medicine distribution box that accommodates the medicine package 81 corresponding to each time of taking is provided, and a medicine distribution box that can be opened and closed for each container is connected to the medicine distribution support device 5 and used. It is possible. In this case, the control unit 51 controls the opening and closing of each of the storage units in the medicine distribution box based on the medicine distribution data so that the medicine corresponding to the medicine timing cannot be taken out unless the medicine time comes. It is possible to do. Thereby, the medicine distribution mistake with respect to the said resident | tenant can be suppressed.
[服薬履歴表示機能]
 また、前記制御部51は、前記配薬データ記憶部523に記憶される前記配薬データ及び服薬結果の履歴を表示させる服薬履歴表示機能を有することが考えられる。ここに、図30~図33は、前記服薬履歴表示機能によって表示可能な履歴画面の一例を示す図である。
[Medication history display function]
Further, it is conceivable that the control unit 51 has a medication history display function for displaying the medication distribution data and the history of medication results stored in the medication data storage unit 523. FIG. 30 to FIG. 33 are diagrams showing examples of history screens that can be displayed by the medication history display function.
 まず、前記制御部51は、前記表示装置54などにメニュー画面が表示された状態で、服薬履歴を表示する所定の操作が行われた場合に、図30に示す履歴画面218を表示させる。前記履歴画面218では、入居者各々の服薬結果が1日単位で表示される。前記履歴画面218では、「○」のマークが服薬、「△」のマークが一部未服薬、「×」のマークが未服薬を示している。なお、前記一部未服薬とは、1日に含まれる複数の服用時期に服薬及び未服薬が含まれている状態を示す。例えば、前記一部未服薬とは、1日に朝、昼、晩の3回の服用時期が含まれている場合に、朝、昼、晩のいずれか一つ又は二つの服用時期が未服用である場合である。また、前記履歴画面218では、服薬有無などに関する情報を除く例えば残薬の情報又は副作用の情報などの情報が記録されている日に対応するマークの背景色又は形状が通常とは異なる背景色又は形状で表示される。 First, the control unit 51 displays a history screen 218 shown in FIG. 30 when a predetermined operation for displaying a medication history is performed in a state where the menu screen is displayed on the display device 54 or the like. On the history screen 218, the medication result of each resident is displayed on a daily basis. In the history screen 218, a mark “◯” indicates medication, a “△” mark indicates that some medications have not been taken, and a “×” symbol indicates medications that have not been taken. In addition, the said partial non-medication shows the state in which the medication and the non-medication are contained in a plurality of taking times included in one day. For example, the partial non-medicine means that one or two dose periods of morning, noon, and evening are not taken when three doses of morning, noon, and evening are included in one day. This is the case. Further, on the history screen 218, the background color or shape of the mark corresponding to the day on which information such as information on remaining medicine or information on side effects is excluded, excluding information on the presence or absence of medication, etc. Displayed in shape.
 ところで、服用開始日、服用終了日、及び服用時期(朝食前、昼食後など)などを含む前記配薬データ又は前記処方データが前記配薬支援装置5に入力されている場合、前記制御部51は、前記履歴画面218において、患者各々に対応する服用の要否予定を表示することが考えられる。なお、前述したように、前記配薬データ又は前記処方データは、例えば前記調剤支援装置1から入力され、前記USBメモリ19から読み取られ、又は前記薬包81から読み取られる。具体的に、前記制御部51は、服用の必要がある日付に対応する欄に、服用の必要がある旨を示すために予め定められた菱形のマークなどを表示させることが考えられる。また、前記制御部51は、前記履歴画面218において、入居者の外出予定又は外泊予定などのように服用の必要がない予定が先に入力されている場合には、前記履歴画面218において、その予定日に対応する欄に、服用の必要がない予定である旨を示すために予め定められた「外」のマークなどを表示させることが考えられる。 By the way, when the medication distribution data or the prescription data including the medication start date, the medication end date, and the medication time (before breakfast, after lunch, etc.) are input to the medication delivery support device 5, the control unit 51 In the history screen 218, it is conceivable to display a schedule of necessity of taking corresponding to each patient. As described above, the medicine distribution data or the prescription data is input from, for example, the dispensing support device 1, read from the USB memory 19, or read from the medicine package 81. Specifically, it is conceivable that the control unit 51 displays a diamond-shaped mark or the like that is set in advance in order to indicate that it is necessary to take a dose in a column corresponding to a date that needs to be taken. In the history screen 218, when a schedule that does not need to be taken, such as a resident's going-out plan or a plan to stay overnight, is input first in the history screen 218, It may be possible to display a predetermined “outside” mark or the like in a column corresponding to the scheduled date to indicate that it is not necessary to take the drug.
 そして、前記履歴画面218で入居者を選択するための操作が行われると、前記制御部51は、前記履歴画面218に代えて図31に示す履歴画面219を表示させる。図31に示す前記履歴画面219では、選択された入居者が服薬した薬品各々の履歴が1日単位で表示される。また、前記履歴画面219では、最下段に「その他の情報」の表示欄が設けられており、その表示欄では、残薬の情報又は副作用の情報などの情報が記録されている日に「○」が記載される。そして、前記制御部51は、「その他の情報」の表示欄のうち「○」が記載されている領域が選択された場合、又はその領域に前記操作装置55又は前記携帯端末6の操作ポインターが存在する場合などに、その表示欄に対応する残薬の情報又は副作用の情報などの情報をポップアップで表示させることが考えられる。 Then, when an operation for selecting a resident is performed on the history screen 218, the control unit 51 displays a history screen 219 shown in FIG. 31 instead of the history screen 218. In the history screen 219 shown in FIG. 31, the history of each medicine taken by the selected resident is displayed on a daily basis. In the history screen 219, a display field of “other information” is provided at the bottom. In the display field, “○” is displayed on the day when information such as information on remaining medicine or information on side effects is recorded. Is described. Then, the control unit 51 selects the area where “◯” is written in the “other information” display field, or the operation pointer of the operation device 55 or the mobile terminal 6 is displayed in the area. In the case where it exists, it may be possible to display information such as residual drug information or side effect information corresponding to the display column in a pop-up.
 また、前記履歴画面219で日付が選択されると、前記制御部51は、前記履歴画面219に代えて図32に示す履歴画面220を表示させる。図32に示す前記履歴画面220では、選択された入居者が服薬した薬品各々の履歴が服用時期単位で表示される。なお、前記履歴画面220でも前記履歴画面219と同様に「その他の情報」の表示欄が表示されている。 In addition, when a date is selected on the history screen 219, the control unit 51 displays a history screen 220 shown in FIG. 32 instead of the history screen 219. In the history screen 220 shown in FIG. 32, the history of each medicine taken by the selected resident is displayed in units of taking time. The history screen 220 also displays a display column of “other information” as in the history screen 219.
 なお、前記履歴画面219又は前記履歴画面220で、「その他の情報」の表示欄において残薬の情報が記録されている箇所が選択された場合、前記制御部51は、前記残薬の情報を前記配薬データ記憶部523から読み出して図33に示す履歴画面221に表示させることが考えられる。図33に示す前記履歴画面221では、薬品M1の残薬状況として「2錠」が示されており、薬品M2の残薬状況として「1.5錠×3」が示されている。ここで、前記薬品M2の残薬状況として1.5錠×3の算出結果である「4.5錠」と表示することも考えられるが、前記制御部51は、前記薬品M2の剤形を考慮して「1.5錠×3」と表示する。これにより、前記薬品M2の残薬が4錠及び0.5錠の合計5粒ではなく、1錠及び0.5錠が3組で合計6粒であることが明示され、例えば次の処方データに含まれる処方薬として使用するか否かの判断を容易に行うことが可能である。このため、前記配薬支援装置5において、前記制御部51は、入居者の薬品各々の残薬情報における薬品の残量を調剤時の状態で管理しており、前記調剤支援装置1にも同様の前記残薬情報を送信する。 In addition, when the place where the information of the remaining medicine is recorded in the display column of “other information” on the history screen 219 or the history screen 220, the control unit 51 displays the information of the remaining medicine. It is conceivable to read out from the medicine distribution data storage unit 523 and display it on the history screen 221 shown in FIG. In the history screen 221 shown in FIG. 33, “2 tablets” is shown as the remaining drug status of the medicine M1, and “1.5 tablets × 3” is shown as the remaining drug status of the medicine M2. Here, it may be possible to display “4.5 tablets” which is the calculation result of 1.5 tablets × 3 as the remaining drug status of the medicine M2, but the control unit 51 determines the dosage form of the medicine M2. In consideration, “1.5 tablets × 3” is displayed. As a result, it is clearly shown that the remaining medicine of the medicine M2 is not a total of 5 tablets of 4 tablets and 0.5 tablets, but a total of 6 tablets of 1 tablet and 0.5 tablets, for example, the following prescription data It is possible to easily determine whether or not to use it as a prescription drug included in. For this reason, in the medicine distribution support device 5, the control unit 51 manages the remaining amount of medicine in the remaining medicine information of each resident's medicine in the state at the time of dispensing, and similarly to the dispensing assistance device 1. The remaining drug information is transmitted.
[アラーム機能]
 ところで、前記制御部51は、前記配薬データ記憶部523に記憶される前記配薬データに基づいてアラームを自動的に設定するアラーム機能を有することが考えられる。ここに、図34~図35は、前記配薬データが入力された場合に表示される服薬予定画面の一例を示す図である。
[Alarm function]
By the way, it is conceivable that the control unit 51 has an alarm function for automatically setting an alarm based on the medicine distribution data stored in the medicine distribution data storage unit 523. FIG. 34 to FIG. 35 are diagrams showing an example of a medication schedule screen that is displayed when the medication distribution data is input.
 ここでは、前記薬品分包装置3において前記服用者別分包処理が実行され、一の服用者が服用する薬品が服用時期ごとに一連の前記薬包81に分包された場合に、その最初又は最後の前記薬包81に一次元コード又は二次元コードによって検薬コードが印刷される場合について説明する。ここに、図36は、最初の前記薬包81に検薬コードが印刷された一連の前記薬包81の一例を示す図である。図36に示す例では、最初の前記薬包81に前記検薬コードとして二次元コードが印刷されており、二つ目以後の前記薬包81には、前記第1配薬情報を示す前記コード811として一次元コードが印刷されている。前記検薬コードには、前記薬包81の検薬に必要な予め定められた情報と共に、入居者ID、入居者名称、服用開始日、服用終了日、及び服用時期コードなどの配薬データが含まれる。前記服用時期コードは、前記服用開始日から前記服用終了日の間に服用する必要がある服用時期(朝食前、朝食後、昼食前など)を示す数字又は記号などである。即ち、ここでは、入居者各々に対応する一連の前記薬包81の最初又は最後の前記薬包81の前記検薬コードが読み取られることによって前記入居者各々に対応する前記配薬データが順に前記配薬管理装置5に入力されるものとする。なお、一連の前記薬包81は、そのままの状態で前記薬局A側から前記老健施設B側に配送され、又は、前記薬包81が個別に切り離された状態で前記薬局A側から前記老健施設B側に配送される。 Here, when the medicine-separating device 3 performs the individual-separation processing by the user, and the medicine taken by one user is packaged into a series of the medicine packages 81 at each time of taking, the first Alternatively, a case where a medicine inspection code is printed on the last medicine pack 81 by a one-dimensional code or a two-dimensional code will be described. FIG. 36 is a view showing an example of a series of the medicine packs 81 in which the medicine inspection code is printed on the first medicine package 81. In the example shown in FIG. 36, a two-dimensional code is printed as the drug detection code on the first medicine pack 81, and the code indicating the first medicine distribution information is displayed on the second and subsequent medicine packs 81. A one-dimensional code is printed as 811. The drug inspection code includes pre-determined information necessary for drug inspection of the medicine package 81 and drug distribution data such as a tenant ID, a tenant name, a start date of taking, an end date of taking, and a taking time code. included. The dosing time code is a number or symbol indicating the dosing time (before breakfast, after breakfast, before lunch, etc.) that needs to be taken between the start date of taking and the end date of taking. That is, here, the medicine distribution data corresponding to each resident is sequentially obtained by reading the drug inspection code of the first or last medicine pack 81 of the series of medicine packs 81 corresponding to each resident. It is assumed that it is input to the medicine distribution management device 5. The series of medicine packs 81 are delivered as they are from the pharmacy A side to the health facility B side, or the medicine packages 81 are individually separated from the pharmacy A side to the health facilities. Delivered to B side.
 そして、前記配薬管理装置5において、前記制御部51は、前記薬包81の前記検薬コードから前記配薬データが読み取られた場合に、前記配薬データに基づいて、前記薬包81に対応する入居者の服薬予定を前記データ記憶部52に登録させる。ここで、前記制御部51は、前記配薬データが読み取られたことを確認するための服用予定画面222を、前記配薬データを読み取った前記読取端末7又は前記表示装置54に表示させることが考えられる。また、前記服用予定画面222は、前記携帯端末6及び前記読取端末7などにおいて、服薬予定を確認するための所定のユーザー操作が行われた場合にも前記携帯端末6及び前記読取端末7などに表示される。 And in the said medicine distribution management apparatus 5, when the said medicine distribution data is read from the said test | inspection code | cord | chord of the said medicine package 81, the said control part 51 will be based on the said medicine distribution data to the said medicine package 81. The corresponding medication schedule of the resident is registered in the data storage unit 52. Here, the control unit 51 may display a dosing schedule screen 222 for confirming that the medicine distribution data has been read on the reading terminal 7 or the display device 54 that has read the medicine distribution data. Conceivable. Further, the dosing schedule screen 222 is displayed on the portable terminal 6 and the reading terminal 7 even when a predetermined user operation for confirming a medication schedule is performed on the portable terminal 6 and the reading terminal 7 or the like. Is displayed.
 ここに、図34は、前記服用予定画面222の一例を示す図である。図34に示されているように、前記服用予定画面222の上段には、最後に前記薬包81から読み取られた前記配薬データに対応する入居者の入居者ID、入居者名称、服用開始日、服用終了日などが表示されている。また、前記服用予定画面222には、下段に、既に読み取られて前記データ記憶部52に記憶されている一又は複数の入居者に対応する前記配薬データの一覧が表示されている。なお、前記服用予定画面222において、特定の前記配薬データが選択され、詳細キーが操作されると、前記配薬データに対応する服用予定の詳細が表示される服用詳細画面223が表示される。なお、前記制御部51は、特定の前記配薬データが選択され、削除キーが操作されると、前記配薬データに対応する服薬予定を削除することも可能である。また、前記服用予定画面222の上段に表示される情報は、前記服用予定画面222の下段における前記配薬データの選択に応じてその選択された配薬データに対応する情報に切り換えられてもよい。 FIG. 34 is a diagram showing an example of the dosing schedule screen 222. As shown in FIG. 34, in the upper part of the dosing schedule screen 222, the resident ID, occupant name, and start of taking corresponding to the medicine distribution data read from the medicine pack 81 at the end are displayed. The date, the end date of taking, etc. are displayed. In addition, the medication schedule screen 222 displays a list of the medicine distribution data corresponding to one or a plurality of residents already read and stored in the data storage unit 52 in the lower part. In addition, when the specific medication distribution data is selected on the medication schedule screen 222 and a detail key is operated, a medication detail screen 223 that displays details of the medication schedule corresponding to the medication data is displayed. . In addition, the said control part 51 can also delete the medication schedule corresponding to the said medicine distribution data, when the said specific medicine distribution data is selected and the deletion key is operated. Further, the information displayed on the upper part of the dosing schedule screen 222 may be switched to information corresponding to the selected medicine distribution data according to the selection of the medicine distribution data on the lower part of the dosing schedule screen 222. .
 ここに、図35は、前記服用詳細画面223の一例を示す図である。図35に示されているように、前記服用詳細画面223には、上段に、読み取られた前記配薬データに対応する入居者の入居者ID、入居者名称、服用開始日、服用終了日などが表示されている。また、前記服用詳細画面223には、下段に、1人の入居者に対応する前記配薬データに対応する服用開始日から服用終了日までの服用予定日及び服用時期が表示される。 Here, FIG. 35 is a diagram showing an example of the dosing detail screen 223. As shown in FIG. 35, in the medication detail screen 223, the resident ID, resident name, medication start date, medication end date, etc. of the resident corresponding to the read medicine distribution data are displayed on the upper row. Is displayed. In the lower part of the dosage detail screen 223, the scheduled dosage date and timing from the medication start date to the medication end date corresponding to the medicine distribution data corresponding to one resident are displayed.
 そして、前記制御部51は、前記配薬データが入力されると、前記配薬データに基づいて、前記配薬データに対応する前記入居者の服用時期各々について予め定められたアラーム条件に従って自動的にアラーム時刻を設定するアラーム設定処理を実行する。ここに、係る処理を実行するときの前記制御部51がアラーム設定手段の一例である。具体的に、前記アラーム条件として、服用時期「昼食後」に対応するアラーム時刻が「13時」、服用時期「昼食間」に対応するアラーム時刻が「15時」、服用時期「夕食前」に対応するアラーム時刻が「18時」であることが考えられる。また、前記アラーム条件として、服用時期「昼食後」に対応するアラーム時刻が「12時30分」、服用時期「昼食間」に対応するアラーム時刻が「15時」、服用時期「夕食前」に対応するアラーム時刻が「18時30分」であることが考えられる。 Then, when the medicine distribution data is input, the control unit 51 automatically, based on the medicine distribution data, according to an alarm condition set in advance for each occupant's dosing time corresponding to the medicine distribution data. The alarm setting process for setting the alarm time is executed. The said control part 51 when performing the process which concerns here is an example of an alarm setting means. Specifically, as the alarm condition, the alarm time corresponding to the taking time “after lunch” is “13:00”, the alarm time corresponding to the taking time “between lunch” is “15:00”, and the taking time “before dinner”. It is conceivable that the corresponding alarm time is “18:00”. In addition, as the alarm conditions, the alarm time corresponding to the taking time “after lunch” is “12:30”, the alarm time corresponding to the taking time “between lunch” is “15:00”, and the taking time “before dinner”. It is conceivable that the corresponding alarm time is “18:30”.
 その後、前記制御部51は、前記アラーム設定処理によって設定された前記服用時期各々の前記アラーム時刻に、当該服用時期に対応する服用完了が入力されていない場合、当該服用時期の服用を促すメッセージ等を前記携帯端末6、前記読取端末7、又は前記配薬支援装置5の表示装置54などに表示させるアラーム報知処理を実行する。ここに、係る処理を実行するときの前記制御部51がアラーム報知手段の一例である。これにより、前記入居者各々について前記服用時期各々における服用漏れが抑制される。なお、前記アラーム報知処理の内容は表示に限らず、例えば音声などによる報知であってもよい。また、前記制御部51は、前記メッセージ等を表示する際、前記服用完了が入力されていない患者の一覧を表示させること、又は前記服用完了が入力されていない患者ごとに順にメッセージ等を表示させることが考えられる。 Thereafter, when the completion of taking corresponding to the taking time is not inputted at the alarm time of each taking time set by the alarm setting process, the control unit 51 urges the taking of the taking time, etc. Is displayed on the portable terminal 6, the reading terminal 7, or the display device 54 of the medicine distribution support device 5 or the like. The said control part 51 when performing the process which concerns here is an example of an alarm alerting | reporting means. Thereby, the omission leak in each said dosing time is suppressed about each said resident. The content of the alarm notification process is not limited to display, but may be notification by voice, for example. In addition, when displaying the message or the like, the control unit 51 displays a list of patients whose dosing completion has not been input, or displays a message or the like in order for each patient whose dosing completion has not been input. It is possible.
 そして、前記制御部51は、前記アラーム時刻に前記アラーム報知処理を実行した後、その報知の対象であった前記服用時期の服用が行われなかったと判断した場合、前記服用時期の服用を未服用として前記データ記憶部52に記録する。これにより、前記制御部51は、前記服用予定画面222が表示される場合、前記未服用の服用時期に該当する欄に「×」のマークを表示させる。例えば、前記制御部51は、前記アラーム報知処理の実行後、予め設定された所定時間内に前記服用時期に対応する前記コード情報811が読み取られなかった場合、又は前記服用時期における服用が不要である旨の操作が行われた場合に、前記服用時期の服用が行われなかったと判断する。また、前記制御部51が、前記服用完了が入力されていない患者の一覧が表示された状態で配薬対象を順に移動させる場合には、現在の配薬対象の患者とは異なる患者に対応する前記コード情報811が読み取られた場合に、現在の配薬対象の患者の服用が行われなかったと判断することも考えられる。なお、前記制御部51は、患者の一覧が表示された状態で配薬対象を順に移動させる場合、現在の配薬対象の患者に対応する前記コード情報811が読み取られた場合に、当該患者の服用が行われたと判断し、次の患者を配薬対象として選択する。同じく、前記制御部51が、前記服用完了が入力されていない患者ごとに順にメッセージ等を表示させる場合には、現在表示中のメッセージ等に対応する患者とは異なる患者に対応する前記コード情報811が読み取られた場合に、表示中のメッセージ等に対応する患者の服用が行われなかったと判断することも考えられる。なお、前記制御部51は、患者ごとに対応するメッセージ等を順に表示させる場合、現在表示中のメッセージ等に対応する患者の前記コード情報811が読み取られた場合に、当該患者の服用が行われたと判断し、次の患者に対応する前記メッセージ等を表示させる。 And after the said control part 51 performs the said alarm alerting | reporting process at the said alarm time, when it is judged that the taking of the said taking time which was the object of the notice was not performed, it has not taken the taking of the said taking time Is recorded in the data storage unit 52. Accordingly, when the planned dosing screen 222 is displayed, the control unit 51 displays a “x” mark in a column corresponding to the non-dosing time. For example, the control unit 51 does not need to take the code information 811 corresponding to the dosing time within a predetermined time after execution of the alarm notification process or when the code information 811 corresponding to the dosing time is not read. When a certain operation is performed, it is determined that the dose at the dose time has not been taken. Moreover, when the said control part 51 moves a drug distribution object in order in the state in which the list of the patients whose dosing completion is not input is displayed, it respond | corresponds to a patient different from the patient of the current drug distribution object. When the code information 811 is read, it may be determined that the current patient to be dispensed has not been taken. In addition, when the said control part 51 moves a drug distribution object in the state where the list of patients is displayed, when the said code information 811 corresponding to the patient of the current drug distribution object is read, the said patient's list is displayed. It is determined that the dose has been taken, and the next patient is selected as a drug distribution target. Similarly, when the control unit 51 sequentially displays a message or the like for each patient for which the completion of taking is not input, the code information 811 corresponding to a patient different from the patient corresponding to the currently displayed message or the like. It is also possible to determine that the patient corresponding to the displayed message or the like has not been taken. In addition, when the control unit 51 displays messages corresponding to each patient in order, when the code information 811 of the patient corresponding to the currently displayed message or the like is read, the patient is taken. The message or the like corresponding to the next patient is displayed.
1 :調剤支援装置
11:制御部
12:データ記憶部
2 :読取端末
3 :薬品分包装置
31:制御部
32:分包プリンタ
4 :プリンタ
5 :配薬支援装置
51:制御部
52:データ記憶部
6 :携帯端末
61:制御部
62:カメラ
7 :読取端末
81:薬包(分包容器の一例)
82:薬袋(配送容器の一例)
10:配薬支援システム
100:配薬支援システム
1: Dispensing support device 11: Control unit 12: Data storage unit 2: Reading terminal 3: Drug packaging device 31: Control unit 32: Packaging printer 4: Printer 5: Drug distribution support device 51: Control unit 52: Data storage Unit 6: portable terminal 61: control unit 62: camera 7: reading terminal 81: medicine package (an example of a packaging container)
82: Medicine bag (an example of a delivery container)
10: Drug distribution support system 100: Drug distribution support system

Claims (21)

  1.  一の服用者が服用する薬品を服用時期ごとに分包する際に用いられる分包容器又は前記分包容器に付される第1記録媒体に、前記服用時期及び予め定められた配送先識別情報を含む第1配薬情報を記録する第1記録手段と、
     予め定められた配薬グループに属する複数の服用者の前記分包容器を同一服用時期ごとに収容する際に用いられる配送容器又は前記配送容器に付される第2記録媒体に、前記服用時期及び予め定められた配送先識別情報を含む第2配薬情報を記録する第2記録手段と、
     前記分包容器又は前記第1記録媒体から読み取られる前記第1配薬情報の前記服用時期及び前記配送先識別情報と前記配送容器又は前記第2記録媒体から読み取られる前記第2配薬情報の前記服用時期及び前記配送先識別情報とが一致するか否かを判定する判定手段と、
     を備える配薬支援システム。
    The taking time and predetermined delivery destination identification information on a packaging container used when packaging a medicine taken by one user at every taking time or a first recording medium attached to the packaging container First recording means for recording first medicine distribution information including:
    A delivery container used when storing the packaging containers of a plurality of users belonging to a predetermined medicine distribution group at the same dosage time or a second recording medium attached to the delivery container, the dosage time and A second recording means for recording second medicine information including predetermined delivery destination identification information;
    The dosing time of the first medicine distribution information read from the packaging container or the first recording medium, the delivery destination identification information, and the second medicine distribution information read from the delivery container or the second recording medium. Determination means for determining whether or not the dosing time and the delivery destination identification information match;
    A drug distribution support system comprising:
  2.  前記判定手段の判定結果を報知する第1報知手段を更に備える請求項1に記載の配薬支援システム。 The medicine distribution support system according to claim 1, further comprising first notification means for notifying a determination result of the determination means.
  3.  前記判定手段が、同一の前記配送容器に収容される前記分包容器として予め定められた全ての前記分包容器又は前記分包容器の前記第1記録媒体から前記第1配薬情報が読み取られたか否かを更に判定する請求項1又は2に記載の配薬支援システム。 The determination means reads the first medicine distribution information from all the packaging containers predetermined as the packaging containers accommodated in the same delivery container or the first recording medium of the packaging containers. The medicine distribution support system according to claim 1 or 2 which further determines whether or not.
  4.  前記判定手段が、同一の前記配送先識別情報に対応する配送先に同時に配送される前記配送容器として予め定められた全ての前記配送容器又は前記配送容器の前記第2記録媒体から前記第2配薬情報が読み取られたか否かを更に判定する請求項1~3のいずれかに記載の配薬支援システム。 The determination means includes all the delivery containers predetermined as delivery containers to be delivered simultaneously to delivery destinations corresponding to the same delivery destination identification information or the second delivery medium from the second recording medium of the delivery containers. The drug distribution support system according to any one of claims 1 to 3, further determining whether or not drug information has been read.
  5.  前記第1配薬情報に、前記服用者の服用者識別情報が含まれており、
     前記服用者識別情報に対応する前記服用者各々の顔画像が記憶される記憶手段と、
     前記分包容器から前記第1配薬情報が読み取られた場合に前記第1配薬情報の前記服用者識別情報に対応する前記服用者の顔画像を前記記憶手段から読み出して表示する表示制御手段と、
     を更に備える請求項1~4のいずれかに記載の配薬支援システム。
    The first medication information includes the user identification information of the user,
    Storage means for storing a face image of each of the users corresponding to the user identification information;
    Display control means for reading out and displaying the face image of the user corresponding to the user identification information of the first medicine information from the storage means when the first medicine information is read from the packaging container When,
    The drug distribution support system according to any one of claims 1 to 4, further comprising:
  6.  前記配送先において前記配送容器から読み取られる前記第2配薬情報の前記配送先識別情報と前記配送先に対応する前記配送先識別情報とが一致するか否かを判定する配送先判定手段と、
     前記配送先判定手段による判定結果を報知する第2報知手段と、
     を更に備える請求項1~5のいずれかに記載の配薬支援システム。
    A delivery destination determination means for determining whether the delivery destination identification information of the second medicine distribution information read from the delivery container at the delivery destination matches the delivery destination identification information corresponding to the delivery destination;
    Second notifying means for notifying the determination result by the delivery destination determining means;
    The drug distribution support system according to any one of claims 1 to 5, further comprising:
  7.  薬品を服用時期ごとに分包容器に分包する際に用いられる処方データに基づいて、前記分包容器に分包された薬品の服用時期及び服用者の情報を含む配薬データを出力可能な配薬データ出力手段を有する薬局側端末と、
     複数の服用者に対応する複数の前記分包容器が配送される配送先で使用可能であり、前記薬局側端末から出力された前記配薬データを入力可能な配薬データ入力手段を有する施設側端末と、
     を備える請求項1~6のいずれかに記載の配薬支援システム。
    Based on the prescription data used when the medicine is packaged in the packaging container at every time of taking the medicine, it is possible to output the medicine distribution data including the time of taking the medicine packed in the packaging container and the information of the user. A pharmacy side terminal having medicine distribution data output means;
    Facility side having medicine distribution data input means that can be used at a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered and can input the medicine distribution data output from the pharmacy side terminal A terminal,
    A drug distribution support system according to any one of claims 1 to 6.
  8.  薬品を服用時期ごとに分包容器に分包する際に用いられる処方データに基づいて、前記分包容器に分包された薬品の服用時期及び服用者の情報を含む配薬データを出力可能な配薬データ出力手段を有する薬局側端末と、
     複数の服用者に対応する複数の前記分包容器が配送される配送先で使用可能であり、前記薬局側端末から出力された前記配薬データを入力可能な配薬データ入力手段を有する施設側端末と、
     を備える配薬支援システム。
    Based on the prescription data used when the medicine is packaged in the packaging container at every time of taking the medicine, it is possible to output the medicine distribution data including the time of taking the medicine packed in the packaging container and the information of the user. A pharmacy side terminal having medicine distribution data output means;
    Facility side having medicine distribution data input means that can be used at a delivery destination to which a plurality of the packaging containers corresponding to a plurality of users are delivered and can input the medicine distribution data output from the pharmacy side terminal A terminal,
    A drug distribution support system comprising:
  9.  前記施設側端末が、前記配薬データ入力手段により入力された前記配薬データに基づいて前記服用者各々と前記服用時期各々との関係を表示させる処方表示手段を更に備える請求項7又は8に記載の配薬支援システム。 The said facility side terminal is further equipped with the prescription display means to display the relationship between each said user and each said taking time based on the said medicine distribution data input by the said medicine distribution data input means. The described medication distribution support system.
  10.  前記処方表示手段が、前記服用時期を選択するための第1表示画面を前記配薬データに基づいて表示する第1表示処理手段と、前記第1選択画面における前記服用時期の選択に応じて前記服用時期における前記服用者各々の配薬の要否を表示する第2表示画面を表示する第2表示処理手段と、を含む請求項9に記載の配薬支援システム。 The prescription display means displays a first display screen for selecting the dosing time based on the medicine distribution data, and according to the selection of the dosing time on the first selection screen The medicine distribution support system according to claim 9, further comprising: a second display processing unit that displays a second display screen that displays whether or not each user needs to dispense medicine at the time of taking the medicine.
  11.  前記第2表示処理手段が、予め定められた複数の服用者を含む配薬グループごとに前記第2表示画面を表示可能である請求項10に記載の配薬支援システム。 The medicine distribution support system according to claim 10, wherein the second display processing means can display the second display screen for each medicine distribution group including a plurality of predetermined users.
  12.  前記第1表示処理手段が、前記第1表示画面において前記服用時期各々の配薬の要否を表示する請求項10又は11に記載の配薬支援システム。 The medicine distribution support system according to claim 10 or 11, wherein the first display processing means displays the necessity of medicine distribution at each of the dose times on the first display screen.
  13.  前記第2表示処理手段が、前記服薬者の服薬の状況を予め設定された表示形態で表示する請求項10~12のいずれかに記載の配薬支援システム。 The medicine distribution support system according to any one of claims 10 to 12, wherein the second display processing means displays the medication status of the medication recipient in a preset display form.
  14.  前記施設側端末が、前記第2表示画面に表示された前記服用者ごとの服薬完了の入力操作を受け付ける服薬完了入力手段を更に備える請求項10~13のいずれかに記載の配薬支援システム。 The medication distribution support system according to any one of claims 10 to 13, wherein the facility terminal further includes a medication completion input means for accepting an input operation of medication completion for each user displayed on the second display screen.
  15.  前記施設側端末が、前記服用者が服用しなかった残薬に関する残薬情報の入力操作を受け付けると共に、前記残薬情報を出力可能な残薬情報出力手段を更に備える請求項7~14のいずれかに記載の配薬支援システム。 The left side information output means which can receive the remaining medicine information input operation which the facility side terminal receives the remaining medicine information about the remaining medicine which the user has not taken, and further outputs the remaining medicine information. The drug distribution support system described in Crab.
  16.  前記薬局側端末が、前記残薬情報出力手段から出力された前記残薬情報を入力可能な残薬情報入力手段と、前記残薬情報入力手段により入力された前記残薬情報と前記配薬データとに基づいて使用可能な残薬の情報を通知可能な残薬通知手段と、を更に備える請求項15に記載の配薬支援システム。 The pharmacy side terminal can input the remaining medicine information output from the remaining medicine information output means, the remaining medicine information input by the remaining medicine information input means and the medicine distribution data The medicine distribution support system according to claim 15, further comprising: a remaining medicine notification means capable of notifying information on a remaining medicine that can be used based on the information.
  17.  前記薬局側端末が、前記配薬データを予め定められた複数の服用者を含む配薬グループの単位で出力可能である請求項7~16のいずれかに記載の配薬支援システム。 The drug distribution support system according to any one of claims 7 to 16, wherein the pharmacy side terminal can output the drug distribution data in units of a drug distribution group including a plurality of predetermined users.
  18.  前記薬局側端末が、前記処方データのうち予め設定された一又は複数の項目を抽出して前記配薬データとして出力可能である請求項7~17のいずれかに記載の配薬支援システム。 The medicine distribution support system according to any one of claims 7 to 17, wherein the pharmacy side terminal can extract one or a plurality of preset items from the prescription data and output it as the medicine distribution data.
  19.  前記配薬データに、前記薬品の副作用に関する情報が含まれる請求項7~18のいずれかに記載の配薬支援システム。 The drug distribution support system according to any one of claims 7 to 18, wherein the drug distribution data includes information on side effects of the drug.
  20.  前記施設側端末が、前記服用時期各々について予め設定されたアラーム時刻に報知を行うアラーム報知処理を実行するアラーム報知手段を更に備える請求項7~19のいずれかに記載の配薬支援システム。 The drug distribution support system according to any one of claims 7 to 19, further comprising alarm notification means for executing an alarm notification process in which the facility-side terminal performs notification at an alarm time set in advance for each of the dose times.
  21.  前記施設側端末が、前記服用時期各々について前記アラーム時刻を予め定められたアラーム条件に従って自動的に設定するアラーム設定処理を実行するアラーム設定手段を更に備える請求項20に記載の配薬支援システム。 21. The medicine distribution support system according to claim 20, further comprising alarm setting means for executing an alarm setting process in which the facility-side terminal automatically sets the alarm time according to a predetermined alarm condition for each of the dose times.
PCT/JP2014/077934 2013-10-22 2014-10-21 Drug distribution assistance system WO2015060296A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015509241A JP5773104B1 (en) 2013-10-22 2014-10-21 Drug distribution support system

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013219686 2013-10-22
JP2013-219686 2013-10-22
JP2014-050034 2014-03-13
JP2014050034 2014-03-13

Publications (1)

Publication Number Publication Date
WO2015060296A1 true WO2015060296A1 (en) 2015-04-30

Family

ID=52992890

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/077934 WO2015060296A1 (en) 2013-10-22 2014-10-21 Drug distribution assistance system

Country Status (2)

Country Link
JP (6) JP5773104B1 (en)
WO (1) WO2015060296A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017033107A (en) * 2015-07-29 2017-02-09 株式会社湯山製作所 Dispensing support system
JP2017045372A (en) * 2015-08-28 2017-03-02 東日本メディコム株式会社 Medicine-taking management system, medicine-taking management method and program
JP2018023451A (en) * 2016-08-08 2018-02-15 株式会社湯山製作所 Drug delivery support system and collation control program
JP2018050936A (en) * 2016-09-28 2018-04-05 株式会社湯山製作所 Pharmaceutical sorting device and pharmaceutical sorting system
JP2018175297A (en) * 2017-04-11 2018-11-15 株式会社湯山製作所 Medicine arrangement confirming system, medicine arrangement confirming method, and medicine arrangement confirming program
JP2020110233A (en) * 2019-01-08 2020-07-27 株式会社Windy Method for collecting respective medicine storage parts for specific date or each medicine taking date or each medicine taking number from medicine calendars for a plurality of patients so as to traverse a plurality of patients and tool for separating and collecting storage parts of medicine calender
JP2020121220A (en) * 2016-08-08 2020-08-13 株式会社湯山製作所 Drug delivery support system and collation control program
WO2020209414A1 (en) * 2019-04-11 2020-10-15 주식회사 에버정보기술 Face recognition-based smart dispenser using image sensor
WO2020241333A1 (en) 2019-05-30 2020-12-03 富士フイルム富山化学株式会社 Medicine management system
JP2021164698A (en) * 2020-05-21 2021-10-14 株式会社湯山製作所 Drug distribution support system and drug distribution support method
JP7389396B2 (en) 2021-07-06 2023-11-30 株式会社湯山製作所 Drug distribution support system, drug distribution support method

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6144392B1 (en) * 2015-12-15 2017-06-07 クラリオン株式会社 Medication support system and medication support method
JP6830974B2 (en) * 2019-03-05 2021-02-17 株式会社Epark Information processing equipment, methods and programs
JP7332854B2 (en) * 2019-04-15 2023-08-24 株式会社湯山製作所 Medication support system, Medication support program

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005211601A (en) * 2004-02-02 2005-08-11 E-F Net Co Ltd Medicine-storing container, medicine management system and medicine management method
JP2005254170A (en) * 2004-03-12 2005-09-22 Toshiba Tec Corp Delivery sorting device and destination collating system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003323497A (en) * 2002-04-30 2003-11-14 Moss Institute Co Ltd Administration control system, information processor, and method and program for controlling administration
JP2004103001A (en) * 2002-08-20 2004-04-02 Yuyama Manufacturing Co Ltd Medication management system
JP2004094363A (en) * 2002-08-29 2004-03-25 Japan Radio Co Ltd Portable patient order information confirmation device
JP2004280149A (en) * 2003-03-12 2004-10-07 Toshiba Tec Corp Prescription drug delivery management system and prescription drug delivery management method
WO2005017792A1 (en) * 2003-08-13 2005-02-24 Yuyama Mfg. Co., Ltd. Medication management system
JP2006285973A (en) * 2005-03-09 2006-10-19 Fujimoto Corporation:Kk Drug management system and drug management method using it
JP2005342527A (en) 2005-07-07 2005-12-15 Yuyama Manufacturing Co Ltd Drug packaging apparatus
JP2007026253A (en) * 2005-07-20 2007-02-01 Seiko Epson Corp Dosing management system, control method of dosing management system, and program thereof
JP2009031889A (en) * 2007-07-25 2009-02-12 Aruze Corp Medical service provision system
JP2009125386A (en) * 2007-11-26 2009-06-11 Mythos:Kk Medication alarm system
KR20100025252A (en) * 2008-08-27 2010-03-09 한국전자통신연구원 Medication management system, apparatus for supporting medication and method for supporting medication in the apparatus
JP5817178B2 (en) * 2011-03-30 2015-11-18 富士通株式会社 Medication management system, method of providing medication management service, and medication management program

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005211601A (en) * 2004-02-02 2005-08-11 E-F Net Co Ltd Medicine-storing container, medicine management system and medicine management method
JP2005254170A (en) * 2004-03-12 2005-09-22 Toshiba Tec Corp Delivery sorting device and destination collating system

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017033107A (en) * 2015-07-29 2017-02-09 株式会社湯山製作所 Dispensing support system
JP2017045372A (en) * 2015-08-28 2017-03-02 東日本メディコム株式会社 Medicine-taking management system, medicine-taking management method and program
JP2018023451A (en) * 2016-08-08 2018-02-15 株式会社湯山製作所 Drug delivery support system and collation control program
JP2020121220A (en) * 2016-08-08 2020-08-13 株式会社湯山製作所 Drug delivery support system and collation control program
JP2018050936A (en) * 2016-09-28 2018-04-05 株式会社湯山製作所 Pharmaceutical sorting device and pharmaceutical sorting system
JP2021164716A (en) * 2017-04-11 2021-10-14 株式会社湯山製作所 Medicine delivery confirmation system
JP2018175297A (en) * 2017-04-11 2018-11-15 株式会社湯山製作所 Medicine arrangement confirming system, medicine arrangement confirming method, and medicine arrangement confirming program
JP7161682B2 (en) 2017-04-11 2022-10-27 株式会社湯山製作所 Drug placement confirmation system
JP2020110233A (en) * 2019-01-08 2020-07-27 株式会社Windy Method for collecting respective medicine storage parts for specific date or each medicine taking date or each medicine taking number from medicine calendars for a plurality of patients so as to traverse a plurality of patients and tool for separating and collecting storage parts of medicine calender
KR20200120778A (en) * 2019-04-11 2020-10-22 주식회사 에버정보기술 Smart dispenser based facial recognition using image sensor
KR102185492B1 (en) 2019-04-11 2020-12-03 주식회사 에버정보기술 Smart dispenser based facial recognition using image sensor
WO2020209414A1 (en) * 2019-04-11 2020-10-15 주식회사 에버정보기술 Face recognition-based smart dispenser using image sensor
WO2020241333A1 (en) 2019-05-30 2020-12-03 富士フイルム富山化学株式会社 Medicine management system
CN113874304A (en) * 2019-05-30 2021-12-31 富士胶片富山化学株式会社 Drug administration system
US11707415B2 (en) 2019-05-30 2023-07-25 Fujifilm Toyama Chemical Co., Ltd. Medicine management system
JP2021164698A (en) * 2020-05-21 2021-10-14 株式会社湯山製作所 Drug distribution support system and drug distribution support method
JP7389396B2 (en) 2021-07-06 2023-11-30 株式会社湯山製作所 Drug distribution support system, drug distribution support method

Also Published As

Publication number Publication date
JP2021007044A (en) 2021-01-21
JP6777175B2 (en) 2020-10-28
JP2019071135A (en) 2019-05-09
JP2023083370A (en) 2023-06-15
JP7381979B2 (en) 2023-11-16
JP5773104B1 (en) 2015-09-02
JP2022058870A (en) 2022-04-12
JPWO2015060296A1 (en) 2017-03-09
JP2015187840A (en) 2015-10-29
JP7417134B2 (en) 2024-01-18
JP7024841B2 (en) 2022-02-24
JP6476973B2 (en) 2019-03-06

Similar Documents

Publication Publication Date Title
JP7024841B2 (en) Drug distribution support system
JP7147939B2 (en) Medication support system
US20140156064A1 (en) Techniques to deliver multiple medications in a synchronized manner
JP6123526B2 (en) Dispensing management system, dispensing management method, dispensing management program
JP6144392B1 (en) Medication support system and medication support method
JP2006092197A (en) Medicine management system and reader used for medicine management system
JP6304422B2 (en) Dispensing management system, dispensing management program
KR101058813B1 (en) Pharmacy Control System
JP6766513B2 (en) Drug delivery support system, collation control program
JP7311747B2 (en) Medication Guidance Support System, Medication Guidance Support Program
US20200160959A1 (en) Drug dispensing device, control program for drug dispensing device, and recording medium with recorded control program
JP2021164698A (en) Drug distribution support system and drug distribution support method
JP7339583B2 (en) Medicine distribution support system, medicine distribution support method
JP7389396B2 (en) Drug distribution support system, drug distribution support method
JP6911975B2 (en) Drug delivery support system, collation control program
JP7436780B2 (en) Packaging data generation device, packaging system, number of packages determining device, limit date determining device, and packaging data generation program
JP2021132902A (en) Medicine taking support system, medicine taking support method, and medicine taking support program
JP2021069914A (en) Preparation support system
JP2005242637A (en) Medicine sale permission decision method, program, and apparatus
JP2020177263A (en) Medicine delivery support system, and medicine delivery support program
JP2020144535A (en) Information processor, method and program

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2015509241

Country of ref document: JP

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14855302

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14855302

Country of ref document: EP

Kind code of ref document: A1